PT J
AU Yousef, GG
   Brown, AF
   Funakoshi, Y
   Mbeunkui, F
   Grace, MH
   Ballington, JR
   Loraine, A
   Lila, MA
AF Yousef, Gad G.
   Brown, Allan F.
   Funakoshi, Yayoi
   Mbeunkui, Flaubert
   Grace, Mary H.
   Ballington, James R.
   Loraine, Ann
   Lila, Mary A.
TI Efficient Quantification of the Health-Relevant Anthocyanin and Phenolic Acid Profiles in Commercial Cultivars and Breeding Selections of Blueberries (Vaccinium spp.)
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE anthocyanins; chlorogenic acid; blueberry; HPLC-DAD-MS; Vaccinium spp.; freeze-drying; health benefits
ID antioxidant capacity; storage; identification; hplc; absorption; extraction; flavonoids; obese; fruit; men
AB Anthocyanins and phenolic acids are major secondary metabolites in blueberry with important implications for human health maintenance. An improved protocol was developed for the accurate, efficient, and rapid comparative screening for large blueberry sample sets. Triplicates of six commercial cultivars and four breeding selections were analyzed using the new method. The compound recoveries ranged from 94.2 to 97.5 +/- 5.3% when samples were spiked with commercial standards prior to extraction. Eighteen anthocyanins and 4 phenolic acids were quantified in frozen and freeze-dried fruits. Large variations for individual and total anthocyanins, ranging from 201.4 to 402.8 mg/100 g, were assayed in frozen fruits. The total phenolic acid content ranged from 23.6 to 61.7 mg/100 g in frozen fruits. Across all genotypes, freeze-drying resulted in minor reductions in anthocyanin concentration (3.9%) compared to anthocyanins in frozen fruits. However, phenolic acids increased by an average of 1.9-fold (+/- 0.3) in the freeze-dried fruit. Different genotypes frequently had comparable overall levels of total anthocyanins and phenolic acids, but differed dramatically in individual profiles of compounds. Three of the genotypes contained markedly higher concentrations of delphinidin 3-O-glucoside, cyanidin 3-O-glucoside, and malvidin 3-0-glucoside, which have previously been implicated as bioactive principles in this fruit The implications of these findings for human health benefits are discussed.
C1 [Yousef, Gad G.; Brown, Allan F.] N Carolina State Univ, Dept Hort Sci, Kannapolis, NC 28081 USA.
   [Yousef, Gad G.; Funakoshi, Yayoi; Mbeunkui, Flaubert; Grace, Mary H.; Lila, Mary A.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Plants Human Hlth Inst, Kannapolis, NC 28081 USA.
   [Ballington, James R.] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA.
   [Loraine, Ann] N Carolina State Univ, Dept Bioinformat & Genom, Kannapolis, NC 28081 USA.
C3 North Carolina State University; North Carolina State University; North Carolina State University; North Carolina State University
RP Lila, MA (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Plants Human Hlth Inst, North Carolina Res Campus, Kannapolis, NC 28081 USA.
EM mlila@ncsu.edu
FU North Carolina Blueberry Council [50407]; University of North Carolina General Administration Special Allocation for Collaborative Research at the NCRC
CR Barnes JS, 2009, J CHROMATOGR A, V1216, P4728, DOI 10.1016/j.chroma.2009.04.032
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Blanck Heidi Michels, 2008, PREV CHRONIC DIS, V5, P0
   Brownmiller C, 2008, J FOOD SCI, V73, PH72, DOI 10.1111/j.1750-3841.2008.00761.x
   Buckow R, 2010, J AGR FOOD CHEM, V58, P10076, DOI 10.1021/jf1015347
   Connor AM, 2002, J AGR FOOD CHEM, V50, P893, DOI 10.1021/jf011212y
   Connor AM, 2002, ACTA HORTIC, V0, PP209, DOI 10.17660/ActaHortic.2002.574.31
   de Groot H, 1998, FUND CLIN PHARMACOL, V12, P249
   Garcia-Viguera C, 1998, PHYTOCHEM ANALYSIS, V9, P274, DOI 10.1002/(SICI)1099-1565(199811/12)9:6<274::AID-PCA416>3.0.CO;2-G
   Gavrilova V, 2011, J AGR FOOD CHEM, V59, P4009, DOI 10.1021/jf104565y
   González-Gallego J, 2010, BRIT J NUTR, V104, PS15, DOI 10.1017/S0007114510003910
   Grace MH, 2012, J FOOD SCI, V77, PH176, DOI 10.1111/j.1750-3841.2012.02788.x
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Gustafson SJ, 2012, J BERRY RES, V2, P215, DOI 10.3233/JBR-2012-041
   Guzman I, 2012, J AGR FOOD CHEM, V60, P7238, DOI 10.1021/jf302475d
   Häkkinen S, 1999, FOOD RES INT, V32, P345, DOI 10.1016/S0963-9969(99)00095-2
   HASEGAWA S, 1966, J AGR FOOD CHEM, V14, P165, DOI 10.1021/jf60144a020
   Ishiguro K, 2007, J AGR FOOD CHEM, V55, P10773, DOI 10.1021/jf072256v
   JACKMAN RL, 1987, J FOOD BIOCHEM, V11, P201, DOI 10.1111/j.1745-4514.1987.tb00123.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kader F, 1996, FOOD CHEM, V55, P35, DOI 10.1016/0308-8146(95)00068-2
   Kalt W, 1996, J AM SOC HORTIC SCI, V121, P142, DOI 10.21273/JASHS.121.1.142
   Kalt W, 1999, CAN J PLANT SCI, V79, P617, DOI 10.4141/P99-009
   Kalt W, 2001, J AGR FOOD CHEM, V49, P4761, DOI 10.1021/jf010653e
   Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l
   Kellogg J, 2010, J AGR FOOD CHEM, V58, P3884, DOI 10.1021/jf902693r
   Klopotek Y, 2005, J AGR FOOD CHEM, V53, P5640, DOI 10.1021/jf047947v
   Lee J, 2008, FOOD CHEM, V110, P782, DOI 10.1016/j.foodchem.2008.03.010
   Manach C, 2005, AM J CLIN NUTR, V81, P230S, DOI 10.1093/ajcn/81.1.230S
   Martin C, 2011, PLANT CELL, V23, P1685, DOI 10.1105/tpc.111.083279
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   McGhie TK, 2003, J AGR FOOD CHEM, V51, P4539, DOI 10.1021/jf026206w
   McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092
   Padda MS, 2008, SCI HORTIC-AMSTERDAM, V119, P17, DOI 10.1016/j.scienta.2008.07.008
   Prior RL, 1999, J. AM. NUTRIENT ASSOC, V2, P46
   Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d
   Prior RL, 2001, J AGR FOOD CHEM, V49, P1270, DOI 10.1021/jf001211q
   Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522
   Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e
   Serafini M, 1998, J NUTR, V128, P1003, DOI 10.1093/jn/128.6.1003
   SHI ZL, 1992, J FOOD SCI, V57, P755, DOI 10.1111/j.1365-2621.1992.tb08088.x
   Srivastava A, 2007, J AGR FOOD CHEM, V55, P2705, DOI 10.1021/jf062914w
   Stevenson D, 2012, J BERRY RES, V2, P179, DOI 10.3233/JBR-2012-038
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Wojdylo A, 2009, J AGR FOOD CHEM, V57, P1337, DOI 10.1021/jf802507j
   Wu XL, 2005, J AGR FOOD CHEM, V53, P2589, DOI 10.1021/jf048068b
   Yi WG, 2006, J AGR FOOD CHEM, V54, P5651, DOI 10.1021/jf0531959
NR 47
TC 95
Z9 105
U1 4
U2 113
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 22
PY 2013
VL 61
IS 20
BP 4806
EP 4815
DI 10.1021/jf400823s
PG 10
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 152SL
UT WOS:000319551300017
PM 23635035
DA 2025-04-28
ER

PT J
AU Dulloo, AG
AF Dulloo, Abdul G.
TI Translational issues in targeting brown adipose tissue thermogenesis for human obesity management
SO UNDERSTANDING ADIPOGENESIS AND FUNCTIONS OF BROWN FAT
LA English
DT Article; Book Chapter
DE obesity; diabetes; thermogenesis; energy expenditure; fat oxidation; brown fat
ID energy-expenditure; weight-loss; oxygen-consumption; fat oxidation; cold-exposure; green tea; caffeine; metabolism; balance; women
AB The recent advancements in unraveling novel mechanisms that control the induction, (trans) differentiation, proliferation, and thermogenic activity and capacity of brown adipose tissue (BAT), together with the application of imaging techniques for human BAT visualization, have generated optimism that these advances will provide novel strategies for targeting BAT thermogenesis, leading to efficacious and safe obesity therapies. This paper first provides an overview of landmark events of the past few decades that have been driving the search for pharmaceutical and nutraceutical compounds that would increase BAT thermogenesis for obesity management. It then addresses issues about what could be expected from an ideal thermogenic antiobesity approach, in particular to what extent daily energy expenditure will need to increase in order to achieve long-term weight loss currently achievable only through bariatric surgery, and whether the human body will have enough thermogenic capacity to reach this target weight loss by future therapies focused on BAT.
C1 Univ Fribourg, Dept Med Physiol, CH-1700 Fribourg, Switzerland.
C3 University of Fribourg
RP Dulloo, AG (corresponding author), Univ Fribourg, Dept Med Physiol, Chemin Musee 5, CH-1700 Fribourg, Switzerland.
EM abdul.dulloo@unifr.ch
CR AMATRUDA JM, 1993, J CLIN INVEST, V92, P1236, DOI 10.1172/JCI116695
   Arch JRS, 2008, N-S ARCH PHARMACOL, V378, P225, DOI 10.1007/s00210-008-0271-1
   ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Boss Olivier, 2012, FRONT ENDOCRINOL (LAUSANNE), V3, P14, DOI 10.3389/fendo.2012.00014
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROOKS SL, 1980, NATURE, V286, P274, DOI 10.1038/286274a0
   Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483
   Chechi K, 2013, TRENDS ENDOCRIN MET, V24, P408, DOI 10.1016/j.tem.2013.04.002
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   DAVIS TR, 1961, J APPL PHYSIOL, V16, P1011, DOI 10.1152/jappl.1961.16.6.1011
   Dulloo A G, 1987, WORLD REV NUTR DIET, V50, P1
   Dulloo AG, 2012, INT J OBESITY, V36, P1418, DOI 10.1038/ijo.2012.114
   Dulloo AG, 2012, OBES REV, V13, P105, DOI 10.1111/j.1467-789X.2012.01041.x
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   Dulloo AG, 2012, P NUTR SOC, V71, P379, DOI 10.1017/S0029665112000225
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035
   Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003
   FROIDEVAUX F, 1993, AM J CLIN NUTR, V57, P35, DOI 10.1093/ajcn/57.1.35
   Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005
   Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, PC670, DOI 10.1152/ajpcell.2000.279.3.C670
   HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204
   JEQUIER E, 1983, AM J CLIN NUTR, V38, P989, DOI 10.1093/ajcn/38.6.989
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   LANDSBERG L, 1984, AM J PHYSIOL, V247, PE181, DOI 10.1152/ajpendo.1984.247.2.E181
   LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036
   Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487
   Levine J, 1999, NEW ENGL J MED, V341, P2100, DOI 10.1056/NEJM199912303412718
   Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, PR285, DOI 10.1152/ajpregu.00652.2010
   Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737
   MA SWY, 1989, CAN J PHYSIOL PHARM, V67, P376, DOI 10.1139/y89-061
   MA SWY, 1988, CAN J PHYSIOL PHARM, V66, P1347, DOI 10.1139/y88-221
   Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523
   Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220
   Montani JP, 2006, INT J OBESITY, V30, PS58, DOI 10.1038/sj.ijo.0803520
   Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   Pourhassan M, 2013, EUR J CLIN NUTR, V67, P446, DOI 10.1038/ejcn.2013.35
   Rothwell NJ, 1983, P208, V0, P0
   ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530
   Sarafian D, 2013, FRONT PHYSIOL, V4, P0, DOI 10.3389/fphys.2013.00155
   Sjöström L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012
   Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x
   Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   TRAYHURN P, 1982, NATURE, V295, P323, DOI 10.1038/295323a0
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   WEBSTER JD, 1984, HUM NUTR-CLIN NUTR, V38C, P299
   Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
   Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546
NR 59
TC 17
Z9 18
U1 0
U2 17
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
SN 0077-8923
EI 
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PD JUN 15
PY 2013
VL 1302
IS 
BP 1
EP 10
DI 10.1111/nyas.12304
PG 10
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA BHM40
UT WOS:000325920200001
PM 24138104
DA 2025-04-28
ER

PT J
AU Hodgson, AB
   Randell, RK
   Jeukendrup, AE
AF Hodgson, Adrian B.
   Randell, Rebecca K.
   Jeukendrup, Asker E.
TI The Effect of Green Tea Extract on Fat Oxidation at Rest and during Exercise: Evidence of Efficacy and Proposed Mechanisms
SO ADVANCES IN NUTRITION
LA English
DT Review
ID catechol-o-methyltransferase; 24-h energy-expenditure; diet-induced obesity; skeletal-muscle; body-weight; insulin sensitivity; endurance exercise; glucose-tolerance; physical-activity; lipid utilization
AB Green tea is made from the leaves of the Camellia sinensis L plant, which is rich in polyphenol catechins and caffeine. There is increasing interest in the potential role of green tea extract (GTE) in fat metabolism and its influence on health and exercise performance. A number of studies have observed positive effects of GTE on fat metabolism at rest and during exercise, following both shorter and longer term intake. However, overall, the literature is inconclusive. The fact that not all studies observed effects may be related to differences in study designs, GTE bioavailability, and variation of the measurement (fat oxidation). In addition, the precise mechanisms of GTE in the human body that increase fat oxidation are unclear. The often-cited in vitro catechol-O-methyltransferase mechanism is used to explain the changes in substrate metabolism with little in vivo evidence to support it. Also, changes in expression of fat metabolism genes with longer term GTE intake have been implicated at rest and with exercise training, including the upregulation of fat metabolism enzyme gene expression in the skeletal muscle and downregulation of adipogenic genes in the liver. The exact molecular signaling that activates changes to fat metabolism gene expression is unclear but may be driven by PPAR-gamma coactivator 1-alpha and PPARs. However, to date, evidence from human studies to support these adaptations is lacking. Clearly, more studies have to be performed to elucidate the effects of GTE on fat metabolism as well as improve our understanding of the underlying mechanisms. Adv. Nutr. 4: 129-140, 2013.
C1 [Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Edgbaston, England.
C3 University of Birmingham
RP Jeukendrup, AE (corresponding author), Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Edgbaston, England.
EM a.e.jeukendrup@bham.ac.uk
FU Unilever
CR Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005
   Achten J, 2003, INT J SPORTS MED, V24, P603, DOI 10.1055/s-2003-43265
   Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+
   Astrup A, 2011, OBES REV, V12, P859, DOI 10.1111/j.1467-789X.2011.00894.x
   Astrup A, 1999, AM J CLIN NUTR, V69, P1117
   Aura Anna-Marja, 2008, PHYTOCHEMISTRY REVIEWS, V7, P407, DOI 10.1007/s11101-008-9095-3
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2007, J AM COLL NUTR, V26, P389S, DOI 10.1080/07315724.2007.10719627
   Carter J, 2002, EUR J APPL PHYSIOL, V86, P435, DOI 10.1007/s00421-001-0572-2
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Danesi F, 2009, BRIT J NUTR, V101, P1736, DOI 10.1017/S0007114508145871
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Friedrich M, 2011, INT J OBES LOND, V36, P735
   Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270
   Gonzalez JT, 2012, BRIT J NUTR, V107, P339, DOI 10.1017/S0007114511006684
   Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191
   Goodpaster Bret H, 2002, CURR DIAB REP, V2, P216, DOI 10.1007/s11892-002-0086-2
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Harada U, 2004, J HEALTH SCI, V51, P7
   Haramizu S, 2011, J APPL PHYSIOL, V111, P1654, DOI 10.1152/japplphysiol.01434.2010
   Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010
   Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003
   Horowitz JF, 1997, AM J PHYSIOL-ENDOC M, V273, PE768, DOI 10.1152/ajpendo.1997.273.4.E768
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ichinose T, 2011, SCAND J MED SCI SPOR, V21, P598, DOI 10.1111/j.1600-0838.2009.01077.x
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Kim HJ, 2009, PHYTOTHER RES, V23, P467, DOI 10.1002/ptr.2647
   KLEMETSDAL B, 1994, EUR J CLIN PHARMACOL, V46, P231
   Kroon PA, 2004, AM J CLIN NUTR, V80, P15
   Lee Kookkyung, 2004, J VET SCI, V5, P325
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Männistö PT, 1999, PHARMACOL REV, V51, P593
   MCLEOD HL, 1994, J PHARMACOL EXP THER, V270, P26
   Meyer T, 2009, SCAND J MED SCI SPOR, V19, P213, DOI 10.1111/j.1600-0838.2008.00775.x
   Mora-Rodriguez R, 2000, AM J PHYSIOL-ENDOC M, V278, PE669, DOI 10.1152/ajpendo.2000.278.4.E669
   Murase T, 2006, AM J PHYSIOL-REG I, V290, PR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, PR708, DOI 10.1152/ajpregu.00693.2004
   Murase T, 2008, AM J PHYSIOL-REG I, V295, PR281, DOI 10.1152/ajpregu.00880.2007
   Nagai M, 2004, DRUG METAB DISPOS, V32, P497, DOI 10.1124/dmd.32.5.497
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Qin BL, 2010, MOL NUTR FOOD RES, V54, PS14, DOI 10.1002/mnfr.200900306
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Randell R, 2012, MED SCI SPO IN PRESS, V0, P0
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P334, DOI 10.1016/j.yrtph.2004.03.001
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   STRALFORS P, 1983, J BIOL CHEM, V258, P5146
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   TOUBRO S, 1995, INT J OBESITY, V19, P544
   van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004
   Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Weltan SM, 1998, AM J PHYSIOL-ENDOC M, V274, PE83, DOI 10.1152/ajpendo.1998.274.1.E83
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   White MD, 1996, J APPL PHYSIOL, V80, P133, DOI 10.1152/jappl.1996.80.1.133
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089
   Zhu BT, 2001, XENOBIOTICA, V31, P879, DOI 10.1080/00498250110079798
   Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586
   ZURLO F, 1990, AM J PHYSIOL, V259, P0
NR 93
TC 64
Z9 67
U1 0
U2 71
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2161-8313
EI 2156-5376
J9 ADV NUTR
JI Adv. Nutr.
PD MAR 15
PY 2013
VL 4
IS 2
BP 129
EP 140
DI 10.3945/an.112.003269
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 120HJ
UT WOS:000317161100001
PM 23493529
DA 2025-04-28
ER

PT J
AU Moudon, AV
   Drewnowski, A
   Duncan, GE
   Hurvitz, PM
   Saelens, BE
   Scharnhorst, E
AF Moudon, Anne Vernez
   Drewnowski, Adam
   Duncan, Glen E.
   Hurvitz, Philip M.
   Saelens, Brian E.
   Scharnhorst, Eric
TI Characterizing the food environment: pitfalls and future directions
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Census of food sources; Health value; Exposure
ID neighborhood characteristics; store availability; racial composition; physical-activity; weight status; restaurants; association; proximity; obesity; access
AB Objective: To assess a county population's exposure to different types of food sources reported to affect both diet quality and obesity rates. Design: Food permit records obtained from the local health department served to establish the full census of food stores and restaurants. Employing prior categorization schemes which classified the relative healthfulness of food sources based on establishment type (i.e. supermarkets v. convenience stores, or full-service v. fast-food restaurants), food establishments were assigned to the healthy, unhealthy or undetermined groups. Setting: King County, WA, USA. Subjects: Full census of food sources. Results: According to all categorization schemes, most food establishments in King County fell into the unhealthy and undetermined groups. Use of the food permit data showed that large stores, which included supermarkets as healthy food establishments, contained a sizeable number of bakery/delis, fish/meat, ethnic and standard quick-service restaurants and coffee shops, all food sources that, when housed in a separate venue or owned by a different business establishment, were classified as either unhealthy or of undetermined value to health. Conclusions: To fully assess the potential health effects of exposure to the extant food environment, future research would need to establish the health value of foods in many such common establishments as individually owned grocery stores and ethnic food stores and restaurants. Within-venue exposure to foods should also be investigated.
C1 [Moudon, Anne Vernez] Univ Washington, Dept Urban Design & Planning, Seattle, WA 98195 USA.
   [Drewnowski, Adam; Duncan, Glen E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Hurvitz, Philip M.] Univ Washington, Urban Form Lab, Seattle, WA 98195 USA.
   [Saelens, Brian E.] Univ Washington, Div Gen Pediat, Seattle Childrens Res Inst, Seattle, WA 98195 USA.
   [Scharnhorst, Eric] Royal Danish Acad Fine Arts, Sch Architecture, Copenhagen, Denmark.
C3 University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle
RP Moudon, AV (corresponding author), Univ Washington, Dept Urban Design & Planning, Box 3548002, Seattle, WA 98195 USA.
EM moudon@uw.edu
FU TWINStudy of environment, lifestyle behaviors, and health [R01AG042176]; Food environment, diet quality, and disparities in obesity [R01DK076608]; The effect of light rail transit on physical activity: a natural experiment [R01HL091881]
CR Andrews M, 2001, FOODREVIEW, V24, P45
   Apparicio P, 2007, INT J HEALTH GEOGR, V6, P0, DOI 10.1186/1476-072X-6-4
   Ayala GX, 2005, J AM DIET ASSOC, V105, P38, DOI 10.1016/j.jada.2004.10.023
   Bodor JN, 2010, J URBAN HEALTH, V87, P771, DOI 10.1007/s11524-010-9460-6
   Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283
   Brown AF, 2008, J GEN INTERN MED, V23, P1137, DOI 10.1007/s11606-008-0601-5
   Casey AA, 2008, PREV MED, V47, P600, DOI 10.1016/j.ypmed.2008.10.001
   Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x
   Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011
   Dennisuk LA, 2011, AM J PREV MED, V40, P625, DOI 10.1016/j.amepre.2011.02.015
   Duerksen SC, 2007, J AM DIET ASSOC, V107, P849, DOI 10.1016/j.jada.2007.02.012
   Economic Research Service, 2011, BRIEF ROOMS FOOD CON, V0, P0
   Fleischhacker SE, 2011, OBES REV, V12, Pe460, DOI 10.1111/j.1467-789X.2010.00715.x
   Forsyth Ann, 2010, J TRANSP LAND USE, V3, P43
   Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003
   Frank L, 2009, BRIT J SPORT MED, V43, P124, DOI 10.1136/bjsm.2008.055533
   Galvez MP, 2008, PUBLIC HEALTH NUTR, V11, P624, DOI 10.1017/S1368980007001097
   Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567
   GiskeS K, 2007, PREV MED, V45, P41, DOI 10.1016/j.ypmed.2007.04.007
   Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019
   Glanz K, 2009, AM J PREV MED, V36, PS93, DOI 10.1016/j.amepre.2009.01.010
   Hackett A, 2008, J HUM NUTR DIET, V21, P428, DOI 10.1111/j.1365-277X.2008.00894.x
   Han E, 2012, INT J BEHAV NUTR PHY, V9, P0, DOI 10.1186/1479-5868-9-46
   He MZ, 2012, PUBLIC HEALTH NUTR, V15, P2331, DOI 10.1017/S1368980012000584
   Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267
   Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039
   Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014
   Kipke MD, 2007, J ADOLESCENT HEALTH, V40, P325, DOI 10.1016/j.jadohealth.2006.10.021
   Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018
   Larson N, 2009, ANN BEHAV MED, V38, PS56, DOI 10.1007/s12160-009-9120-9
   Latham J, 2007, HEALTH PLACE, V13, P273, DOI 10.1016/j.healthplace.2006.01.006
   Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005
   Lytle LA, 2009, AM J PREV MED, V36, PS134, DOI 10.1016/j.amepre.2009.01.018
   McKinnon RA, 2009, AM J PREV MED, V36, PS124, DOI 10.1016/j.amepre.2009.01.012
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2
   Ohri-Vachaspati P, 2011, AM J HEALTH PROMOT, V26, P116, DOI 10.4278/ajhp.100120-QUAN-21
   Powell LM, 2011, HEALTH PLACE, V17, P1122, DOI 10.1016/j.healthplace.2011.05.010
   Raja S, 2008, J PLAN EDUC RES, V27, P469, DOI 10.1177/0739456X08317461
   Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590
   Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022
   Sharkey JR, 2011, INT J HEALTH GEOGR, V10, P0, DOI 10.1186/1476-072X-10-37
   Sharkey JR, 2009, INT J HEALTH GEOGR, V8, P0, DOI 10.1186/1476-072X-8-9
   Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021
   Sturm R, 2008, PUBLIC HEALTH, V122, P681, DOI 10.1016/j.puhe.2007.09.004
   US Census Bureau, 2007, N AM IND CLASS SYST, V0, P0
   US Department of Agriculture, 2010, FOOD MARK SYST US FO, V0, P0
   VerPloeg M, 2009, ACCESS AFFORDABLE NU, V0, P0
   Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013
   Wang MC, 2008, PUBLIC HEALTH NUTR, V11, P963, DOI 10.1017/S136898000700105X
   Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680
   Wrigley N, 2003, ENVIRON PLANN A, V35, P151, DOI 10.1068/a35150
   Zenk SN, 2006, ETHNIC DIS, V16, P275
   Zenk SN, 2005, AM J PREV MED, V29, P1, DOI 10.1016/j.amepre.2005.03.002
   Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150
NR 56
TC 39
Z9 45
U1 0
U2 28
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUL 15
PY 2013
VL 16
IS 7
BP 1238
EP 1243
DI 10.1017/S1368980013000773
PG 6
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 153PO
UT WOS:000319614800011
PM 23570695
DA 2025-04-28
ER

PT J
AU Soga, S
   Ota, N
   Shimotoyodome, A
AF Soga, Satoko
   Ota, Noriyasu
   Shimotoyodome, Akira
TI Stimulation of Postprandial Fat Utilization in Healthy Humans by Daily Consumption of Chlorogenic Acids
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE fat utilization; energy expenditure; indirect calorimetry; human; chlorogenic acid
ID diet-induced obesity; green tea; coffee consumption; energy-expenditure; body-fat; risk; catechins; oxidation; glucose; combination
AB Long-term ingestion of coffee polyphenols (chlorogenic acids, CGAs) reduces body fat in humans and rodents. While CGA supplementation has been shown to increase fat utilization in rodents, evidence in humans is still limited. The present study clarifies the effect of daily CGA consumption on energy metabolism in humans. Eighteen healthy male subjects (36.1 +/- 7.4 y of age) participated in a placebo-controlled, double-blind, crossover, intervention study with two different test beverages. The subjects consumed 185 mL of a test beverage with or without CGAs (329 mg) daily for 4 wk. The energy metabolism was evaluated by using indirect calorimetry before and after the test period during fasting and up to 180 min postprandially. Indirect calorimetry showed that a 4-wk ingestion of the CGA beverage led to a significantly higher postprandial energy expenditure than that of the control beverage. The subjects ingesting the CGA beverage exhibited higher postprandial fat utilization than those consuming the control beverage. The daily CGA consumption therefore increased postprandial fat utilization in healthy humans.
C1 [Soga, Satoko; Ota, Noriyasu; Shimotoyodome, Akira] Kao Corp, Biol Sci Res, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Shimotoyodome, A (corresponding author), Kao Corp, Biol Sci Res, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM shimotoyodome.akira@kao.co.jp
CR Unknown -, 2006, BMC COMPLEM ALTERN M, V0, P0
   Unknown -, 2009, JPN PHARN ACOL THER, V0, P0
   Arts ICW, 2005, AM J CLIN NUTR, V81, P317S, DOI 10.1093/ajcn/81.1.317S
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Giovannucci E, 1998, AM J EPIDEMIOL, V147, P1043, DOI 10.1093/oxfordjournals.aje.a009398
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155
   Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Murase T, 2006, AM J PHYSIOL-REG I, V290, PR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, PR708, DOI 10.1152/ajpregu.00693.2004
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nichenametla SN, 2006, CRIT REV FOOD SCI, V46, P161, DOI 10.1080/10408390591000541
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Shimazu T, 2005, INT J CANCER, V116, P150, DOI 10.1002/ijc.20989
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Watanabe T, 2008, JPN PHARMACOL THER, V36, P465
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Yamaji T, 2004, DIABETOLOGIA, V47, P2145, DOI 10.1007/s00125-004-1590-5
NR 34
TC 41
Z9 42
U1 1
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD AUG 15
PY 2013
VL 77
IS 8
BP 1633
EP 1636
DI 10.1271/bbb.130147
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology
GA 210XO
UT WOS:000323868600005
PM 23924724
DA 2025-04-28
ER

PT J
AU Park, S
   Onufrak, S
   Blanck, HM
   Sherry, B
AF Park, Sohyun
   Onufrak, Stephen
   Blanck, Heidi M.
   Sherry, Bettylou
TI Characteristics Associated with Consumption of Sports and Energy Drinks among US Adults: National Health Interview Survey, 2010
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Sports drinks; Energy drinks; Sugar-sweetened beverages; Behaviors; Adults
ID sweetened beverage consumption; body-weight; dietary; risk; adolescents; patterns
AB Sales of sports and energy drinks have increased dramatically, but there is limited information on regular consumers of sports and energy drinks. Characteristics associated with sports and energy drink intake were examined among a sample representing the civilian noninstitutionalized US adult population. The 2010 National Health Interview Survey data for 25,492 adults (18 years of age or older; 48% males) were used. Nationwide, 31.3% of adults were sports and energy drink consumers during the past 7 days, with 21.5% consuming sports and energy drinks one or more times per week and 11.5% consuming sports and energy drinks three or more times per week. Based on multivariable logistic regression, younger adults, males, non-Hispanic blacks and Hispanics, not-married individuals, adults with higher family income, those who lived in the South or West, adults who engaged in leisure-time physical activity, current smokers, and individuals whose satisfaction with their social activities/relationships was excellent had significantly higher odds for drinking sports and energy drinks one or more times per week. In this model, the factor most strongly associated with weekly sports and energy. drink consumption was age (odds ratio [OR]=10.70 for 18- to 24-year-olds, OR=6.40 for 25- to 39-year-olds, OR=3.17 for 40- to 59-year-olds vs 60 years or older). Lower odds for consuming sports and energy drinks one or more times per week were associated with other/multiracial (OR=0.80 vs non-Hispanic white) and obesity (OR=0.87 vs underweight/normal weight). Separate modeling of the association between other beverage intake and sports and energy drink intake showed that higher intake of regular soda, sweetened coffee/tea drinks, fruit drinks, milk, 100% fruit juice, and alcohol were significantly associated with greater odds for drinking sports and energy drinks one or more times per week. These findings can help medical care providers and public health officials identify adults most in need of encouragement to reduce sports and energy drink intake and increase healthier beverage intake. J Acad Nutr Diet. 2013;113:112-119.
C1 [Park, Sohyun; Onufrak, Stephen; Blanck, Heidi M.; Sherry, Bettylou] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
C3 Centers for Disease Control & Prevention - USA
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,Mailstop K26, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR Unknown -, 2011, USDA NAT NUTR DAT ST, V0, P0
   Unknown -, 1998, NIH PUBL, V0, P0
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Burt B A, 2001, J DENT EDUC, V65, P1017
   Burt BA, 2006, CARIES RES, V40, P473, DOI 10.1159/000095645
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU, V0, P0
   Clauson KA, 2008, J AM PHARM ASSOC, V48, PE55, DOI 10.1331/JAPhA.2008.07055
   Coombes JS, 2000, SPORTS MED, V29, P181, DOI 10.2165/00007256-200029030-00004
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Gibson S, 2008, HYPERTENSION, V51, PE54, DOI 10.1161/HYPERTENSIONAHA.108.112763
   Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Institute of Medicine Food and Nutrition Board, 2005, DIET REF INT EN CARB, V0, P0, DOI DOI 10.17226/10490
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x
   Libuda L, 2009, CURR OPIN CLIN NUTR, V12, P596, DOI 10.1097/MCO.0b013e32833189f6
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malinauskas BM, 2007, NUTR J, V6, P0, DOI 10.1186/1475-2891-6-35
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   National Policy and Legal Analysis Network to Prevent Childhood Obesity, 2011, BREAK CHAIN GUID SOF, V0, P0
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   Ranjit N, 2010, PEDIATRICS, V126, PE754, DOI 10.1542/peds.2010-1229
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, PE1596, DOI 10.1210/jc.2011-1251
   Venables MC, 2005, MED SCI SPORT EXER, V37, P39, DOI 10.1249/01.MSS.0000150017.74892.F5
   West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 37
TC 48
Z9 52
U1 1
U2 70
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD JAN 15
PY 2013
VL 113
IS 1
BP 112
EP 119
DI 10.1016/j.jand.2012.09.019
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 107SZ
UT WOS:000316242400012
PM 23260728
DA 2025-04-28
ER

PT J
AU Vinknes, KJ
   Elshorbagy, AK
   Nurk, E
   Drevon, CA
   Gjesdal, CG
   Tell, GS
   Nygård, O
   Vollset, SE
   Refsum, H
AF Vinknes, Kathrine J.
   Elshorbagy, Amany K.
   Nurk, Eha
   Drevon, Christian A.
   Gjesdal, Clara G.
   Tell, Grethe S.
   Nygard, Ottar
   Vollset, Stein E.
   Refsum, Helga
TI Plasma Stearoyl-CoA Desaturase Indices: Association with Lifestyle, Diet, and Body Composition
SO OBESITY
LA English
DT Article
ID fatty-acid-composition; adipose-tissue; hordaland homocysteine; mass index; obesity; alcohol; serum; disease; men; cholesterol
AB Objective: Stearoyl-coenzyme A desaturase-1 (SCD1) is a key enzyme in fatty acid and energy metabolism. Increased hepatic SCD1 activity is associated with obesity and obesity-related diseases. We examined the relations of two plasma SCD activity indices (16:1n-7/16:0, 18:1n-9/18:0) with body composition, and the association of lifestyle and dietary variables with the plasma SCD indices. Design and Methods: This population-based, cross-sectional study of 2021 elderly (71-74 y) men and women from the Hordaland Health Study in Western Norway was conducted using a validated food frequency questionnaire, body composition measurements by dual-energy X-ray absorptiometry and determination of the plasma fatty acid profile. Results: In multivariate regression analyses, plasma SCD indices were positively associated with BMI and body fat (P<0.001 for both). From the 2.5th to 97.5th percentiles of plasma SCD-16 and SCD-18 indices, fat mass differed by about 8 kg and 5 kg, respectively. Intake of polyunsaturated fatty acids were negatively associated with SCD-16 (partial r = -0.30) and SCD-18 (partial r = -0.24) (P<0.001 for both). Alcohol intake was positively associated with SCD-16 (partial r = 0.26) and SCD-18 (partial r = 0.16) (P<0.001 for both), whereas coffee consumption and physical activity were inversely associated with SCD-16 (P = 0.026 and P = 0.006, respectively) and SCD-18 (P = 0.001 and P = 0.022, respectively). Conclusions: In this elderly population, plasma markers of SCD1 activity are associated with increased adiposity. Furthermore, modifiable dietary habits and lifestyle are associated with plasma SCD indices. These results suggest that SCD1 activity may be a promising target for weight control.
C1 [Vinknes, Kathrine J.; Nurk, Eha; Drevon, Christian A.; Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway.
   [Elshorbagy, Amany K.; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England.
   [Elshorbagy, Amany K.] Univ Alexandria, Dept Physiol, Fac Med, Alexandria, Egypt.
   [Nurk, Eha] Natl Inst Hlth Dev, Dept Surveillance & Evaluat, Tallinn, Estonia.
   [Gjesdal, Clara G.] Univ Bergen, Dept Med, Bergen, Norway.
   [Gjesdal, Clara G.] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway.
   [Tell, Grethe S.; Vollset, Stein E.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.
   [Nygard, Ottar] Univ Bergen, Inst Med, Cardiol Sect, Bergen, Norway.
   [Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.
   [Vollset, Stein E.] Norwegian Inst Publ Hlth, Oslo, Norway.
C3 University of Oslo; University of Oxford; Egyptian Knowledge Bank (EKB); Alexandria University; National Institute for Health Development - Estonia; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH)
RP Vinknes, KJ (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway.
EM kathrine.vinknes@medisin.uio.no
FU Advanced Research Programme of Norway; Research Council of Norway; Norwegian Rheumatism Association; Johan Throne Holst Foundation for Nutrition Research; University of Oslo, Norway
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921
   Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b
   Buckley JD, 2009, OBES REV, V10, P648, DOI 10.1111/j.1467-789X.2009.00584.x
   Caterson ID, 2004, CIRCULATION, V110, PE476, DOI 10.1161/01.CIR.0000140114.83145.59
   Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817
   Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367
   Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215
   ENSER M, 1975, BIOCHEM J, V148, P551, DOI 10.1042/bj1480551
   Flowers MT, 2009, CLIN CHEM, V55, P2071, DOI 10.1373/clinchem.2009.135152
   Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694
   Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003
   Houston DK, 2009, J AM DIET ASSOC, V109, P1886, DOI 10.1016/j.jada.2009.08.014
   Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V0, P300
   Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004
   Ntambi JM, 1999, J LIPID RES, V40, P1549
   Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Nurk E, 2007, AM J CLIN NUTR, V86, P1470, DOI 10.1093/ajcn/86.5.1470
   NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526
   Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017
   Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274
   Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, PE941, DOI 10.1152/ajpendo.1996.271.6.E941
   Poudyal Hemant, 2011, ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, V11, P217
   Refsum H, 2006, J NUTR, V136, P1731S, DOI 10.1093/jn/136.6.1731S
   Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834
   Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200
   Simon JA, 1996, AM J EPIDEMIOL, V144, P325, DOI 10.1093/oxfordjournals.aje.a008933
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   Warensjö E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001
   Warensjö E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002
   WARNET JM, 1985, BMJ-BRIT MED J, V290, P1859, DOI 10.1136/bmj.290.6485.1859
   Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012
NR 40
TC 42
Z9 44
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 
J9 OBESITY
JI Obesity
PD MAR 15
PY 2013
VL 21
IS 3
BP E294
EP E302
DI 10.1002/oby.20011
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 187AK
UT WOS:000322087600016
PM 23404690
DA 2025-04-28
ER

PT J
AU Liu, AG
   Smith, SR
   Fujioka, K
   Greenway, FL
AF Liu, Ann G.
   Smith, Steven R.
   Fujioka, Ken
   Greenway, Frank L.
TI The Effect of Leptin, Caffeine/Ephedrine and their Combination Upon Visceral Fat Mass and Weight Loss
SO OBESITY
LA English
DT Article
ID adipose-tissue compartments; recombinant leptin; obese subjects; risk; ephedrine; efficacy; placebo; safety; adults
AB Objective: To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks. Design and Methods: In this randomized, double-blind, parallel-arm trial, 90 obese subjects received one of the three treatments for 24 weeks: 200 mg caffeine/20 mg ephedrine t.i.d. (CE), leptin A-200 (recombinant methionyl human Fc-leptin, 20 mg q.d.) (L), or combination leptin A-200 and caffeine/ephedrine (LCE). Outcomes included change in weight, visceral fat mass by computed tomography, lean mass and fat mass by dual energy X-ray absorptiometry. Results: Groups treated with CE and LCE lost significant amounts of weight (-5.9 +/- 1.2% and -6.5 +/- 1.1%, P < 0.05) and whole body fat mass (-9.6 +/- 2.4% and -12.4 +/- 2.3%, P < 0.05) compared to leptin only group. Only treatment with LCE significantly reduced visceral fat mass (-11.0 +/- 3.3%, P < 0.05). There were no differences in lean mass between treatment groups. Conclusions: Our study provides evidence that CE is a modestly effective weight loss agent and produces significant reductions in fat mass. Leptin A-200 was not effective in producing weight loss and did not have any significant additive or synergistic actions when combined with CE.
C1 [Liu, Ann G.; Greenway, Frank L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
   [Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Translat Res Inst Metab & Diabet, Orlando, FL USA.
   [Fujioka, Ken] Scripps Clin, La Jolla, CA 92037 USA.
C3 Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sanford Burnham Prebys Medical Discovery Institute; Adventist Health Services; AdventHealth; Scripps Research Institute
RP Greenway, FL (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA USA.
EM Frank.Greenway@pbrc.edu
FU Amgen Pharmaceuticals
CR Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693
   Food and Drug Administration HHS, 2004, FED REGIST, V69, P6787
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Greenway F L, 2001, OBES REV, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Hallas J, 2008, AM J EPIDEMIOL, V168, P966, DOI 10.1093/aje/kwn191
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Hukshorn CJ, 2000, J CLIN ENDOCR METAB, V85, P4003, DOI 10.1210/jc.85.11.4003
   LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257
   Mittendorfer B, 2011, DIABETES, V60, P1474, DOI 10.2337/db10-1302
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Moon HS, 2011, DIABETES, V60, P1647, DOI 10.2337/db10-1791
   Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475
   Zelissen PMJ, 2005, DIABETES OBES METAB, V7, P755, DOI 10.1111/j.1463-1326.2005.00468.x
NR 20
TC 25
Z9 26
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD OCT 15
PY 2013
VL 21
IS 10
BP 1991
EP 1996
DI 10.1002/oby.20416
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 231OT
UT WOS:000325427300006
PM 23686786
DA 2025-04-28
ER

PT J
AU Gavrieli, A
   Karfopoulou, E
   Kardatou, E
   Spyreli, E
   Fragopoulou, E
   Mantzoros, CS
   Yannakoulia, M
AF Gavrieli, A.
   Karfopoulou, E.
   Kardatou, E.
   Spyreli, E.
   Fragopoulou, E.
   Mantzoros, C. S.
   Yannakoulia, M.
TI Effect of Different Amounts of Coffee on Dietary Intake and Appetite of Normal-Weight and Overweight/Obese Individuals
SO OBESITY
LA English
DT Article
ID caffeine consumption; chlorogenic acid; energy-intake; long-term; insulin; men; mannooligosaccharides; secretion; obesity; tea
AB Objective: To investigate the effects of different coffee amounts on dietary intake and appetite feelings in normal-weight and overweight/obese individuals. Design and Methods: Thirty-three volunteers (16 normal-weight, 17 overweight/obese) participated in three trials: they consumed a standard breakfast along with 200 ml of either coffee with 3 or 6 mg caffeine/kg body weight (Coffee 3 and Coffee 6, respectively), or water. At fasting and at standard time points for the 3 h following breakfast/drink consumption participants recorded their appetite feelings on visual analogue scales. At 180 min, participants consumed an ad libitum meal and the next day they recalled their food intake during the experimental day. Results: A significant intervention effect was found for the energy intake of the ad libitum meal (P = 0.05) and of the whole day (P = 0.02) only in overweight/obese individuals. Specifically, Coffee 6 resulted in a reduced energy intake during the ad libitum meal compared to Coffee 3 (P = 0.03) and in the total day compared to both water (P = 0.04) and Coffee 3 (P = 0.008). No effect was observed for the appetite feelings. Conclusions: A moderate coffee amount can effectively reduce energy intake in the following meal and in the total day compared to lower or no coffee intake in overweight/obese participants.
C1 [Gavrieli, A.; Karfopoulou, E.; Kardatou, E.; Spyreli, E.; Fragopoulou, E.; Yannakoulia, M.] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   [Mantzoros, C. S.] VA Boston Healthcare Syst, Endocrinol Sect, Dept Vet Affairs, Boston, MA USA.
   [Mantzoros, C. S.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.
C3 Harokopio University Athens; Harvard University; Harvard University Medical Affiliates; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center
RP Yannakoulia, M (corresponding author), Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
EM myiannak@hua.gr
FU Department of Nutrition and Dietetics, Harokopio University
CR Unknown -, 2010, USDA NATIONAL NUTRIENT DATABASE FOR STANDARD REFERENCE, V0, P0
   Unknown -, 2006, DEV VAL REL HAR PHYS, V0, P0
   Brennan IM, 2009, AM J PHYSIOL-GASTR L, V297, PG602, DOI 10.1152/ajpgi.00051.2009
   DOUGLAS BR, 1990, AM J CLIN NUTR, V52, P553, DOI 10.1093/ajcn/52.3.553
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Neary MT, 2009, PHARMACOL THERAPEUT, V124, P44, DOI 10.1016/j.pharmthera.2009.06.005
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207
   Salinardi TC, 2010, J NUTR, V140, P1943, DOI 10.3945/jn.110.128207
   St-Onge MP, 2012, OBESITY, V20, P343, DOI 10.1038/oby.2011.289
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T
   Vinson JA, 2012, DIABET METAB SYND OB, V5, P21, DOI 10.2147/DMSO.S27665
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866
   Yannakoulia M, 2010, J AM GERIATR SOC, V58, P1208, DOI 10.1111/j.1532-5415.2010.02893.x
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 27
TC 45
Z9 53
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD JUN 15
PY 2013
VL 21
IS 6
BP 1127
EP 1132
DI 10.1002/oby.20190
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 192LV
UT WOS:000322487000010
PM 23671022
DA 2025-04-28
ER

PT J
AU Pan, A
   Malik, VS
   Hao, T
   Willett, WC
   Mozaffarian, D
   Hu, FB
AF Pan, A.
   Malik, V. S.
   Hao, T.
   Willett, W. C.
   Mozaffarian, D.
   Hu, F. B.
TI Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE water; beverage; body weight; prospective cohort study
ID sugar-sweetened beverages; body-weight; energy-intake; food-intake; induced thermogenesis; caloric beverages; drinking-water; older-adults; us adults; consumption
AB OBJECTIVE: To examine the long-term relationship between changes in water and beverage intake and weight change. SUBJECTS: Prospective cohort studies of 50 013 women aged 40-64 years in the Nurses' Health Study (NHS, 1986-2006), 52 987 women aged 27-44 years in the NHS II (1991-2007) and 21 988 men aged 40-64 years in the Health Professionals Follow-up Study (1986-2006) without obesity and chronic diseases at baseline. MEASURES: We assessed the association of weight change within each 4-year interval, with changes in beverage intakes and other lifestyle behaviors during the same period. Multivariate linear regression with robust variance and accounting for within-person repeated measures were used to evaluate the association. Results across the three cohorts were pooled by an inverse-variance-weighted meta-analysis. RESULTS: Participants gained an average of 1.45 kg (5th to 95th percentile: -1.87 to 5.46) within each 4-year period. After controlling for age, baseline body mass index and changes in other lifestyle behaviors (diet, smoking habits, exercise, alcohol, sleep duration, TV watching), each 1 cup per day increment of water intake was inversely associated with weight gain within each 4-year period (-0.13 kg; 95% confidence interval (CI): -0.17 to -0.08). The associations for other beverages were: sugar-sweetened beverages (SSBs) (0.36 kg; 95% CI: 0.24-0.48), fruit juice (0.22 kg; 95% CI: 0.15-0.28), coffee (-0.14 kg; 95% CI: -0.19 to -0.09), tea (-0.03 kg; 95% CI: -0.05 to -0.01), diet beverages (-0.10 kg; 95% CI: -0.14 to -0.06), low-fat milk (0.02 kg; 95% CI: -0.04 to 0.09) and whole milk (0.02 kg; 95% CI: -0.06 to 0.10). We estimated that replacement of 1 serving per day of SSBs by 1 cup per day of water was associated with 0.49 kg (95% CI: 0.32-0.65) less weight gain over each 4-year period, and the replacement estimate of fruit juices by water was 0.35 kg (95% CI: 0.23-0.46). Substitution of SSBs or fruit juices by other beverages (coffee, tea, diet beverages, low-fat and whole milk) were all significantly and inversely associated with weight gain. CONCLUSION: Our results suggest that increasing water intake in place of SSBs or fruit juices is associated with lower long-term weight gain.
C1 [Pan, A.; Malik, V. S.; Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Pan, A.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore.
   [Pan, A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   [Pan, A.] Natl Univ Hlth Syst, Singapore, Singapore.
   [Hao, T.; Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.
   [Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Mozaffarian, D.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital
RP Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,Bldg 2,Floor 3, Boston, MA 02115 USA.
EM ephanp@nus.edu.sg; frank.hu@channing.harvard.edu
FU National Institutes of Health [P01CA087969, R01CA050385, U19CA055075, R01DK058845, P30DK046200, U54CA155626]
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780
   Boschmann M, 2007, J CLIN ENDOCR METAB, V92, P3334, DOI 10.1210/jc.2006-1438
   Brown CM, 2006, J CLIN ENDOCR METAB, V91, P3598, DOI 10.1210/jc.2006-0407
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   Davy BM, 2008, J AM DIET ASSOC, V108, P1236, DOI 10.1016/j.jada.2008.04.013
   DellaValle DM, 2005, APPETITE, V44, P187, DOI 10.1016/j.appet.2004.11.003
   Dennis EA, 2010, OBESITY, V18, P300, DOI 10.1038/oby.2009.235
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Libuda L, 2008, BRIT J NUTR, V99, P1370, DOI 10.1017/S0007114507862362
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Louie JCY, 2011, OBES REV, V12, PE582, DOI 10.1111/j.1467-789X.2011.00881.x
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Olsen NJ, 2009, OBES REV, V10, P68, DOI 10.1111/j.1467-789X.2008.00523.x
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559
   ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963
   Van Walleghen EL, 2007, OBESITY, V15, P93, DOI 10.1038/oby.2007.506
   Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x
NR 39
TC 168
Z9 185
U1 0
U2 66
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD OCT 15
PY 2013
VL 37
IS 10
BP 1378
EP 1385
DI 10.1038/ijo.2012.225
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 233CG
UT WOS:000325542200013
PM 23318721
DA 2025-04-28
ER

PT J
AU Hursel, R
   Westerterp-Plantenga, MS
AF Hursel, Rick
   Westerterp-Plantenga, Margriet S.
TI Catechin- and caffeine-rich teas for control of body weight in humans
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Proceedings Paper
ID brown adipose-tissue; o-methyltransferase genotype; randomized controlled-trial; dietary-fat oxidation; green tea; energy-expenditure; epigallocatechin gallate; gut microbiota; double-blind; white tea
AB Maintaining the level of daily energy expenditure during weight loss and weight maintenance is as important as maintaining satiety while decreasing energy intake. In this context, different catechin- and caffeine-rich teas (CCRTs), such as green, oolong, and white teas, as well as caffeine have been proposed as tools for maintaining or enhancing energy expenditure and for increasing fat oxidation. Tea polyphenols have been proposed to counteract the decrease in metabolic rate that is usually present during weight loss. Their effects may be of particular importance during weight maintenance after weight loss. Although the thermogenic effect of CCRT has the potential to produce significant effects on these metabolic targets as well as on fat absorption and energy intake, possibly via its impact on the gut microbiota and gene expression, a clinically meaningful outcome also depends on compliance by the subjects. Limitations to this approach require further examination, including moderating factors such as genetic predisposition, habitual caffeine intake, and catechin composition and dose. Nevertheless, CCRTs may be useful agents that could help in preventing a positive energy balance and obesity.
C1 [Hursel, Rick; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@maastrichtuniversity.nl
FU Tea Council of the USA; American Cancer Society; American College of Nutrition; American Institute for Cancer Research; American Medical Women's Association; American Society for Nutrition; Linus Pauling Institute
CR Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a
   Arts MJTJ, 2001, FOOD CHEM TOXICOL, V39, P787, DOI 10.1016/S0278-6915(01)00020-5
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bajerska J, 2010, PAKISTAN JOURNAL OF NUTRITION, V9, P696
   Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bodenmann S, 2010, SLEEP, V33, P1027, DOI 10.1093/sleep/33.8.1027
   Boschmann M, 2007, J AM COLL NUTR, V26, P389S, DOI 10.1080/07315724.2007.10719627
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROWN PJ, 1963, J CHROMATOGR, V11, P504, DOI 10.1016/S0021-9673(01)80953-5
   Cabrera C, 2003, J AGR FOOD CHEM, V51, P4427, DOI 10.1021/jf0300801
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen W, 1998, JPN J CLIN NUTR, V20, P83
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227
   Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146
   Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Egert S, 2013, EUR J NUTR, V52, P281, DOI 10.1007/s00394-012-0330-8
   Ferruzzi MG, 2012, PHYSIOL BEHAV, V107, P591, DOI 10.1016/j.physbeh.2012.02.020
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gosselin C, 2013, BRIT J NUTR, V110, P282, DOI 10.1017/S0007114512005089
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T, 2001, JOURNAL OF OLEO SCIENCE, V50, P599, DOI 10.5650/jos.50.599
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Himmerich H, 2010, PROTEIN PEPTIDE LETT, V17, P186, DOI 10.2174/092986610790225941
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2011, NUTRIENTS, V3, P725, DOI 10.3390/nu3080725
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Inoue-Choi M, 2010, INT J MOL EPIDEMIOL, V1, P114
   Jakicic JM, 2012, NESTLE NUTR WORKS SE, V73, P21, DOI 10.1159/000341283
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jöbstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Josse AR, 2012, AM J CLIN NUTR, V96, P665, DOI 10.3945/ajcn.112.038794
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kataoka K, 2004, PROGRESS IN MEDICINE, V24, P3358
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, JOURNAL OF MEDICAL INVESTIGATION, V50, P170
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Lin HV, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0035240
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   Lu CW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038332
   Lu H, 2003, DRUG METAB DISPOS, V31, P452, DOI 10.1124/dmd.31.4.452
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Lyon MR, 2011, ALTERN MED REV, V16, P348
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Männistö PT, 1999, PHARMACOL REV, V51, P593
   Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Miller RJ, 2012, MOL NUTR FOOD RES, V56, P966, DOI 10.1002/mnfr.201100726
   Miller RJ, 2012, EUR J NUTR, V51, P47, DOI 10.1007/s00394-011-0189-0
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Miyajima E, 2005, PROG MED TOKYO, V25, P831
   Mobbs CV, 2005, PHYSIOL BEHAV, V85, P3, DOI 10.1016/j.physbeh.2005.04.005
   Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2001, JOURNAL OF OLEO SCIENCE, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nagy TR, 1996, J APPL PHYSIOL, V80, P1743, DOI 10.1152/jappl.1996.80.5.1743
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Otsuka K, 2002, JAPANESE J NUTR ASSE, V19, P365
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Ryan L, 2010, NUTR RES, V30, P14, DOI 10.1016/j.nutres.2009.11.005
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   SCHUTZ Y, 1989, AM J CLIN NUTR, V50, P307, DOI 10.1093/ajcn/50.2.307
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Siebert KJ, 1996, J AGR FOOD CHEM, V44, P80, DOI 10.1021/jf9502459
   Söhle J, 2009, NUTR METAB, V6, P0, DOI 10.1186/1743-7075-6-20
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   Takashima S, 2004, PROGRESS IN MEDICINE, V24, P3371
   Takeshita M, 2008, JPN PHARMACOL THER, V36, P767
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   tsuchida t, 2002, PROG MED, V9, P2189
   Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384
   Unachukwu UJ, 2010, J FOOD SCI, V75, PC541, DOI 10.1111/j.1750-3841.2010.01705.x
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   Walker J, 2012, FOOD CHEM TOXICOL, V50, P390, DOI 10.1016/j.fct.2011.09.041
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
   Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 160
TC 84
Z9 89
U1 4
U2 94
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD DEC 15
PY 2013
VL 98
IS 6
BP 1682S
EP 1693S
DI 10.3945/ajcn.113.058396
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 266DJ
UT WOS:000328002400010
PM 24172301
DA 2025-04-28
ER

PT J
AU Han, E
   Powell, LM
   Kim, TH
AF Han, Euna
   Powell, Lisa M.
   Kim, Tae Hyun
TI Trends in exposure to television food advertisements in South Korea
SO APPETITE
LA English
DT Article
DE TV food advertising; Targeted ratings data; South Korea
ID body-mass index; united-states; nutrition transition; us adults; children; dietary; adolescents; obesity; consumption; patterns
AB Given the increased concern about the impact of TV food advertisements (ads) on individual food choices, we provide important evidence on TV food ad exposure between 2004 and 2009 in South Korea. We used monthly targeted ratings data by age group as the number of ads seen daily from Korean Nielsen Media Research. We generated six food groups: beverages (milk, soda, fruit drinks, sports/energy drinks, water, coffee/tea products, and other); snacks/sweets (cookies/chips, candy, and chewing gum); fast food (Domino's pizza, Lotteria, McDonald's, Mr. Pizza, Pizza Hut, local chicken and pizza franchises, and other); instant noodle; full-service restaurants; and other. From 2004 to 2009, overall exposure to television food ads fell by 19.0% (from 6.8 to 5.5 ads daily), although exposure to full-service restaurant ads increased over that time period by 45.7%. While fast-food ad exposure fell overall, exposure to ads for local fried chicken franchises nearly doubled, making them the most commonly seen fast-food ads by 2009. Fast-food and instant noodle ads made up larger proportions of total ad exposure in 2009 than in 2004 in all age groups, with the largest increase among adolescents. Beverage ads continue to be the most prevalent food ads seen in South Korea. Differential trends found in exposure across and within food product categories and differences by age groups highlight the need for continued monitoring to help inform the regulatory policy debate on food advertising, particularly with regards to ads directed at children and adolescents. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Han, Euna] Gachon Univ, Gachon Inst Pharmaceut Sci, Coll Pharm, Inchon 406799, South Korea.
   [Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Sch Publ Hlth, Hlth Policy & Adm, Chicago, IL 60608 USA.
   [Kim, Tae Hyun] Yonsei Univ, Inst Hlth Serv Res, Grad Sch Publ Hlth, Seoul 120752, South Korea.
C3 Gachon University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yonsei University; Yonsei University Health System
RP Kim, TH (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Grad Sch Publ Hlth, 50 Yonsei Ro, Seoul 120752, South Korea.
EM thkim@yuhs.ac
FU Korea National Research Foundation [NRF-2012007096]
CR Advertising Information Center, 2008, SUMM ADV EXP QUART M, V0, P0
   Unknown -, 2006, MMWR - MORBIDITY MORTALITY WEEKLY REPORT, V0, P0
   Unknown -, 2001, SURG GEN CALL ACT PR, V0, P0
   Unknown -, 2005, YOUTH OPPORTUNITY MONTHLY DATA AND RATE ANALYSIS REPORT, V0, P0
   Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357
   Brunello G, 2009, RISE OBESITY ATLANTT, V0, P0
   Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012
   Cho KY, 2009, KOREAN J PEDIAT GAST, V11, P150
   CONDRY J, 1988, J BROADCAST ELECTRON, V32, P255
   Connor SM, 2006, PEDIATRICS, V118, P1478, DOI 10.1542/peds.2005-2837
   COTUGNA N, 1988, J NUTR EDUC, V20, P125
   Emery S, 2005, ARCH PEDIAT ADOL MED, V159, P639, DOI 10.1001/archpedi.159.7.639
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Fox MK, 2010, J AM DIET ASSOC, V110, PS52, DOI 10.1016/j.jada.2010.09.002
   French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429
   Gamble M, 1999, AM J HEALTH BEHAV, V23, P261, DOI 10.5993/AJHB.23.4.3
   Gantz W, 2007, FOOD THOUGHT TELEVIS, V0, P0
   Harris JL, 2010, FAST FOOD F.A.C.T.S.: EVALUATING FAST FOOD NUTRITION AND MARKETING TO YOUTH, V0, P0
   Harris JL, 2012, CEREAL FACTS LTD PRO, V0, P0
   Harris JL, 2009, CEREAL FACTS NUTR MA, V0, P0
   Harrison K, 2005, AM J PUBLIC HEALTH, V95, P1568, DOI 10.2105/AJPH.2004.048058
   Hastings G, 2003, REV RES EFFECTS FOOD, V0, Pi
   Holt D, 2007, CHILDRENS EXPOSURE T, V0, P0
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Kim S, 2000, AM J CLIN NUTR, V71, P44
   Korea Center for Disease Control and Prevention, 2010, PUBLIC HLTH WKLY REP, V3, P597
   Korea Food and Drug Administration, 2010, BAN HIGH CAL LOW NUT, V0, P0
   Korea Food Consumption Information, 2011, HDB FOOD CONSUMPTION, V0, P0
   Korean Nutrition Society, 2005, NUTR DAT CD, V0, P0
   KOTZ K, 1994, J AM DIET ASSOC, V94, P1296, DOI 10.1016/0002-8223(94)92463-5
   Kunkel D, 2009, THE IMPACT OF INDUSTRY SELF-REGULATION ON THE NUTRITIONAL QUALITY OF FOODS ADVERTISED ON TELEVISION TO CHILDREN, V0, P0
   Lee JungSug Lee JungSug, 2009, KOREAN JOURNAL OF NUTRITION, V42, P723
   Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Ministry of Health and Welfare, 2006, NAT HLTH NUTR EX SUR, V0, P0
   Ministry of Health and Welfare, 2009, HLTH EAT GUID KOR, V0, P0
   Moon YS, 2009, KOR ADV ASS SPRING C, V0, P52
   Park WI, 2008, 0804 KOR BROADC I, V0, P0
   Powell LM, 2007, ARCH PEDIAT ADOL MED, V161, P553, DOI 10.1001/archpedi.161.6.553
   Powell LM, 2011, ARCH PEDIAT ADOL MED, V165, P1078, DOI 10.1001/archpediatrics.2011.131
   Powell LM, 2010, ARCH PEDIAT ADOL MED, V164, P794, DOI 10.1001/archpediatrics.2010.139
   서정완, 2008, CLINICAL AND EXPERIMENTAL PEDIATRICS, V51, P576
   Song Y, 2005, BRIT J NUTR, V93, P943, DOI 10.1079/BJN20051435
   Southwell BG, 2002, J HEALTH COMMUN, V7, P445, DOI 10.1080/10810730290001800
   TARAS HL, 1995, ARCH PEDIAT ADOL MED, V149, P649, DOI 10.1001/archpedi.1995.02170190059010
   The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005, HLTH EX KOR CTR DIS, V0, P38
   TNS Media Korea, 2011, EXP TV ADV GEN TARG, V0, P0
   Wakefield M, 2005, ADDICTION, V100, P1875, DOI 10.1111/j.1360-0443.2005.01298.x
   Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971
   Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685
   World Instant Noodle Association, 2012, NAT TRENDS INST NOOD, V0, P0
   Youngah Ah, 2010, JOURNAL OF SCHOOL SOCIAL WORK 학교사회복지, V18, P29
NR 54
TC 18
Z9 19
U1 1
U2 56
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD MAR 1
PY 2013
VL 62
IS 
BP 225
EP 231
DI 10.1016/j.appet.2012.10.015
PG 7
WC Behavioral Sciences; Nutrition & Dietetics
SC Behavioral Sciences; Nutrition & Dietetics
GA 091SO
UT WOS:000315070300032
PM 23108149
DA 2025-04-28
ER

PT J
AU Papandreou, D
   Andreou, E
   Heraclides, A
   Rousso, I
AF Papandreou, D.
   Andreou, E.
   Heraclides, A.
   Rousso, I
TI Is beverage intake related to overweight and obesity in school children?
SO HIPPOKRATIA
LA English
DT Article
DE Sugar beverage intake; obesity; children; Greece
ID sugar-sweetened beverages; consumption; association; childhood; risk; frequency
AB Background and Aim: Recently, considerable attention has been given to beverage intake as a source of calories which may be linked to pediatric obesity. The purpose of our study was to evaluate the beverage intake in school children and adolescents aged 7 to 15 years old. Methods: Six hundred and seven (607) out of 655 children participated in the study. One hundred percent fruit juice were classified those beverages that contain 100% fruit juice, without sweetener. Sweetened sugar beverages (SSBs) were included (fruit drinks sweetened fruit juice, fruit-flavored drink or drink that contained fruit juice in part, sweeten soft drinks, coffee, and tea). Results: Around 84% of subjects consumed water while 81% of children who were included in the analysis consumed milk, 49.5% consumed 100% fruit juice, and 79.4 % SSBs. Whole milk was consumed by 40.9% of school children. Skim milk and 1% milk were consumed by 3.6% and 4.7% of the children, respectively. Children and adolescents consuming SSBs were 2.57 (95% CI: 1.06, 3.38) times more likely to become obese compared to normal peers. Conclusion: Sugar beverage drinks but not 100% fruit juices and milk are associated with obesity. Further studies investigating the relationship among beverage consumption, total energy intake, and development of overweight are needed.
C1 [Papandreou, D.; Rousso, I] Aristotle Univ Thessaloniki, Dept Pediat 2, Sch Med, TK-54636 Thessaloniki, Greece.
   [Papandreou, D.; Andreou, E.; Heraclides, A.] Univ Nicosia, Sch Sci, Dept Life & Hlth Sci, CY-1700 Nicosia, Cyprus.
C3 Aristotle University of Thessaloniki; University of Nicosia
RP Papandreou, D (corresponding author), Univ Nicosia, 46 Makedonittisas Ave, CY-1700 Nicosia, Cyprus.
EM papandreoudimitrios@yahoo.gr
CR Unknown -, 2004, J AM DIET ASSOC, V104, P660, DOI 10.1016/j.jada.2004.01.030
   Antonogeorgos G, 2012, PEDIATR OBES, V7, P65, DOI 10.1111/j.2047-6310.2011.00006.x
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   Baker SS, 2001, PEDIATRICS, V107, P1210, DOI 10.1542/peds.107.5.1210
   Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300
   Baur L, 2004, OBES REV, V5, P4, DOI 10.1111/j.1467-
   Briefel RR, 2009, J AM DIET ASSOC, V109, PS79, DOI 10.1016/j.jada.2008.10.064
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Farajian P, 2013, PUBLIC HEALTH NUTR, V16, P240, DOI 10.1017/S1368980012002625
   Linardakis M, 2008, BMC PUBLIC HEALTH, V8, P0, DOI 10.1186/1471-2458-8-279
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malindretos P, 2009, HIPPOKRATIA, V13, P46
   Manios Y, 2004, AM J HUM BIOL, V16, P639, DOI 10.1002/ajhb.20075
   Manios Y, 2010, J AM DIET ASSOC, V110, P1527, DOI 10.1016/j.jada.2010.07.004
   Manios Y, 2009, OBESITY, V17, P2047, DOI 10.1038/oby.2009.50
   Noel SE, 2011, J NUTR, V141, P2035, DOI 10.3945/jn.111.143420
   Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743
   Pereira MA, 2006, INT J OBESITY, V30, PS28, DOI 10.1038/sj.ijo.0803489
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Trichopoulou A, 2004, COMPOSITION TABLES OF FOODS AND GREEK DISHES, V0, P0
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Welsh JA, 2005, PEDIATRICS, V115, PE223, DOI 10.1542/peds.2004-1148
NR 25
TC 38
Z9 41
U1 0
U2 17
PU LITHOGRAPHIA
PI THESSALONIKI
PA ANTONIADIS I-PSARRAS TH G P, NEA REDESTOS, THESSALONIKI, 00000, GREECE
SN 1108-4189
EI 
J9 HIPPOKRATIA
JI Hippokratia
PD JAN-MAR 15
PY 2013
VL 17
IS 1
BP 42
EP 46
DI 
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 174PE
UT WOS:000321167100009
PM 23935343
DA 2025-04-28
ER

PT J
AU Hashimoto, T
   Sato, K
   Iemitsu, M
AF Hashimoto, Takeshi
   Sato, Koji
   Iemitsu, Motoyuki
TI Exercise-inducible factors to activate lipolysis in adipocytes
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE obesity; lipid droplet; lipid droplet-associated protein; mitochondria
ID human adipose-tissue; droplet-associated proteins; mitochondrial biogenesis; lipid droplets; nitric-oxide; perilipin; expression; pgc-1-alpha; mice; diet
AB We examined the effects of exercise training on the levels of lipid droplet (LD)-associated and mitochondria-related proteins in diet-induced obese (DIO) rats. Furthermore, we assessed putative factors induced by exercise to activate lipolysis in differentiated 3T3-L1 adipocytes. DIO Wistar male rats (age 20 wk) were divided into sedentary control (SED, n = 7) and exercise training (EX, n = 7) groups. EX animals were subjected to treadmill running (25 m/min, 1 h/day, 5 days/wk) for 6 wk. Epididymal fat was dissected and used for protein analyses. 3T3-L1 adipocytes were incubated with media containing hydrogen peroxide (H2O2), sodium-lactate, caffeine, AICAR, or SNAP (NO donor) for 6 h, or 1 mM H2O2 for 15 min, followed by incubation with normal media for up to 24 h total. Protein expression levels and lipolytic activities were biochemically assayed. Epididymal fat significantly decreased in EX animals compared with SED animals. Levels of cytochrome c oxidase (COx), perilipin, hormone sensitive lipase (HSL), and adipose triglyceride lipase (ATGL) proteins in epididymal fat pads of EX animals were significantly increased compared with those in SED animals. In 3T3-L1 cells, glycerol or fatty acid release was significantly increased by all treatments. Lactate or SNAP significantly increased PGC-1 alpha expression, and H2O2 significantly increased COx protein levels compared with controls. Expression of perilipin, HSL, ATGL, or comparative gene identification (CGI)-58 was significantly increased by all treatments. By increasing lipolytic activity in adipocytes, the exercise-inducible factors are attractive therapeutic effectors against LD-associated metabolic diseases.
C1 [Hashimoto, Takeshi; Sato, Koji; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.
C3 Ritsumeikan University
RP Hashimoto, T (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.
EM thashimo@fc.ritsumei.ac.jp
FU Japan Society for Promotion of Science; Yamaha Motor Foundation for Sports; Nakatomi Foundation; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [23700849, 25560378, 25560344, 22700652, 23680071] Funding Source: KAKEN
CR Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Campbell JE, 2009, METABOLISM, V58, P651, DOI 10.1016/j.metabol.2009.01.002
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   de Glisezinski I, 2003, AM J PHYSIOL-ENDOC M, V285, PE984, DOI 10.1152/ajpendo.00152.2003
   De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155
   Enevoldsen LH, 2000, AM J PHYSIOL-ENDOC M, V279, PE585, DOI 10.1152/ajpendo.2000.279.3.E585
   Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gaudiot N, 1998, J BIOL CHEM, V273, P13475, DOI 10.1074/jbc.273.22.13475
   Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200
   GIUDICELLI Y, 1977, BIOCHIM BIOPHYS ACTA, V486, P385, DOI 10.1016/0005-2760(77)90035-2
   Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006
   Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478
   Gustafsson J, 2007, SCAND J CLIN LAB INV, V67, P155, DOI 10.1080/00365510600995259
   Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com
   Hashimoto T, 2012, J CELL SCI, V125, P6127, DOI 10.1242/jcs.113084
   JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805
   Kawanami H, 2002, JPN J PHYSIOL, V52, P343, DOI 10.2170/jjphysiol.52.343
   Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910
   Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200
   Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200
   McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009
   Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352
   Moro C, 2009, J CLIN ENDOCR METAB, V94, P2579, DOI 10.1210/jc.2009-0051
   Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x
   Ogasawara J, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040876
   Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339
   Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200
   Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x
   Sato K, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-47
   Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, PE274, DOI 10.1152/ajpendo.00564.2010
   Satoor SN, 2011, SCI REP-UK, V1, P0, DOI 10.1038/srep00081
   Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464
   Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998
   Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, PE208, DOI 10.1152/ajpendo.00051.2003
   Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wohlers LM, 2011, J CELL BIOCHEM, V112, P3675, DOI 10.1002/jcb.23302
   Wohlers LM, 2010, J CELL BIOCHEM, V110, P420, DOI 10.1002/jcb.22553
   Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342
   You TJ, 2004, J CLIN ENDOCR METAB, V89, P1739, DOI 10.1210/jc.2003-031310
   Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200
NR 45
TC 28
Z9 35
U1 0
U2 20
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JUL 15
PY 2013
VL 115
IS 2
BP 260
EP 267
DI 10.1152/japplphysiol.00427.2013
PG 8
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA 183MH
UT WOS:000321819000015
PM 23681914
DA 2025-04-28
ER

PT J
AU Arçari, DP
   Santos, JC
   Gambero, A
   Ribeiro, ML
AF Arcari, Demetrius Paiva
   Santos, Juliana Carvalho
   Gambero, Alessandra
   Ribeiro, Marcelo Lima
TI The in vitro and in vivo effects of yerba mate (Ilex paraguariensis) extract on adipogenesis
SO FOOD CHEMISTRY
LA English
DT Article
DE Yerba mate; Obesity; Gene expression; Wnt pathway
ID oxidative stress biomarkers; activated-receptor-gamma; transcription factors; gene-expression; potential role; ppar-gamma; insulin; tea; protein; diet
AB The aim of this study was to evaluate the effects of yerba mate extract and its principal bioactive compounds on adipogenesis. The anti-adipogenic effects of yerba mate, chlorogenic acid, quercetin and rutin were evaluated in 3T3-L1 cells using a PCR array. The results obtained in vitro were validated in vivo in a high-fat diet-induced model of obesity. The in vitro and in vivo results demonstrated that yerba mate extract down-regulated the expression of genes that regulate adipogenesis, such as Creb-1 and C/EBP alpha, and the extract up-regulated the expression of genes related to the inhibition of adipogenesis, including Dlk1, Gata2, Gata3, Klf2, Lrp5, Ppar gamma 2, Sfrp1, Tcf7l2, Wnt10b, and Wnt3a. In summary, it was demonstrated that yerba mate and its bioactive compounds regulate the expression of genes related to in vitro adipogenesis. Furthermore, yerba mate might regulate adipogenesis through the Wnt pathway. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Arcari, Demetrius Paiva; Santos, Juliana Carvalho; Gambero, Alessandra; Ribeiro, Marcelo Lima] Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, BR-12900000 Braganca Paulista, SP, Brazil.
   [Arcari, Demetrius Paiva; Santos, Juliana Carvalho; Ribeiro, Marcelo Lima] Univ Estadual Campinas, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil.
C3 Universidade Sao Francisco; Universidade Estadual de Campinas
RP Ribeiro, ML (corresponding author), Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, Av Sao Francisco de Assis,218 Jd Sao Jose, BR-12900000 Braganca Paulista, SP, Brazil.
EM marcelo.ribeiro@usf.edu.br
FU FAPESP; CNPq
CR Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Fernandes ES, 2012, NUTRITION, V28, P1157, DOI 10.1016/j.nut.2012.04.011
   Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200
   Gosmann G, 2012, PLANT FOOD HUM NUTR, V67, P156, DOI 10.1007/s11130-012-0289-x
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Kaczynski J, 2003, GENOME BIOL, V4, P0, DOI 10.1186/gb-2003-4-2-206
   Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340
   Kang Young-Rye, 2012, LAB ANIM RES, V28, P23, DOI 10.5625/lar.2012.28.1.23
   Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3
   Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Morrison RF, 2000, J NUTR, V130, P3116S, DOI 10.1093/jn/130.12.3116S
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pereira DF, 2012, PHYTOMEDICINE, V19, P868, DOI 10.1016/j.phymed.2012.05.008
   Pimentel GD, 2012, J NUTR BIOCH, V24, P809
   Pomilio AB, 2002, PHYTOCHEM ANALYSIS, V13, P235, DOI 10.1002/pca.647
   Puangpraphant S, 2011, MOL NUTR FOOD RES, V55, P1509, DOI 10.1002/mnfr.201100128
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000
   Rodríguez E, 2004, OBES RES, V12, P1455, DOI 10.1038/oby.2004.182
   Rosen ED, 2000, GENE DEV, V14, P1293
   Santos Ana Paula, 2010, RECENT PAT FOOD NUTR AGRIC, V2, P195, DOI 10.2174/1876142911002030195
   Shen YN, 2009, BMB REP, V42, P691, DOI 10.5483/BMBRep.2009.42.10.691
   Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005
   Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173
   Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953
   Waxman A, 2005, WORLD REV NUTR DIET, V95, P162, DOI 10.1159/000088302
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
   Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200
NR 52
TC 54
Z9 58
U1 3
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD NOV 15
PY 2013
VL 141
IS 2
BP 809
EP 815
DI 10.1016/j.foodchem.2013.04.062
PG 7
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 183GW
UT WOS:000321803500021
PM 23790851
DA 2025-04-28
ER

PT J
AU Lopez, HL
   Ziegenfuss, TN
   Hofheins, JE
   Habowski, SM
   Arent, SM
   Weir, JP
   Ferrando, AA
AF Lopez, Hector L.
   Ziegenfuss, Tim N.
   Hofheins, Jennifer E.
   Habowski, Scott M.
   Arent, Shawn M.
   Weir, Joseph P.
   Ferrando, Arny A.
TI Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
DE Dietary supplement; Raspberry ketone; Adipokine; Body composition; Fat loss; Capsaicin
ID fat-free mass; adipose-specific protein; down-regulation; expenditure; adiponectin; caffeine; association; capsaicin; hypoadiponectinemia; thermogenesis
AB Background: Numerous natural products are marketed and sold claiming to decrease body weight and fat, but few undergo finished product-specific research demonstrating their safety and efficacy. Objective: To determine the safety and efficacy of a multi-ingredient supplement containing primarily raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium (Prograde Metabolism (TM) [METABO]) as an adjunct to an eight-week weight loss program. Methods: Using a randomized, placebo-controlled, double-blind design, 70 obese but otherwise healthy subjects were randomly assigned to METABO or a placebo and underwent 8 weeks of daily supplementation, a calorie restricted diet, and exercise training. Subjects were tested for changes in body composition, serum adipocytokines (adiponectin, resistin, leptin, TNF-alpha, IL-6) and markers of health including heart rate and blood pressure. Results: Of the 45 subjects who completed the study, significant differences were observed in: body weight (METABO -2.0% vs. placebo -0.5%, P < 0.01), fat mass (METABO -7.8 vs. placebo -2.8%, P < 0.001), lean mass (METABO +3.4% vs. placebo +0.8%, P < 0.03), waist girth (METABO -2.0% vs. placebo -0.2%, P < 0.0007), hip girth (METABO -1.7% vs. placebo -0.4%, P < 0.003), and energy levels per anchored visual analogue scale (VAS) (METABO +29.3% vs. placebo +5.1%, P < 0.04). During the first 4 weeks, effects/trends for maintaining elevated serum leptin (P < 0.03) and decreased serum resistin (P < 0.08) in the METABO group vs. placebo were also observed. No changes in systemic hemodynamics, clinical blood chemistries, adverse events, or dietary intake were noted between groups. Conclusions: METABO administration is a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. Adherence to the eight-week weight loss program also led to beneficial changes in body fat in placebo. Ongoing studies to confirm these results and clarify the mechanisms (i.e., biochemical and neuroendocrine mediators) by which METABO exerts the observed salutary effects are being conducted.
C1 [Lopez, Hector L.; Ziegenfuss, Tim N.; Hofheins, Jennifer E.; Habowski, Scott M.] Ctr Appl Hlth Sci, Stow, OH 44224 USA.
   [Arent, Shawn M.] Rutgers State Univ, Dept Exercise Sci & Sport Studies, New Brunswick, NJ 08901 USA.
   [Weir, Joseph P.] Univ Kansas, Dept Hlth Sport & Exercise Sci, Lawrence, KS 66045 USA.
   [Ferrando, Arny A.] Univ Arkansas Med Sci, Ctr Translat Res Aging & Longev, Little Rock, AR 72205 USA.
C3 Rutgers University System; Rutgers University New Brunswick; University of Kansas; University of Arkansas System; University of Arkansas Medical Sciences
RP Lopez, HL (corresponding author), Ctr Appl Hlth Sci, 4302 Allen Rd,STE 120, Stow, OH 44224 USA.
EM hl@appliedhealthsciences.org
FU Ultimate Wellness Systems Inc; Integrity Nutraceuticals Inc.; Ultimate Wellness Systems, Inc. (Lutz, FL)
CR Ahnis A, 2012, PATIENT PREFER ADHER, V6, P165, DOI 10.2147/PPA.S28022
   Albarracini CA, 2008, DIABETES-METAB RES, V24, P41, DOI 10.1002/dmrr.755
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104
   Ban JO, 2012, PHYTOTHER RES, V26, P1265, DOI 10.1002/ptr.3729
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G
   Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-72
   Campbell WW, 2009, OBESITY, V17, P1332, DOI 10.1038/oby.2009.2
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Ernsberger P, 2007, AM J HYPERTENS, V20, P866, DOI 10.1016/j.amjhyper.2007.02.015
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, PW822, DOI 10.1377/hlthaff.28.5.w822
   Goldstein ER, 2010, J INT SOC SPORT NUTR, V7, P0, DOI 10.1186/1550-2783-7-5
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hunter GR, 2008, OBESITY, V16, P1045, DOI 10.1038/oby.2008.38
   Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Inelmen EM, 2005, INT J OBESITY, V29, P122, DOI 10.1038/sj.ijo.0802846
   Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046
   Josse AR, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-65
   Keophiphath M, 2009, J NUTR, V139, P2055, DOI 10.3945/jn.109.105452
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Lohman TG, 1991, ANTHROPOMETRIC STANDARDIZATION REFERENCE MANUAL, V0, P0
   Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100
   Maridakis V, 2009, INT J NEUROSCI, V119, P975, DOI 10.1080/00207450802333995
   Martin CK, 2008, APPETITE, V51, P324, DOI 10.1016/j.appet.2008.03.002
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Okamoto M, 2011, J MED CHEM, V54, P6295, DOI 10.1021/jm200662c
   Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Sadashiv, 2012, WORLD J DIABETES, V3, P135, DOI 10.4239/wjd.v3.i7.135
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sahebkar A, 2011, WORLD J GASTROENTERO, V17, P271, DOI 10.3748/wjg.v17.i2.271
   Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664
   Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026
   Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x
   Valcour V, 2009, HIV MED, V10, P103, DOI 10.1111/j.1468-1293.2008.00658.x
   Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717
   Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 50
TC 38
Z9 45
U1 0
U2 84
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD APR 19
PY 2013
VL 10
IS 
BP 
EP 
DI 10.1186/1550-2783-10-22
PG 14
WC Nutrition & Dietetics; Sport Sciences
SC Nutrition & Dietetics; Sport Sciences
GA 139SK
UT WOS:000318604300001
PM 23601452
DA 2025-04-28
ER

PT J
AU Rondanelli, M
   Giacosa, A
   Opizzi, A
   Faliva, MA
   Sala, P
   Perna, S
   Riva, A
   Morazzoni, P
   Bombardelli, E
AF Rondanelli, Mariangela
   Giacosa, Attilio
   Opizzi, Annalisa
   Faliva, Milena Anna
   Sala, Patrizio
   Perna, Simone
   Riva, Antonella
   Morazzoni, Paolo
   Bombardelli, Ezio
TI Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE artichoke leaf extract; chlorogenic acid; cholesterol; dietary supplement; HDL cholesterol; luteolin
ID high-density-lipoprotein; coronary-heart-disease; cardiovascular-disease; paraoxonase activity; diabetes-mellitus; a-i; prevention; atherosclerosis; intervention; dyslipidemia
AB The aim of this study was to evaluate the effects of artichoke leaf extract (ALE) supplementation (250 mg, 2 b.i.d.) on the lipid pattern. A randomized, double-blind, placebo-controlled clinical trial was performed on 92 overweight subjects with primary mild hypercholesterolaemia for 8 weeks. Forty-six subjects were randomized to supplementation (age: 54.2 +/- 6.6 years, body mass index (BMI): 25.8 +/- 3.9 kg/m(2), male/female: 20/26) and 46 subjects to placebo (age: 53.8 +/- 9.0 years, BMI: 24.8 +/- 1.6 kg/m(2), male/female: 21/25). Verum supplementation was associated with a significant increase in mean high-density lipoprotein (HDL)-cholesterol (p < 0.001) and in mean change in HDL-cholesterol (HDL-C) (p = 0.004). A significantly decreased difference was also found for the mean change in total cholesterol (p = 0.033), low-density lipoprotein (LDL)-cholesterol (p < 0.001), total cholesterol/HDL ratio (p < 0.001) and LDL/HDL ratio (p < 0.001), when verum and placebo treatment were compared. These results indicate that ALE could play a relevant role in the management of mild hypercholesterolaemia, favouring in particular the increase in HDL-C, besides decreasing total cholesterol and LDL-cholesterol.
C1 [Rondanelli, Mariangela; Opizzi, Annalisa; Faliva, Milena Anna; Sala, Patrizio; Perna, Simone] Univ Pavia, Sect Human Nutr, Dept Hlth Sci, Azienda Serv Persona, I-27100 Pavia, Italy.
   [Giacosa, Attilio] Policlin Monza, Dept Gastroenterol, Milan, Italy.
   [Riva, Antonella; Morazzoni, Paolo; Bombardelli, Ezio] Indena SPA, I-20141 Milan, Italy.
C3 University of Pavia
RP Rondanelli, M (corresponding author), Univ Pavia, Endocrinol & Nutr Unit, Sect Human Nutr & Dietet, Dept Appl Hlth Sci,Fac Med,ASP, Via Palestro 3, I-27100 Pavia, Italy.
EM mariangela.rondanelli@unipv.it
CR Andersson LO, 1997, CURR OPIN LIPIDOL, V8, P225, DOI 10.1097/00041433-199708000-00006
   Unknown -, 1988, CIRCULATION, V77, P0
   BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488
   Boden WE, 2000, AM J CARDIOL, V86, P0
   Brown JE, 1998, FREE RADICAL RES, V29, P247, DOI 10.1080/10715769800300281
   Bundy R, 2008, PHYTOMEDICINE, V15, P668, DOI 10.1016/j.phymed.2008.03.001
   Coon JST, 2003, J FAM PRACTICE, V52, P470
   Englisch W, 2000, ARZNEIMITTELFORSCH, V50, P0
   Eriksson M, 1999, CIRCULATION, V100, P594, DOI 10.1161/01.CIR.100.6.594
   Forster-Coull L, 2004, BRIT COLUMBIA NUTR S, V0, P0
   FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808
   Gebhardt R, 2002, PHYTOTHER RES, V16, P368, DOI 10.1002/ptr.960
   Goldenberg I, 2009, AM J CARDIOL, V103, P41, DOI 10.1016/j.amjcard.2008.08.033
   GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9
   Gouédard C, 2004, MOL CELL BIOL, V24, P5209, DOI 10.1128/MCB.24.12.5209-5222.2004
   Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Kawashiri M A, 2000, CURR ATHEROSCLER REP, V2, P363, DOI 10.1007/s11883-000-0074-4
   Keys A, 1997, NUTRITION, V13, P250
   Kostapanos MS, 2010, AM J CARDIOVASC DRUG, V10, P11, DOI 10.2165/13168600-000000000-00000
   Küskü-Kiraz Z, 2010, PHYTOTHER RES, V24, P565, DOI 10.1002/ptr.2985
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lupattelli G, 2004, LIFE SCI, V76, P775, DOI 10.1016/j.lfs.2004.07.018
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146
   Mooradian AD, 2003, ARCH INTERN MED, V163, P33, DOI 10.1001/archinte.163.1.33
   Pandino G, 2010, J AGR FOOD CHEM, V58, P1026, DOI 10.1021/jf903311j
   Qiang ZY, 2012, PHYTOTHER RES, V26, P1048, DOI 10.1002/ptr.3698
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60
   Sirtori CR, 2009, ATHEROSCLEROSIS, V203, P8, DOI 10.1016/j.atherosclerosis.2008.06.019
   Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823
   van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9
   Wegener T, 1999, WIEN MED WOCHENSCHR, V149, P241
   Wider B, 2009, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003335.pub2
NR 35
TC 48
Z9 49
U1 1
U2 42
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD FEB 15
PY 2013
VL 64
IS 1
BP 7
EP 15
DI 10.3109/09637486.2012.700920
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 067JL
UT WOS:000313290000002
PM 22746542
DA 2025-04-28
ER

PT J
AU Browning, HF
   Laxer, RE
   Janssen, I
AF Browning, H. Frances
   Laxer, Rachel E.
   Janssen, Ian
TI Food and Eating Environments In Canadian Schools
SO CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH
LA English
DT Article
AB Purpose: This national study was conducted to examine healthy eating programs, healthy eating education, and the food retail environments of schools. Methods: A total of 436 Canadian schools were studied. Administrators completed a questionnaire designed to assess school healthy eating programs, healthy eating education, and food retail environment. The number of chain fast food restaurants, chain cafes/coffee shops, and convenience stores within 1 km of schools was measured using geographic information systems food retailer measures from DMTI Spatial Inc. and the Yellow Pages. Results: During the preceding year, 67% of schools had initiated healthy eating lunch programs while 18% had junk food-free days. The majority of schools offered cooking classes (59%) and healthy eating media literacy education (67%), while a minority offered gardening activities (15%) and field trips to farmers' markets (27%) and grocery stores (36%). Fifty-three percent had a school cafeteria, and most had a school tuck shop (75%) and pop/juice vending machines (76%). Fifty percent had a chain fast food restaurant, 33% had a chain cafe/coffee shop, and 41% had a convenience store within 1 km. Conclusions: An important aspect of addressing childhood obesity will be improving the food environments of schools and their surrounding neighbourhoods, and providing healthy eating education for all students.
C1 [Browning, H. Frances; Laxer, Rachel E.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.
   [Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada.
C3 Queens University - Canada; Queens University - Canada
RP Browning, HF (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.
FU Canadian Institutes of Health Research [MOP 9762, PCR 101415]; Heart and Stroke Foundation of Canada; Public Health Agency of Canada and Health Canada; Canada Research Chair position
CR BC Healthy Living Alliance, 2007, BC HLTH LIV ALL HLTH, V0, P0
   Bergen D, 2006, J AM DIET ASSOC, V106, P1866, DOI 10.1016/j.jada.2006.08.002
   Buscher LA, 2001, J AM DIET ASSOC, V101, P909, DOI 10.1016/S0002-8223(01)00223-1
   Campbell D, 2010, TAKEWAY BAN NEAR SCH, V0, P0
   Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033
   De Niet JE, 2011, MINERVA PEDIATR, V63, P491
   Finkelstein DM, 2008, PEDIATRICS, V122, PE251, DOI 10.1542/peds.2007-2814
   Garriguet D, 2004, OVERVIEW CANADIANS E, V0, P0
   Héroux M, 2012, HEALTH PLACE, V18, P1240, DOI 10.1016/j.healthplace.2012.09.004
   Institute of Medicine, 2005, PREVENTING CHILDHOOD, V0, P0
   Kubik MY, 2005, ARCH PEDIAT ADOL MED, V159, P1111, DOI 10.1001/archpedi.159.12.1111
   Ledrou Ingird, 2005, HEALTH REP, V16, P47
   Must A, 1999, INT J OBESITY, V23, PS2, DOI 10.1038/sj.ijo.0800852
   Neumark-Sztainer Dianne, 2005, INT J BEHAV NUTR PHYS ACT, V2, P14, DOI 10.1186/1479-5868-2-14
   Public Health Agency of Canada, 2011, ACT TAK FUT DIR 2011, V0, P0
   Public Health Agency of Canada, 2011, CURB CHILDH OB FED P, V0, P0
   Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813
   Seliske L, 2013, INT J BEHAV NUTR PHY, V10, P0, DOI 10.1186/1479-5868-10-19
   Seliske L, 2012, INT J ENV RES PUB HE, V9, P2715, DOI 10.3390/ijerph9082715
   Seliske LM, 2009, HEALTH PLACE, V15, P903, DOI 10.1016/j.healthplace.2008.11.001
   Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021
   Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x
   Tremblay Mark S, 2010, HEALTH REP, V21, P7
   Vanasse A, 2006, INT J OBESITY, V30, P677, DOI 10.1038/sj.ijo.0803168
NR 24
TC 21
Z9 25
U1 1
U2 20
PU DIETITIANS CANADA
PI TORONTO
PA 480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA
SN 1486-3847
EI 2292-9592
J9 CAN J DIET PRACT RES
JI Can. J. Diet. Pract. Res.
PD DEC 15
PY 2013
VL 74
IS 4
BP 160
EP 166
DI 10.3148/74.4.2013.160
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA V36RB
UT WOS:000209227400003
PM 24472163
DA 2025-04-28
ER

PT J
AU Júdice, PB
   Magalhaes, JP
   Santos, DA
   Matias, CN
   Carita, AI
   Armada-Da-Silva, PAS
   Sardinha, LB
   Silva, AM
AF Judice, Pedro B.
   Magalhaes, Joao P.
   Santos, Diana A.
   Matias, Catarina N.
   Carita, Ana Isabel
   Armada-Da-Silva, Paulo A. S.
   Sardinha, Luis B.
   Silva, Analiza M.
TI A moderate dose of caffeine ingestion does not change energy expenditure but decreases sleep time in physically active males: a double-blind randomized controlled trial
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article
DE caffeine; energy expenditure; physical activity; total sleep time; accelerometry; free-living conditions; body composition
ID fat oxidation; heart-rate; green tea; duration; obesity; association; calibration; metabolism; balance; model
AB Research on the effect of caffeine on energy expenditure (EE), physical activity (PA), and total sleep time (TST) during free-living conditions using objective measures is scarce. We aimed to determine the impact of a moderate dose of caffeine on TST, resting EE (REE), physical activity EE (PAEE), total EE (TEE), and daily time spent in sedentary, light, moderate, and vigorous intensity activities in a 4-day period and the acute effects on heart rate (HR) and EE in physically active males. Using a double-blind crossover trial (ClinicalTrials.gov ID: NCT01477294) with two conditions (4 days each with 3-day washout) randomly ordered as caffeine (5 mg/kg of body mass/day) and placebo (maltodextrin) administered twice per day (2.5 mg/kg), 30 nonsmoker males, low-caffeine users (<100 wmg/day), aged 20-39, were followed. Body composition was assessed by dual-energy X-ray absorptiometry. PA was assessed by accelerometry, while a combined HR and movement sensor estimated EE and HR on the second hour after the first administration dose. REE was assessed by indirect calorimetry, and PAEE was calculated as [TEE - (REE + 0.1TEE)]. TST and daily food records were obtained. Repeated measures ANOVA and ANCOVA were used. After a 4-day period, adjusting for fat-free mass, PAEE, and REE, TST was reduced (p = 0.022) under caffeine intake, while no differences were found between conditions for REE, PAEE, TEE, and PA patterns. Also, no acute effects on HR and EE were found between conditions. Though a large individual variability was observed, our findings revealed no acute or long-term effects of caffeine on EE and PA but decreased TST during free-living conditions in healthy males.
C1 [Judice, Pedro B.; Magalhaes, Joao P.; Santos, Diana A.; Matias, Catarina N.; Sardinha, Luis B.; Silva, Analiza M.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, Exercise & Hlth Lab, P-1499002 Cruz Quebrada, Portugal.
   [Carita, Ana Isabel] Univ Tecn Lisboa, Fac Motricidade Humana, BIOLAD CIPER, Math Methods Lab, P-1499002 Cruz Quebrada, Portugal.
   [Armada-Da-Silva, Paulo A. S.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, P-1499002 Cruz Quebrada, Portugal.
C3 Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa
RP Silva, AM (corresponding author), Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, Exercise & Hlth Lab, P-1499002 Cruz Quebrada, Portugal.
EM analiza@fmh.utl.pt
FU Hydration and Health Portuguese Institute
CR Adamec O, 2010, IEEE ENG MED BIO, V0, PP2342, DOI 10.1109/IEMBS.2010.5627774
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, PE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bland M, 1995, INTRO MED STAT, V2nd, P0
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006
   Butte NE, 2010, J NUTR, V140, P1516, DOI 10.3945/jn.109.120162
   Calamaro CJ, 2009, PEDIATRICS, V123, PE1005, DOI 10.1542/peds.2008-3641
   Carrier J, 2007, NEUROPSYCHOPHARMACOL, V32, P964, DOI 10.1038/sj.npp.1301198
   Carrier J, 2009, SLEEP MED, V10, P1016, DOI 10.1016/j.sleep.2009.01.001
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   CURRIE SR, 1995, CLIN J PAIN, V11, P214
   Drapeau C, 2006, J SLEEP RES, V15, P133, DOI 10.1111/j.1365-2869.2006.00518.x
   Drescher AA, 2011, J CLIN SLEEP MED, V7, P337, DOI 10.5664/JCSM.1182
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hamada T, 2008, TOHOKU J EXP MED, V214, P365, DOI 10.1620/tjem.214.365
   HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   James JE, 1998, NEUROPSYCHOBIOLOGY, V38, P32, DOI 10.1159/000026514
   Kawada T, 2012, INT J BEHAV MED, V19, P398, DOI 10.1007/s12529-011-9180-7
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521
   Lohman TG, 1988, ANTHROPOMETRIC STANDARDIZATION REFERENCE MANUAL, V0, P0
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   Paterson LM, 2009, J PSYCHOPHARMACOL, V23, P475, DOI 10.1177/0269881109104846
   PERKINS KA, 1994, AM J CLIN NUTR, V60, P312, DOI 10.1093/ajcn/60.3.312
   Porkka-Heiskanen Tarja, 2011, HANDB EXP PHARMACOL, V0, PP331, DOI 10.1007/978-3-642-13443-2_12
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   SENN S, 1993, STAT MED, V12, P2147, DOI 10.1002/sim.4780122208
   Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003
   Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23
   Troiano RP, 2005, MED SCI SPORT EXER, V37, PS487, DOI 10.1249/01.mss.0000185473.32846.c3
   Trost SG, 2005, MED SCI SPORT EXER, V37, PS531, DOI 10.1249/01.mss.0000185657.86065.98
   Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x
   Ward DS, 2005, MED SCI SPORT EXER, V37, PS582, DOI 10.1249/01.mss.0000185292.71933.91
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   World Medical Association, 2013, ETHICAL PRINCIPLES FOR MEDICAL RESEARCH INVOLVING HUMAN SUBJECTS, V0, P0, DOI DOI 10.1515/9783110208856.233
NR 46
TC 9
Z9 14
U1 2
U2 51
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JAN 15
PY 2013
VL 38
IS 1
BP 49
EP 56
DI 10.1139/apnm-2012-0145
PG 8
WC Nutrition & Dietetics; Physiology; Sport Sciences
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 081XH
UT WOS:000314355200009
PM 23368828
DA 2025-04-28
ER

PT J
AU Gavrieli, A
   Fragopoulou, E
   Mantzoros, CS
   Yannakoulia, M
AF Gavrieli, Anna
   Fragopoulou, Elizabeth
   Mantzoros, Christos S.
   Yannakoulia, Mary
TI Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Caffeine; Obesity; Women
ID type-2 diabetes-mellitus; hormone-binding globulin; decaffeinated coffee; prospective cohort; chlorogenic acid; menstrual-cycle; tolerance test; blood-glucose; double-blind; consumption
AB Objective. To examine the effects of different coffee amounts on blood glucose and insulin concentrations of healthy volunteers, and to assess potential effect modification by sex and body mass index category. Materials/Methods. Thirty-three volunteers [16 female/17 male, 16 normal-weight and 17 overweight/obese, 27.3 +/- 7.2 (19-44) y] took part in this randomized, crossover study. In the morning of each experimental day volunteers received a standardized meal along with 200 mL of water or instant coffee containing either 3 or 6 mg of caffeine/kg body weight. Blood samples were obtained and analyzed for glucose and insulin concentrations in the fasting state, immediately after meal/drink consumption and at standard time points for the next 3 h thereafter. Results. Coffee delayed the rise of insulin in response to the standardized meal and the fall of glucose concentrations from its maximum levels in the entire study sample. Glucose incremental area under the curve (IAUC) was significantly different between interventions (P = .009) with both coffee amounts inducing a greater area compared to water. Secondary, subgroup analysis at the nominal level showed that this might be more evident among females (P-IAUC = .05) and overweight/obese participants (P-IAUC = .03). Furthermore, coffee, mainly the 6 mg dose, could be lowering insulin concentrations the first 30 min after its consumption compared to water in men and overweight/obese participants. Conclusions. Coffee exerts an acute effect on postprandial glucose and insulin concentrations. This effect may be modified by sex and overweight/obese status. Future research is necessary to elucidate underlying mechanisms. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Gavrieli, Anna; Fragopoulou, Elizabeth; Yannakoulia, Mary] Harokopio Univ, Dept Nutr & Dietet, Athens 17671, Greece.
   [Mantzoros, Christos S.] VA Boston Healthcare Syst, Endocrinol Sect, Boston, MA USA.
   [Mantzoros, Christos S.] Beth Israel Deaconess Med Ctr Boston, Div Endocrinol Diabet & Metab, Boston, MA USA.
C3 Harokopio University Athens; Harvard University; Harvard University Medical Affiliates; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard University Medical Affiliates; Beth Israel Deaconess Medical Center
RP Yannakoulia, M (corresponding author), Harokopio Univ, Dept Nutr & Dietet, Athens 17671, Greece.
EM myiannak@hua.gr
FU Department of Nutrition and Dietetics, Harokopio University.
CR Unknown -, 2012, USDA NAT NUTR DAT ST, V0, P0
   Unknown -, 2012, GLOBAL DATABASE ON BODY MASS INDEX, V0, P0
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Brennan IM, 2009, AM J PHYSIOL-GASTR L, V297, PG602, DOI 10.1152/ajpgi.00051.2009
   Chao CY, 2011, METABOLISM, V60, P799, DOI 10.1016/j.metabol.2010.07.031
   Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Goralczyk T, 2012, METABOLISM, V61, P1171, DOI 10.1016/j.metabol.2011.12.013
   Goto A, 2011, DIABETES, V60, P269, DOI 10.2337/db10-1193
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Krebs JD, 2012, METABOLISM, V0, P0
   Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014
   Lane JD, 2004, DIABETES CARE, V27, P2047, DOI 10.2337/diacare.27.8.2047
   LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Lovallo WR, 1996, PHARMACOL BIOCHEM BE, V55, P365, DOI 10.1016/S0091-3057(96)00105-0
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   MISHKINSKY J, 1967, LANCET, V2, P1311
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Mooren FC, 2011, DIABETES OBES METAB, V13, P281, DOI 10.1111/j.1463-1326.2010.01332.x
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Pulido JME, 1999, ARCH MED RES, V30, P19, DOI 10.1016/S0188-0128(98)00008-6
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI 10.1139/H11-072
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
   WACHMAN A, 1970, METABOLIS, V19, P539, DOI 10.1016/0026-0495(70)90009-0
   Wedick NM, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-86
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
NR 40
TC 26
Z9 30
U1 0
U2 31
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 
J9 METABOLISM
JI Metab.-Clin. Exp.
PD AUG 15
PY 2013
VL 62
IS 8
BP 1099
EP 1106
DI 10.1016/j.metabol.2013.02.003
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 195ED
UT WOS:000322684200011
PM 23498899
DA 2025-04-28
ER

PT J
AU Narita, Y
   Inouye, K
AF Narita, Yusaku
   Inouye, Kuniyo
TI Degradation Kinetics of Chlorogenic Acid at Various pH Values and Effects of Ascorbic Acid and Epigallocatechin Gallate on Its Stability under Alkaline Conditions
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE chlorogenic acid; caffeic acid; (-)-epigallocatechin gallate; degradation kinetics; Weibull equation
ID green coffee beans; nonlinear least-squares; caffeic acid; thermal-stability; derivatives; l.; identification; polyphenolics; oxidation; extract
AB 5-Caffeoylquinic acid (5-CQA) is generally referred to as chlorogenic acid and exhibits various biological activities such as antioxidant activity and porcine pancreas a-amylase inhibitory activities. 5-CQA may be useful as an antioxidant for food and to prevent diabetes and obesity. The degradation of 5-CQA and caffeic acid (CA) in an aqueous solution at 37 degrees C and pH 5.0-9.0 was studied. The degradation of 5-CQA and CA, demonstrating time and pH dependence (i.e., the rate constant, k, was higher at higher pH), was satisfactorily described by the Weibull equation. The stability of 5-CQA at pH 7.4 and 9.0 was improved by adding (-)-epigallocatechin gallate (EGCG) and ascorbic acid (AA). Moreover, the degradation of 5-CQA in the presence of EGCG or AA could be described by the Weibull equation. The k value in the presence of EGCG or AA was dependent on their concentration.
C1 [Narita, Yusaku; Inouye, Kuniyo] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.
   [Narita, Yusaku] UCC Ueshima Coffee Co Ltd, R&D Ctr, Takatsuki, Osaka 5690036, Japan.
C3 Kyoto University
RP Inouye, K (corresponding author), Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.
EM inouye@kais.kyoto-u.ac.jp
CR Unknown -, 1976, BIOCHEM J, V153, P23
   Arakawa R, 2004, J AM SOC MASS SPECTR, V15, P1228, DOI 10.1016/j.jasms.2004.05.007
   Chen ZY, 1998, J AGR FOOD CHEM, V46, P2512, DOI 10.1021/jf971022g
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Cunha LM, 1998, J FOOD ENG, V37, P175, DOI 10.1016/S0260-8774(98)00085-5
   Dawidowicz AL, 2011, EUR FOOD RES TECHNOL, V233, P223, DOI 10.1007/s00217-011-1513-x
   Dawidowicz AL, 2010, J AGR FOOD CHEM, V58, P12578, DOI 10.1021/jf103373t
   de Levie R, 1999, J CHEM EDUC, V76, P1594, DOI 10.1021/ed076p1594
   Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   Harris DC, 1998, J CHEM EDUC, V75, P119, DOI 10.1021/ed075p119
   Hotta H, 2002, ANAL BIOCHEM, V303, P66, DOI 10.1006/abio.2002.5577
   Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166
   Islam MS, 2002, J AGR FOOD CHEM, V50, P3718, DOI 10.1021/jf020120l
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Iwai K, 2012, FOOD SCI TECHNOL RES, V18, P849, DOI 10.3136/fstr.18.849
   Jin UH, 2005, LIFE SCI, V77, P2760, DOI 10.1016/j.lfs.2005.02.028
   Khajavi SH, 2005, J FOOD ENG, V68, P309, DOI 10.1016/j.jfoodeng.2004.06.004
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Kurata R, 2007, J AGR FOOD CHEM, V55, P185, DOI 10.1021/jf0620259
   Ky CL, 2001, FOOD CHEM, V75, P223, DOI 10.1016/S0308-8146(01)00204-7
   Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206
   Manso MC, 2001, INT J FOOD SCI TECH, V36, P303, DOI 10.1046/j.1365-2621.2001.t01-1-00460.x
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   MURATA M, 1995, BIOSCI BIOTECH BIOCH, V59, P1887, DOI 10.1271/bbb.59.1887
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Narita Y, 2011, FOOD CHEM, V127, P1532, DOI 10.1016/j.foodchem.2011.02.013
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Oomori T, 2004, BIOCHEM ENG J, V18, P143, DOI 10.1016/j.bej.2003.08.002
   Shima M, 2007, J BIOSCI BIOENG, V103, P278, DOI 10.1263/jbb.103.278
   Takenaka M, 2003, J AGR FOOD CHEM, V51, P793, DOI 10.1021/jf020735i
   TRUGO LC, 1984, ANALYST, V109, P263, DOI 10.1039/an9840900263
   Watanabe Y, 2009, JAPAN JOURNAL OF FOOD ENGINEERING, V0, P0, DOI DOI 10.11301/jsfe.10.117
   Xie C, 2011, J AGR FOOD CHEM, V59, P11078, DOI 10.1021/jf203104k
   Yoshimoto M, 2002, BIOSCI BIOTECH BIOCH, V66, P2336, DOI 10.1271/bbb.66.2336
   Zhang HY, 1997, ANAL LETT, V30, P1293, DOI 10.1080/00032719708007217
   Zhao YK, 2000, CHROMATOGRAPHIA, V51, P483, DOI 10.1007/BF02490489
NR 39
TC 82
Z9 96
U1 1
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JAN 30
PY 2013
VL 61
IS 4
BP 966
EP 972
DI 10.1021/jf304105w
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 083VF
UT WOS:000314492600024
PM 23298331
DA 2025-04-28
ER

PT J
AU Vernarelli, JA
   Lambert, JD
AF Vernarelli, Jacqueline A.
   Lambert, Joshua D.
TI Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE NHANES; Tea; Obesity; Waist circumference; BMI; Metabolic syndrome
ID sugar-sweetened beverages; green tea; energy-expenditure; body-weight; risk; inhibition; prevention; obesity; coffee; fat
AB Tea (Camellia sinensis) is a widely consumed beverage, and laboratory and some intervention studies have indicated the potential health benefits of hot tea. The present study examines the association between tea consumption (evaluating hot and iced tea independently) and markers for metabolic syndrome adults in a sample of 6,472 who participated in the 2003-2006 National Health and Nutrition Examination surveys. Tea consumption was evaluated using food frequency questionnaires and 24-h dietary recalls. Seventy percent of the sample reported any consumption of iced tea and 16 % were daily consumers, whereas approximately 56 % of this sample reported hot tea consumption and 9 % were daily consumers. Hot tea consumption was inversely associated with obesity: tea consumers had lower mean waist circumference and lower BMI (25 vs. 28 kg/m(2) in men; 26 vs. 29 kg/m(2) in women; both P < 0.01) than non-consumers after controlling for age, physical activity, total energy intake, and other confounders. For iced tea consumption, the association was reversed: increased iced tea consumption was associated with higher BMI, greater waist circumference, and greater subcutaneous skinfold thickness after controlling for age, physical activity, energy intake, sugar intake, and other confounders. Hot tea consumption was associated with beneficial biomarkers of cardiovascular disease risk and inflammation (increased high-density lipoprotein-associated cholesterol and decreased C-reactive protein in both sexes, and reduced triglycerides in women), whereas the association with iced tea consumption was again reversed. These cross-sectional results support growing laboratory data, which demonstrate the negative association of hot tea intake with markers of MetS.
C1 [Vernarelli, Jacqueline A.] Penn State Univ, Dept Nutr Sci, Chandlee Lab 110, University Pk, PA 16802 USA.
   [Vernarelli, Jacqueline A.; Lambert, Joshua D.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Penn State Behrend; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Penn State Behrend
RP Vernarelli, JA (corresponding author), Penn State Univ, Dept Nutr Sci, Chandlee Lab 110, University Pk, PA 16802 USA.
EM jvern@psu.edu; jdl134@psu.edu
FU National Institutes of Health [AT 004678]
CR Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brewer HB, 2011, J CLIN ENDOCR METAB, V96, P1246, DOI 10.1210/jc.2010-0163
   de Couto G, 2010, NAT REV CARDIOL, V7, P334, DOI 10.1038/nrcardio.2010.51
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Goris AHC, 2000, AM J CLIN NUTR, V71, P130
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   HOLLANDS MA, 1981, AM J CLIN NUTR, V34, P2291, DOI 10.1093/ajcn/34.10.2291
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kim MK, 2011, DIABETES RES CLIN PR, V93, P174, DOI 10.1016/j.diabres.2011.04.009
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Liang YC, 2002, NUTR CANCER, V42, P217, DOI 10.1207/S15327914NC422_11
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Seeram NP, 2008, J AGR FOOD CHEM, V56, P1415, DOI 10.1021/jf073035s
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Tooze JA, 2004, AM J CLIN NUTR, V79, P795
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Ukil A, 2006, BRIT J PHARMACOL, V149, P121, DOI 10.1038/sj.bjp.0706847
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
   Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008
NR 35
TC 73
Z9 80
U1 0
U2 64
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD APR 15
PY 2013
VL 52
IS 3
BP 1039
EP 1048
DI 10.1007/s00394-012-0410-9
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 119DY
UT WOS:000317078900018
PM 22777108
DA 2025-04-28
ER

PT J
AU Gosselin, C
   Haman, F
AF Gosselin, Chantal
   Haman, Francois
TI Effects of green tea extracts on non-shivering thermogenesis during mild cold exposure in young men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Epigallocatechin-3-gallate; Caffeine; Non-shivering thermogenesis
ID brown adipose-tissue; energy-expenditure; fuel selection; muscle glycogen; carbohydrate availability; catechin-polyphenols; plasma-glucose; fat oxidation; humans; caffeine
AB The effects of epigallocatechin-3-gallate (EGCG) and caffeine on non-shivering thermogenesis (NST) during cold exposure is unknown. The purpose of the present study was to quantify the effects of co-ingesting EGCG and caffeine on the thermogenic responses of a 3 h cold exposure. A total of eight healthy males were exposed to mild cold, using a liquid-conditioned suit perfused with 15 degrees C water, on two occasions and consumed a placebo or an extract of 1600 mg of EGCG and 600 mg of caffeine (Green tea). Thermic, metabolic and electromyographic measurements were monitored at baseline and during the cold exposure. Results showed that the AUC of shivering intensity over the cold exposure period was reduced by approximately 20% in the Green tea (266 (SEM 6)% maximal voluntary contraction (MVC) x min) compared with the Placebo (332 (SEM 69)% MVC x min) (P=0.01) treatments. In contrast, the total AUC for energy expenditure (EE) was approximately 10% higher in the Green tea (23.5 (SEM 1.4) kJ/kg x 180 min) compared with the Placebo (327 (SEM 74) kJ/kg 180 min) (P=0.007) treatments. The decrease in shivering activity combined with an increase in EE, following the ingestion of EGCG and caffeine during the cold exposure, indicates that NST pathways can be significantly stimulated in adult human subjects. The present study provides an experimental approach for human investigations into the potential role of diet and bioactive food ingredients in modulating NST during cold exposure. Stimulating NST pathways in such a manner may also provide important targets in the search of targets for the management of obesity and diabetes.
C1 [Gosselin, Chantal; Haman, Francois] Hop Montfort, Unite Rech Nutr & Metab, Ottawa, ON K1K 0T2, Canada.
   [Gosselin, Chantal; Haman, Francois] Univ Ottawa, Ottawa, ON K1N 6N5, Canada.
C3 University of Ottawa; University of Ottawa
RP Haman, F (corresponding author), Hop Montfort, Unite Rech Nutr & Metab, 713 Chemin Montreal, Ottawa, ON K1K 0T2, Canada.
EM fhaman@uottawa.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC Canada); Ontario Graduate Scholarship (OGS)
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ASTRUP A, 1985, AM J PHYSIOL, V248, PE507, DOI 10.1152/ajpendo.1985.248.5.E507
   Bartness TJ, 2010, INT J OBESITY, V34, PS36, DOI 10.1038/ijo.2010.182
   Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409
   BELL DG, 1992, J APPL PHYSIOL, V72, P2336, DOI 10.1152/jappl.1992.72.6.2336
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535
   Blondin DP, 2012, MED SCI SPORT EXER, V44, P1706, DOI 10.1249/MSS.0b013e318254e952
   Blondin DP, 2011, J APPL PHYSIOL, V111, P1014, DOI 10.1152/japplphysiol.00293.2011
   Blondin DP, 2010, J APPL PHYSIOL, V109, P654, DOI 10.1152/japplphysiol.00440.2010
   Blondin DP, 2010, EUR J APPL PHYSIOL, V108, P289, DOI 10.1007/s00421-009-1210-7
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1984, BRIT J NUTR, V52, P179, DOI 10.1079/BJN19840087
   ELIA M, 1991, AM J PHYSIOL, V260, PE75, DOI 10.1152/ajpendo.1991.260.1.E75
   Garofalo MAR, 1996, J AUTONOM NERV SYST, V60, P206, DOI 10.1016/0165-1838(96)00037-9
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005
   Haman F, 2005, J PHYSIOL-LONDON, V566, P247, DOI 10.1113/jphysiol.2005.086272
   Haman F, 2004, J PHYSIOL-LONDON, V556, P305, DOI 10.1113/jphysiol.2003.055152
   Haman F, 2004, J APPL PHYSIOL, V96, P41, DOI 10.1152/japplphysiol.00428.2003
   Haman F, 2004, J APPL PHYSIOL, V96, P32, DOI 10.1152/japplphysiol.00427.2003
   Haman F, 2002, J APPL PHYSIOL, V93, P77, DOI 10.1152/japplphysiol.00773.2001
   Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461
   HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44
   JANSKY L, 1973, BIOL REV, V48, P85
   Kim J, 2008, J THEOR BIOL, V251, P523, DOI 10.1016/j.jtbi.2007.12.005
   Lichtenbelt WDV, 2003, CURR OPIN CLIN NUTR, V6, P469, DOI 10.1097/01.mco.0000078992.96795.5f
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   MACNAUGHTON KW, 1990, J APPL PHYSIOL, V68, P1889, DOI 10.1152/jappl.1990.68.5.1889
   Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   VALLERAND AL, 1989, J APPL PHYSIOL, V67, P438, DOI 10.1152/jappl.1989.67.1.438
   Vallerand AL, 1999, AVIAT SPACE ENVIR MD, V70, P42
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 44
TC 38
Z9 40
U1 0
U2 37
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUL 28
PY 2013
VL 110
IS 2
BP 282
EP 288
DI 10.1017/S0007114512005089
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 166HD
UT WOS:000320544400009
PM 23237788
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Loizzo, MR
   Nicoletti, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Loizzo, Monica Rosa
   Nicoletti, Marcello
   Menichini, Francesco
   Conforti, Filomena
TI Inhibition of Key Enzymes Linked to Obesity by Preparations From Mediterranean Dietary Plants: Effects on α-Amylase and Pancreatic Lipase Activities
SO PLANT FOODS FOR HUMAN NUTRITION
LA English
DT Article
DE Wild edible plants; Pancreatic lipase; alpha-amylase; Inhibitors; Phenolic composition; Lipophilic composition
ID glucosidase inhibitors
AB One of the most important strategy in the treatment of obesity includes the development of nutrient digestion and absorption inhibitors. Inhibition of digestive enzymes is one of the most widely studied mechanisms used to determine the potential efficacy of natural products as hypolipidemic and hypoglycaemic agents. In vitro studies here reported were performed to evaluate the inhibitory activity of five species (as hydroalcoholic extracts) of edible plants from Calabria region (Italy) on amylase and lipase by monitoring the hydrolysis of p-NPC and the hydrolysis of glycoside bonds in digestible carbohydrate foods. The formulation obtained from Clematis vitalba L. exhibited the strongest inhibitory effect on pancreatic lipase (IC50 = 0.99 mg/ml) and on alpha-amylase (IC50 = 31.52 mu g/ml). In order to explore metabolome production HPTLC analysis of the extracts was performed, revealing the predominance of (+/-)-catechin, caffeic acid and chlorogenic acid in C. vitalba formulation at concentration of 23.18 +/- 3.14, 13.63 +/- 0.65 and 18.88 +/- 0.76 mg/g, respectively. GC/MS analysis was used to identify fatty acids and terpene composition.
C1 [Marrelli, Mariangela; Loizzo, Monica Rosa; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
   [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy.
C3 University of Calabria; Sapienza University Rome
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
CR Adisakwattana S, 2013, PLANT FOOD HUM NUTR, V66, P143
   Barrett ML, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-24
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Chen XL, 2006, CURR MED CHEM, V13, P109, DOI 10.2174/092986706789803035
   CHIASSON JL, 2006, TRIAL END PRACT, V1, P25
   Conforti F, 2008, FOOD CHEM TOXICOL, V46, P3325, DOI 10.1016/j.fct.2008.08.004
   Conforti F, 2012, PHYTOTHER RES, V26, P600, DOI 10.1002/ptr.3603
   Elkhayat ES, 2008, J ASIAN NAT PROD RES, V10, P1039, DOI 10.1080/10286020802320590
   Glensk M, 1999, J NAT PROD, V62, P717, DOI 10.1021/np980505r
   Loizzo MR, 2008, J MED FOOD, V11, P184, DOI 10.1089/jmf.2007.638
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Morikawa T, 2010, YAKUGAKU ZASSHI, V130, P673, DOI 10.1248/yakushi.130.673
   MULIMANI VH, 1993, PLANT FOOD HUM NUTR, V44, P181, DOI 10.1007/BF01088383
   Nair SindhuS, 2013, EUR J EXP BIOL, V3, P128
   Nicoletti M, 2011, REV BRAS FARMACOGN, V21, P818, DOI 10.1590/S0102-695X2011005000131
   Piccin A, 2012, NUTRAFOODS, V11, P29
   Rekha MR, 2002, PLANT FOOD HUM NUTR, V57, P285, DOI 10.1023/A:1021837115267
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
NR 19
TC 52
Z9 53
U1 2
U2 57
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-9668
EI 1573-9104
J9 PLANT FOOD HUM NUTR
JI Plant Food Hum. Nutr.
PD DEC 15
PY 2013
VL 68
IS 4
BP 340
EP 346
DI 10.1007/s11130-013-0390-9
PG 7
WC Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Plant Sciences; Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 253JS
UT WOS:000327081800002
PM 24122547
DA 2025-04-28
ER

PT J
AU Melo, ASC
   Moreira, JS
   Noites, A
   Couto, MF
   Melo, CA
AF Melo, A. S. C.
   Moreira, J. S.
   Noites, A.
   Couto, M. F.
   Argel Melo, C.
TI Clay body wrap with microcurrent: Effects in central adiposity
SO APPLIED CLAY SCIENCE
LA English
DT Article
DE Central adiposity; Body wrap; Microcurrent; Green clay; Physical exercise
ID skin penetration; exercise; health; theophylline; adipocytes; minerals; aluminum; caffeine; tissue; energy
AB Introduction: Increased fat mass is becoming more prevalent in women and its accumulation in the abdominal region can lead to numerous health risks such as diabetes mellitus. The clay body wrap using compounds such as green clay, green tea and magnesium sulfate, in addition to microcurrent, may reduce abdominal fat mass and minimize or prevent numerous health problems. Objective: This study aims at measuring the influence of the clay body wrap with microcurrent and aerobic exercise on abdominal fat. Methods: Nineteen female patients, randomized into intervention (n = 10) and control (n = 9) groups, were evaluated using ultrasound for visceral and subcutaneous abdominal fat, calipers and abdominal region perimeter for subcutaneous fat and bioimpedance for weight, fat mass percentage and muscular mass. During 10 sessions (5 weeks, twice a week) both groups performed aerobic exercise in a cycloergometer and a clay body wrap with microcurrent was applied to the intervention group. Results: When comparing both groups after 5 weeks of protocol, there was a significant decrease in the subcutaneous fat around left anterior superior iliac spine in the intervention group (p = 0.026 for a confidence interval 95%). When comparing initial and final abdominal fat in the intervention group, measured by ultrasound (subcutaneous and visceral fat) and by skinfold (subcutaneous fat), we detected a significant abdominal fat reduction. Conclusion: This study demonstrated that the clay body wrap used with microcurrent and aerobic exercise can have a positive effect on central fat reduction. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Melo, A. S. C.] Oporto Polytech Inst, Sch Allied Hlth Sci, P-4400330 Vila Nova De Gaia, Portugal.
C3 Instituto Politecnico do Porto
RP Melo, ASC (corresponding author), Oporto Polytech Inst, Sch Allied Hlth Sci, Rua Valente Perfeito 322, P-4400330 Vila Nova De Gaia, Portugal.
EM ana.scmelo@gmail.com
CR Unknown -, 2006, JECFA67SC, V0, P0
   Bajerska J, 2011, NUTR RES, V31, P157, DOI 10.1016/j.nutres.2011.01.005
   Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572
   Boonen J, 2011, PHARMAZIE, V66, P463, DOI 10.1691/ph.2011.0854
   Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0
   Cook CE, 2008, J MAN MANIP THER, V16, P5, DOI 10.1179/106698108790818558
   Corvis Y, 2007, LANGMUIR, V23, P3338, DOI 10.1021/la0629429
   Curtis D, 2010, J BODYWORK MOVEMENT, V0, P1
   dal Belo SE, 2009, SKIN PHARMACOL PHYS, V22, P299, DOI 10.1159/000241299
   EMA European Medicines Agency - Science Medicines Health, 2010, EMACHMP3810642010, V0, P0
   Eston R, 2009, KINANTHROPOMETRY EXE, V1, P0
   Flarend R, 2001, FOOD CHEM TOXICOL, V39, P163, DOI 10.1016/S0278-6915(00)00118-6
   Freedland ES, 2004, NUTR METAB, V1, P1
   GOATES CY, 1994, BBA-BIOMEMBRANES, V1195, P169, DOI 10.1016/0005-2736(94)90024-8
   Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777
   Heinrich MBJ, 2004, FUNDAMENTALS PHARMAC, V1st, P0
   Horowitz JF, 2003, TRENDS ENDOCRIN MET, V14, P386, DOI 10.1016/S1043-2760(03)00143-7
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   Kirsch D, 2002, PAIN MANAGEMENT PRAC, V0, P149
   Komatsu Tatsushi, 2003, JOURNAL OF MEDICAL INVESTIGATION, V50, P170
   Laudanska Halina, 2002, RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, V112, P16
   Lin J, 2005, OBES RES, V0, P982
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2
   Miquel-Jeanjean C, 2012, PHOTOCHEM PHOTOBIOL, V88, P1513, DOI 10.1111/j.1751-1097.2012.01181.x
   Nafisi S, 2004, J MOL STRUCT, V705, P35, DOI 10.1016/j.molstruc.2004.04.022
   Nafisi S, 2002, J MOL STRUCT, V608, P1, DOI 10.1016/S0022-2860(01)00876-6
   ODonovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212
   Pénicaud L, 2000, NUTRITION, V16, P903, DOI 10.1016/S0899-9007(00)00427-5
   Puhar I, 2011, J PERIODONTAL IMPLAN, V41, P117, DOI 10.5051/jpis.2011.41.3.117
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rawlings AV, 2006, INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, V28, P175, DOI 10.1111/j.1467-2494.2006.00318.x
   Rayssiguier Y, 1990, MAGNES RES, V3, P93
   Rosner B, 2006, FUNDAMENTALS OF BIOSTATISTICS, V0, P0
   Rumberger JM, 2004, DIABETES, V53, P2535, DOI 10.2337/diabetes.53.10.2535
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   SHANI J, 1985, PHARMACOL RES COMMUN, V17, P501, DOI 10.1016/0031-6989(85)90123-7
   Soma M, 2003, LPIDS LIPID METABOLI, V0, P0
   Standring Susan, 2008, ANTERIOR ABDOMINAL W, V0, P1059
   Tateo F, 2007, APPL CLAY SCI, V36, P64, DOI 10.1016/j.clay.2006.05.011
   Vogels E, 2003, CLINICAL PRACTICE GUIDELINES FOR PHYSICAL THERAPY IN CARDIAC REHABILITATION. KNGF-GUIDELINES FOR PHYSICAL THERAPY IN CARDIAC REHABILITATION, V0, P0
   Westphal Sydney A, 2008, CLIN CORNERSTONE, V9, P23, DOI 10.1016/S1098-3597(08)60025-3
   WHO (World Health Organization), 2006, WHO GLOB DAT BMI, V0, P0
   Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144
NR 44
TC 5
Z9 6
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
EI 1872-9053
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD AUG 15
PY 2013
VL 80-81
IS 
BP 140
EP 146
DI 10.1016/j.clay.2013.06.017
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA 226LZ
UT WOS:000325039100019
DA 2025-04-28
ER

PT J
AU Lee, SR
   Schriefer, JM
   Gunnels, TA
   Harvey, IC
   Bloomer, RJ
AF Lee, Sang-Rok
   Schriefer, JohnHenry M.
   Gunnels, Trint A.
   Harvey, Innocence C.
   Bloomer, Richard J.
TI Acute oral intake of a higenamine-based dietary supplement increases circulating free fatty acids and energy expenditure in human subjects
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Lipolysis; Thermogenesis; Fat mobilization; Weight loss; Nutritional supplements
ID sympathetic-nerve activity; lipid mobilization; metabolic-rate; obese women; caffeine; yohimbine; men; oxidation; lipolysis; mice
AB Background: Higenamine, also known as norcoclaurine, is an herbal constituent thought to act as a beta-2 adrenergic receptor agonist-possibly stimulating lipolysis. It was the purpose of this study to determine the impact of a higenamine-based dietary supplement on plasma free fatty acids and energy expenditure following acute oral ingestion. Methods: Sixteen healthy subjects (8 men; 26.1 +/- 2.5 yrs; 8 women 22.4 +/- 3.1 yrs) ingested a dietary supplement containing a combination of higenamine, caffeine (270 mg), and yohimbe bark extract or a placebo, on two separate occasions in a double-blind, randomized, cross-over design, separated by 6-8 days. Blood samples were collected immediately before ingestion, and at 30, 60, 120, and 180 minutes post ingestion, and analyzed for plasma free fatty acids (FFA) and glycerol. Breath samples were collected at the same times for a measure of kilocalorie expenditure and respiratory exchange ratio (RER) using indirect calorimetry. Heart rate and blood pressure were recorded at all times. Data collection occurred in the morning following a 10 hour overnight fast. Results: A condition effect was noted for both FFA (p < 0.0001) and kilocalorie expenditure (p = 0.001), with values higher for supplement compared to placebo at 60, 120, and 180 minutes post ingestion. No statistically significant effects were noted for glycerol or RER (p > 0.05). A condition effect was noted for heart rate (p = 0.03) and systolic blood pressure (p < 0.0001), with values higher for supplement compared to placebo. Conclusion: Ingestion of a higenamine-based dietary supplement stimulates lipolysis and energy expenditure, as evidenced by a significant increase in circulating FFA and kilocalorie expenditure. The same supplement results in a moderate increase in heart rate (similar to 3 bpm) and systolic blood pressure (similar to 12 mmHg), which is consistent with previous studies evaluating moderate doses of caffeine and yohimbine, suggesting that higenamine contributes little to the increase in these hemodynamic variables. These findings are in reference to young, healthy and active men and women.
C1 [Lee, Sang-Rok; Schriefer, JohnHenry M.; Gunnels, Trint A.; Harvey, Innocence C.; Bloomer, Richard J.] Univ Memphis, Dept Hlth & Sport Sci, Cardioresp Metab Lab, Memphis, TN 38152 USA.
C3 University of Memphis
RP Bloomer, RJ (corresponding author), Univ Memphis, Dept Hlth & Sport Sci, Cardioresp Metab Lab, 106 Roane Field House, Memphis, TN 38152 USA.
EM rbloomer@memphis.edu
FU USPlabs, LLC; University of Memphis
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Unknown -, 2009, NCHS DATA BRIEF, V0, P0, DOI DOI 10.CDC/NCHS
   BERLAN M, 1991, INT J OBESITY, V15, P305
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, P0, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, P0, DOI 10.1186/1550-2783-6-10
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Feng S, 2012, ACTA PHARMACOL SIN, V33, P1353, DOI 10.1038/aps.2012.114
   GALITZKY J, 1988, EUR J CLIN INVEST, V18, P587, DOI 10.1111/j.1365-2362.1988.tb01272.x
   GALITZKY J, 1991, BRIT J PHARMACOL, V104, P514, DOI 10.1111/j.1476-5381.1991.tb12460.x
   GOLDSTEIN DS, 1991, HYPERTENSION, V18, P0
   GROSSMAN E, 1991, AM J PHYSIOL, V260, PR142, DOI 10.1152/ajpregu.1991.260.1.R142
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Hartley TR, 2004, AM J CARDIOL, V93, P1022, DOI 10.1016/j.amjcard.2003.12.057
   Hashimoto T, 2013, J APPL PHYSIOL, V115, P260, DOI 10.1152/japplphysiol.00427.2013
   LANE JD, 1983, PSYCHOSOM MED, V45, P447, DOI 10.1097/00006842-198310000-00008
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   LITOSCH I, 1982, MOL PHARMACOL, V22, P109
   Lo CF, 1997, PLANTA MED, V63, P95, DOI 10.1055/s-2006-957619
   Major GC, 2008, BRIT J NUTR, V99, P1157, DOI 10.1017/S0007114507853335
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-25
   PARIS R, 1958, ANN PHARM FR, V16, P15
   Pasman WJ, 1997, APPETITE, V29, P77, DOI 10.1006/appe.1997.0091
   Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SAX L, 1991, INT J OBESITY, V15, P561
   Stewart LK, 2008, METABOLISM, V57, PS39, DOI 10.1016/j.metabol.2008.03.003
   Tam SW, 2001, PHARMACOL THERAPEUT, V91, P215, DOI 10.1016/S0163-7258(01)00156-5
   Tambalis KD, 2013, J PAEDIATR CHILD H, V49, P769, DOI 10.1111/jpc.12253
   Zhou Su-juan, 2003, ZHONGGUO ZHONGYAO ZAZHI, V28, P910
NR 34
TC 28
Z9 29
U1 1
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-511X
EI 
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD OCT 21
PY 2013
VL 12
IS 
BP 
EP 
DI 10.1186/1476-511X-12-148
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 245BX
UT WOS:000326435000001
PM 24139127
DA 2025-04-28
ER

PT J
AU Miller, PE
   McKinnon, RA
   Krebs-Smith, SM
   Subar, AF
   Chriqui, J
   Kahle, L
   Reedy, J
AF Miller, Paige E.
   McKinnon, Robin A.
   Krebs-Smith, Susan M.
   Subar, Amy F.
   Chriqui, Jamie
   Kahle, Lisa
   Reedy, Jill
TI Sugar-Sweetened Beverage Consumption in the US Novel Assessment Methodology
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID soft drink consumption; metabolic syndrome; risk-factors; weight-gain; children; adolescents; adults; young; obesity; trial
AB Background: Sugar-sweetened beverage (SSB) consumption has been linked with poor diet quality, weight gain, and increased risk for obesity, diabetes, and cardiovascular disease. Previous studies have been hampered by inconsistent definitions and a failure to capture all types of SSBs. Purpose: To comprehensively examine total SSB consumption in the U.S. using an all-encompassing definition that includes beverages calorically sweetened after purchase in addition to presweetened beverages. Methods: Data from the 2005-2008 National Health and Nutrition Examination Survey (N=17,078) were analyzed in September 2012 and used to estimate calories (kilocalories) of added sugars from SSBs and to identify top sources of SSBs. Results: On average, Americans aged >= 2 years consumed 171 kcal (8% of total kcal) per day from added sugars in SSBs; the top sources were soda, fruit drinks, tea, coffee, energy/sports drinks, and flavored milks. Male adolescents (aged 12-19 years) had the highest mean intakes (293 kcal/day; 12% of total kcal). Conclusions: Americans consume more calories from added sugars in beverages than previously reported. The methodology presented in this paper allows for more-comprehensive estimates than those previously used regarding the extent to which SSBs provide calories from added sugars. (C) 2013 American Journal of Preventive Medicine. All rights reserved.
C1 [Miller, Paige E.] NCI, Canc Prevent Fellowship Program, Rockville, MD USA.
   [McKinnon, Robin A.; Krebs-Smith, Susan M.; Subar, Amy F.; Reedy, Jill] NCI, Div Canc Control & Populat Sci, Rockville, MD USA.
   [Kahle, Lisa] Informat Management Serv Inc, Calverton, MD USA.
   [Miller, Paige E.] Exponent Inc, Ctr Epidemiol Biostat & Computat Biol, Chicago, IL 60661 USA.
   [Chriqui, Jamie] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH Division of Cancer Control & Population Sciences; Information Management Services, Inc.; Exponent; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital
RP Miller, PE (corresponding author), Exponent Inc, 525 West Monroe St,Suite 1050, Chicago, IL 60661 USA.
EM pmiller@exponent.com
FU Cancer Prevention Fellowship Program of the National Cancer Institute
CR Unknown -, 2010, DIETARY GUIDELINES FOR AMERICANS, V0, P0, DOI 10.1177/21650799211026980
   Unknown -, 2012, NHANES QUEST DAT REL, V0, P0
   Basu S, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057873
   Bleich SN, 2011, DIABETES CARE, V34, P551, DOI 10.2337/dc10-1687
   Bowman SA, 2008, MYPYRAMID EQUIAVALNE, V0, P0
   Chen LW, 2009, DIABETES CARE, V32, P2236, DOI 10.2337/dc09-0866
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Harris JL, 2011, SUGAR DRINK FACTS EV, V0, P0
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012
   Koegel KL, 2011, CTR NUTR POLICY PROM, V0, P0
   KREBSSMITH SM, 1989, J AM DIET ASSOC, V89, P671
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Marshall TA, 2005, J AM COLL NUTR, V24, P65, DOI 10.1080/07315724.2005.10719445
   Mathias KC, 2013, AM J PREV MED, V44, P351, DOI 10.1016/j.amepre.2012.11.036
   ONeil CE, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-17
   Ogden Cynthia L, 2012, NCHS DATA BRIEF, V0, P1
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.39
   Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Rodríguez-Artalejo F, 2003, BRIT J NUTR, V89, P419, DOI 10.1079/BJN2002787
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
   Yoo S, 2004, AM J CLIN NUTR, V80, P841, DOI 10.1093/ajcn/80.4.841
NR 36
TC 53
Z9 61
U1 0
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD OCT 15
PY 2013
VL 45
IS 4
BP 416
EP 421
DI 10.1016/j.amepre.2013.05.014
PG 6
WC Public, Environmental & Occupational Health; Medicine, General & Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 228NQ
UT WOS:000325193900006
PM 24050417
DA 2025-04-28
ER

PT J
AU Bhatti, SK
   O'Keefe, JH
   Lavie, CJ
AF Bhatti, Salman K.
   O'Keefe, James H.
   Lavie, Carl J.
TI Coffee and tea: perks for health and longevity?
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE beverages; caffeine; coffee; LDL; HDL; tea
ID green tea; decaffeinated coffee; metabolic syndrome; blood-pressure; cancer-risk; black tea; consumption; caffeine; metaanalysis; catechins
AB Purpose of reviewTea and coffee, after water, are the most commonly consumed beverages in the world and are the top sources of caffeine and antioxidant polyphenols in the American diet. The purpose of this review is to assess the health effects of chronic tea and/or coffee consumption.Recent findingsTea consumption, especially green tea, is associated with significantly reduced risks for stroke, diabetes and depression, and improved levels of glucose, cholesterol, abdominal obesity and blood pressure. Habitual coffee consumption in large epidemiological studies is associated with reduced mortality, both for all-cause and cardiovascular deaths. In addition, coffee intake is associated with risks of heart failure, stroke, diabetes mellitus and some cancers in an inverse dose-dependent fashion. Surprisingly, coffee is associated with neutral to reduced risks for both atrial and ventricular arrhythmias. However, caffeine at high doses can increase anxiety, insomnia, calcium loss and possibly the risk of fractures.SummaryCoffee and tea can generally be recommended as health-promoting additions to an adult diet. Adequate dietary calcium intake may be particularly important for tea and coffee drinkers.
C1 [Bhatti, Salman K.; O'Keefe, James H.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA.
   [Bhatti, Salman K.; O'Keefe, James H.] Univ Missouri, Kansas City, MO 64110 USA.
   [Lavie, Carl J.] Univ Queensland, Sch Med, Ochsner Clin Sch, John Ochsner Heart & Vasc Inst, New Orleans, LA USA.
   [Lavie, Carl J.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA.
C3 Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Queensland; Ochsner Health System; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center
RP Bhatti, SK (corresponding author), St Lukes Mid Amer Heart Inst, 4330 Wornall Rd,Ste 2000, Kansas City, MO 64111 USA.
EM jokeefe@saint-lukes.org
CR Unknown -, 2012, NAT COFF DRINK TREND, V0, P0
   Aurora RN, 2012, CHEST, V142, P631, DOI 10.1378/chest.11-2894
   Bahorun T, 2012, PREV MED, V54, PS98, DOI 10.1016/j.ypmed.2011.12.009
   Beresniak A, 2012, BMJ OPEN, V2, P0, DOI 10.1136/bmjopen-2011-000648
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bravi F, 2013, CLIN GASTROENTEROL H, V0, P0, DOI DOI 10.1016/j.cgh.2013.04.039
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Chang CT, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031808
   DElia GC, 2012, J HYPERTENS SA, V30, P0
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Floegel A, 2012, AM J CLIN NUTR, V95, P901, DOI 10.3945/ajcn.111.023648
   Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Gutiérrez-Grobe Y, 2012, ANN HEPATOL, V11, P350, DOI 10.1016/S1665-2681(19)30931-7
   Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186
   Houtkooper L, 2011, CALCIUM SUPPLEMENT G, V0, P0
   Je Y, 2012, INT J CANCER, V131, P1700, DOI 10.1002/ijc.27408
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Kim A, 2011, J AM DIET ASSOC, V111, P1720, DOI 10.1016/j.jada.2011.08.009
   Kim B, 2012, KOREAN J FAM MED, V33, P356, DOI 10.4082/kjfm.2012.33.6.356
   Klatsky Arthur L, 2011, PERM J, V15, P19
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Li GW, 2013, PUBLIC HEALTH NUTR, V16, P346, DOI 10.1017/S1368980012002601
   Li JM, 2011, BREAST CANCER RES, V13, P0, DOI 10.1186/bcr2879
   Liu HF, 2012, ARCH MED SCI, V8, P776, DOI 10.5114/aoms.2012.31612
   Liu J, 2013, MAYO CLIN P, V0, P0
   Matheson EM, 2011, ANN FAM MED, V9, P299, DOI 10.1370/afm.1262
   Mayo Foundation for Medical Education and Research Staff MC, 2011, CAFF CONT COFF TEA S, V0, P0
   Mostofsky E, 2012, CIRC-HEART FAIL, V5, P401, DOI 10.1161/CIRCHEARTFAILURE.112.967299
   OKeefe JH, 2013, J AM COLL CARDIOL, V0, P0
   Pham NM, 2013, PUBLIC HLTH NUTR, V0, P0, DOI DOI 10.1017/S1368980013000360
   Pyshchyta G, 2012, CLIN NUTR, V31, P267, DOI 10.1016/j.clnu.2011.10.011
   Ras RT, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0016974
   Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280
   Renda G, 2012, AM J CLIN NUTR, V95, P241, DOI 10.3945/ajcn.111.018267
   Shafique K, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-42
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Siasos G, 2013, VASC MED, V18, P55, DOI 10.1177/1358863X13480258
   Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Thomas-Jean F, 2013, EUR SOC HYP ESH 2013, V0, P0
   Tsuneki Hiroshi, 2004, BMC PHARMACOLOGY, V4, P18, DOI 10.1186/1471-2210-4-18
   Valls-Pedret C, 2012, J ALZHEIMERS DIS, V29, P773, DOI 10.3233/JAD-2012-111799
   van Woudenbergh GJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036910
   Vercambre MN, 2013, J ALZHEIMERS DIS, V35, P413, DOI 10.3233/JAD-122371
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7
   Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009
   Wein S, 2013, J MED FOOD, V16, P312, DOI 10.1089/jmf.2012.0205
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 52
TC 45
Z9 52
U1 3
U2 138
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD NOV 15
PY 2013
VL 16
IS 6
BP 688
EP 697
DI 10.1097/MCO.0b013e328365b9a0
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 247BA
UT WOS:000326586800013
PM 24071782
DA 2025-04-28
ER

PT J
AU Mubarak, A
   Hodgson, JM
   Considine, MJ
   Croft, KD
   Matthews, VB
AF Mubarak, Aidilla
   Hodgson, Jonathan M.
   Considine, Michael J.
   Croft, Kevin D.
   Matthews, Vance B.
TI Supplementation of a High-Fat Diet with Chlorogenic Acid Is Associated with Insulin Resistance and Hepatic Lipid Accumulation in Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Chlorogenic acid; glucose tolerance; insulin sensitivity; fatty acid oxidation; mouse; metabolic syndrome
ID nitric-oxide status; endothelial function; metabolic syndrome; blood-pressure; caffeic acid; coffee; obesity; polyphenols; mortality; oxidation
AB The increasing prevalence of the metabolic syndrome requires a greater need for therapeutic and prevention strategies. Higher coffee consumption is consistently associated with a lower risk of type 2 diabetes in population studies. Dietary polyphenols have been linked to benefits on several features of the metabolic syndrome. Chlorogenic acid (CGA), a major component of coffee, is one of the most consumed polyphenols in the diet. In our study, we conducted a controlled dietary intervention over 12 weeks in male mice. There were three dietary groups: (i) normal diet, (ii) high-fat diet, and (iii) high-fat diet + CGA. We assessed the effect of CGA at a physiologically obtainable dose (1 g/kg of diet) on high-fat-diet-induced obesity, glucose intolerance, insulin resistance, and also fatty acid oxidation and insulin signaling in C57BL/6 male mice. Supplementation of CGA in the high-fat diet did not reduce body weight compared to mice fed the high-fat diet alone (p = 0.32). CGA resulted in increased insulin resistance compared to mice fed a high-fat diet only (p < 0.05). CGA resulted in decreased phosphorylation of AMP-activated protein kinase (AMPK) (p < 0.001) and acetyl carboxylase beta (ACC beta), a downstream target of AMPK (p < 0.05), in liver. The liver of mice fed a high-fat diet supplemented with CGA had a higher lipid content (p < 0.05) and more steatosis relative to mice fed a high-fat diet only, indicating impaired fatty acid oxidation. This study suggests that CGA supplementation in a high-fat diet does not protect against features of the metabolic syndrome in diet-induced obese mice.
C1 [Mubarak, Aidilla; Considine, Michael J.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia.
   [Mubarak, Aidilla; Considine, Michael J.] Univ Western Australia, Inst Agr, Crawley, WA 6009, Australia.
   [Mubarak, Aidilla; Hodgson, Jonathan M.; Croft, Kevin D.] Univ Western Australia, Med Res Fdn, Sch Med & Pharmacol, Perth, WA 6000, Australia.
   [Mubarak, Aidilla] Univ Malaysia Terengganu, Fac Agrotechnol & Food Sci, Kuala Terengganu 21030, Malaysia.
   [Considine, Michael J.] Dept Agr & Food Western Australia, S Perth, WA 6151, Australia.
   [Matthews, Vance B.] Med Res Fdn, Western Australian Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Perth, WA 6000, Australia.
C3 University of Western Australia; University of Western Australia; University of Western Australia; Universiti Malaysia Terengganu; Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia
RP Matthews, VB (corresponding author), Med Res Fdn, Western Australian Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Level 6,Rear 50 Murray St, Perth, WA 6000, Australia.
EM vance.matthews@waimr.uwa.edu.au
FU Australian Research Council [LP0882884]; Australian Research Council [LP0882884] Funding Source: Australian Research Council
CR Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078
   Cascio G, 2012, CURR DIABETES REV, V8, P2, DOI 10.2174/157339912798829241
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769
   HA J, 1994, J BIOL CHEM, V269, P22162
   Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267
   Holland WL, 2007, NUTR REV, V65, PS39, DOI 10.1301/nr.2007.jun.S39-S46
   INGS RMJ, 1990, XENOBIOTICA, V20, P1201, DOI 10.3109/00498259009046839
   Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y
   Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P10256, DOI 10.1021/jf302903k
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Muthusamy VS, 2010, BRIT J NUTR, V104, P813, DOI 10.1017/S0007114510001480
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, PE1378, DOI 10.1152/ajpendo.00698.2006
   Renaud SC, 2004, AM J CLIN NUTR, V80, P621
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Tavani A, 2000, EUR J CANCER PREV, V9, P241, DOI 10.1097/00008469-200008000-00004
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383
   Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117
   Winzell MS, 2004, DIABETES, V53, PS215, DOI 10.2337/diabetes.53.suppl_3.S215
NR 35
TC 70
Z9 76
U1 1
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 8
PY 2013
VL 61
IS 18
BP 4371
EP 4378
DI 10.1021/jf400920x
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 143AT
UT WOS:000318839400021
PM 23586419
DA 2025-04-28
ER

PT J
AU Flores, G
   Lin, H
AF Flores, G.
   Lin, H.
TI Factors predicting severe childhood obesity in kindergarteners
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE overweight; children; early childhood; recursive partitioning analysis
ID body-mass index; beverage consumption; cardiovascular risk; physical-activity; weight status; life-style; children; overweight; care; bmi
AB BACKGROUND: Severe obesity has increased >300% in US children since 1976, and is associated with multiple cardiovascular risk factors and high adult obesity rates. OBJECTIVE: The objective of this study was to identify predictors of severe obesity in kindergarteners. METHODS: Multivariable logistic regression and recursive partitioning analysis (RPA) were used to identify prenatal/pregnancy, infant, and early childhood predictors of severe kindergarten obesity (body mass index (BMI) >= 99th percentile) in the Early Childhood Longitudinal Study Birth Cohort, a nationally representative longitudinal study that followed children from birth through kindergarten. RESULTS: For the 6800 children, the severe kindergarten obesity prevalence was 5.7%, with higher adjusted odds for crossing the 85th percentile of BMI at 2 years old (odds ratio (OR), 8.0; 95% confidence interval (CI), 4.1-15.7), preschool age (OR, 7.9; 95% CI, 4.9-12.8) and 9 months old (OR, 1.8; 95% CI, 1.2-2.6); maternal severe obesity (OR, 3.4; 95% CI, 1.9-5.8) and gestational diabetes (OR, 2.9; 95% CI, 1.5-5.5); drinking tea or coffee between meals/before bedtime at 2 years old (OR, 3.3; 95% CI, 1.3-8.5); Latino (OR, 2.3; 95% CI, 1.4-3.7) and multiracial (OR, 2.3; 95% CI, 1.1-4.8) race/ethnicity; and drinking sugary beverages at kindergarten age at least weekly (OR, 2.3; 95% CI, 1.4-3.7). Ever-attending center-based daycare (OR, 0.3; 95% CI, 0.1-0.9), eating fruit at least weekly at kindergarten age (OR, 0.3; 95% CI, 0.1-0.7), and maternal history of a prior newborn birth weight >= 4000 g (OR, 0.1; 95% CI, 0.02-0.6) were associated with reduced odds of severe obesity. RPA identified low severe obesity prevalence (1.9%) for non-85th BMI-percentile preschool crossers and high severe obesity (56-80%) for predictor clusters which included crossing the 85th BMI percentile at earlier ages, low parental education, specific maternal age cutoffs, preschooler bedtime rules, and outside walking/play frequency for 9-month-olds. CONCLUSIONS: Certain parental, prenatal/pregnancy, infant, and early childhood factors, both alone and in combination, are potent predictors of severe obesity in kindergarteners. International Journal of Obesity (2013) 37, 31-39; doi: 10.1038/ijo.2012.168; published online 13 November 2012
C1 [Flores, G.; Lin, H.] UT SW Med Ctr, Dept Pediat, Div Gen Pediat, Dallas, TX 75390 USA.
   [Flores, G.] Childrens Med Ctr, Dallas, TX 75235 USA.
C3 University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Flores, G (corresponding author), UT SW Med Ctr, Dept Pediat, Div Gen Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM glenn.flores@utsouthwestern.edu
CR Ambalavanan N, 2011, PEDIATRICS, V128, PE1216, DOI 10.1542/peds.2011-1142
   Unknown -, 2007, 2007084 NCES US DEP, V0, P0
   Unknown -, 2010, 2010009 NCES US DEP, V0, P0
   Barlow SE, 2007, PEDIATRICS, V120, PS164, DOI 10.1542/peds.2007-2329C
   Benjamin SE, 2009, PEDIATRICS, V124, P555, DOI 10.1542/peds.2008-2857
   Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538
   Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64
   Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Ekelund U, 2006, AM J CLIN NUTR, V83, P324
   Feinstein AR, 1996, MULTIVARIABLE ANALYSIS: AN INTRODUCTION, V0, P0
   Flores G, 2008, PEDIATRICS, V121, PE286, DOI 10.1542/peds.2007-1243
   Flores G, 2012, J ACAD NUTR DIET, V112, P81, DOI 10.1016/j.jada.2011.08.041
   Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042
   Freedman DS, 2006, OBESITY, V14, P301, DOI 10.1038/oby.2006.39
   Freedman DS, 2009, PEDIATRICS, V124, PS23, DOI 10.1542/peds.2008-3586E
   Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361
   Hui LL, 2008, ARCH PEDIAT ADOL MED, V162, P212, DOI 10.1001/archpediatrics.2007.62
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Kim SY, 2011, EXP DIABETES RES, V0, P0, DOI DOI 10.1155/2011/541308
   KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295
   Koleilat M, 2012, MATERN CHILD HLTH J, V16, P706, DOI 10.1007/s10995-011-0774-0
   Lumeng JC, 2005, INT J OBESITY, V29, P60, DOI 10.1038/sj.ijo.0802848
   Maffeis C, 1998, INT J OBESITY, V22, P758, DOI 10.1038/sj.ijo.0800655
   Maher EJ, 2008, PEDIATRICS, V122, P322, DOI 10.1542/peds.2007-2233
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Mårild S, 2004, ACTA PAEDIATR, V93, P1588, DOI 10.1080/08035250410018265
   Moraeus L, 2012, INT J OBESITY, V36, P969, DOI 10.1038/ijo.2012.79
   Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367
   Ortega H, 2012, J ASTHMA, V49, P158, DOI 10.3109/02770903.2011.649872
   Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y
   Rappaport EB, 2011, J SCHOOL HEALTH, V81, P341, DOI 10.1111/j.1746-1561.2011.00599.x
   Rolls BJ, 2004, NUTR REV, V62, P1, DOI 10.1301/nr.2004.jan.1–17
   Scott JG, 2012, CANCER-AM CANCER SOC, V118, P5595, DOI 10.1002/cncr.27570
   Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621
   Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108
   Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005
   Skinner AC, 2010, PEDIATRICS, V125, PE801, DOI 10.1542/peds.2009-2182
   Skinner AC, 2009, PEDIATRICS, V124, PE905, DOI 10.1542/peds.2009-0179
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Tandon PS, 2012, J NUTR EDUC BEHAV, V44, P355, DOI 10.1016/j.jneb.2011.10.009
   Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149
   Therneau TM, 1997, INTRO RECURSIVE PART, V0, P1
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301
   Zask A, 2012, HEALTH PROMOT J AUST, V23, P10, DOI 10.1071/HE12010
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
NR 50
TC 49
Z9 63
U1 0
U2 67
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD JAN 15
PY 2013
VL 37
IS 1
BP 31
EP 39
DI 10.1038/ijo.2012.168
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 068HW
UT WOS:000313358100004
PM 23147114
DA 2025-04-28
ER

PT J
AU Balzan, S
   Hernandes, A
   Reichert, CL
   Donaduzzi, C
   Pires, VA
   Gasparotto, A
   Cardozo, EL
AF Balzan, Silvie
   Hernandes, Aline
   Reichert, Cristiane Loiva
   Donaduzzi, Carmen
   Pires, Vanessa Aranega
   Gasparotto Junior, Arquimedes
   Cardozo Junior, Euclides Lara
TI Lipid-lowering effects of standardized extracts of Ilex paraguariensis in high-fat-diet rats
SO FITOTERAPIA
LA English
DT Article
DE Ilex paraguariensis; Chlorogenic acid; Phenolic compounds; Dyslipidemias
ID high-density-lipoprotein; mate ilex; aqueous extract; phenolic-compounds; chlorogenic acid; antioxidant activity; st hil.; cholesterol; obesity; methylxanthines
AB Mate (Ilex paraguariensis A. St-Hil) is a native species of South America used to prepare traditional beverages. Recently a possible effect of its infusion on oxidative stress found in dyslipidemias has been reported. The main compounds related to these activities are phenolic compounds derived from chlorogenic acid. This study aimed to determine the anticholesteremic effect of the hydroethanolic extract (HEIP) and its n-butanolic fraction (n-BFIP), with standardized content of phenolic compounds derived from chlorogenic add, in rats treated with high-fat diet (HFD). The contents of these compounds in the ethanol extract and n-butanol fraction were respectively two and three times higher than in traditional infusion with predominance of dicaffeoylquinic derivatives. The extracts were able to reduce serum triglycerides and cholesterol and decrease the atherogenic index in treated animals. These results support a potential effect of the mate extract in cardiovascular disease. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Balzan, Silvie; Hernandes, Aline; Reichert, Cristiane Loiva; Cardozo Junior, Euclides Lara] Univ Paranaense, Inst Ciencias Biol Med & Saude, BR-85903170 Toledo, PR, Brazil.
   [Gasparotto Junior, Arquimedes] Univ Paranaense, Inst Ciencias Biol Med & Saude, Umuarama, PR, Brazil.
   [Donaduzzi, Carmen; Pires, Vanessa Aranega] Prati Donaduzzi Pharmaceut, Toledo, PR, Brazil.
C3 Universidade Paranaense; Universidade Paranaense
RP Cardozo, EL (corresponding author), Univ Paranaense, Lab Quim & Farmacol Prod Nat, Av Parigot de Souza 3636, BR-85903170 Toledo, PR, Brazil.
EM euclideslc@unipar.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil); Diretoria Executiva de Gestalt) da Pesquisa e Pos-Graduacao (DEGPP/UNIPAR-Brazil)
CR Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624
   Balogun EA, 2007, PHARMACOGNOSY MAGAZINE, V3, P16
   Bastos DHM, 2006, BRAZ ARCH BIOL TECHN, V49, P399, DOI 10.1590/S1516-89132006000400007
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Bravo L, 2007, FOOD RES INT, V40, P393, DOI 10.1016/j.foodres.2006.10.016
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   Cardozo EL, 2007, J FOOD COMPOS ANAL, V20, P553, DOI 10.1016/j.jfca.2007.04.007
   Cardozo EL, 2010, PESQUI AGROPECU BRAS, V45, P171, DOI 10.1590/S0100-204X2010000200008
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001
   CLIFFORD MN, 1990, FOOD CHEM, V35, P13, DOI 10.1016/0308-8146(90)90126-O
   da Silva EL, 2008, FOOD RES INT, V41, P973, DOI 10.1016/j.foodres.2008.08.004
   Dugo P, 2009, J CHROMATOGR A, V1216, P7213, DOI 10.1016/j.chroma.2009.08.030
   Filip R, 2001, FITOTERAPIA, V72, P774, DOI 10.1016/S0367-326X(01)00331-8
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gillett RC, 2011, AM FAM PHYSICIAN, V83, P711
   Grujic N, 2012, MOLECULES, V17, P2518, DOI 10.3390/molecules17032518
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Heck CI, 2007, J FOOD SCI, V72, PR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Ho FM, 2012, J ETHNOPHARMACOL, V142, P175, DOI 10.1016/j.jep.2012.04.034
   Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Meier B, 2012, EUR HEART J, V33, P705, DOI 10.1093/eurheartj/ehr443
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Peralta IN, 2013, PHYTOTHER RES, V27, P192, DOI 10.1002/ptr.4700
   Rivelli Diogo Pineda, 2007, REV. BRAS. CIENC. FARM., V43, P215, DOI 10.1590/S1516-93322007000200007
   Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55
   Saghir MR, 2012, PAK J PHARM SCI, V25, P333
   Schinella G, 2005, CLIN NUTR, V24, P360, DOI 10.1016/j.clnu.2004.11.013
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Schinella G, 2009, FOOD RES INT, V42, P1403, DOI 10.1016/j.foodres.2009.07.004
   Siddiqi HS, 2012, LIPIDS HLTH DIS, V10, P11
   Siri-Tarino PW, 2011, CURR ATHEROSCLER REP, V13, P453, DOI 10.1007/s11883-011-0207-y
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   Talayero Beatriz G, 2011, CURR CARDIOL REP, V13, P544, DOI 10.1007/s11886-011-0220-3
   Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831
   Turkmen N, 2006, FOOD CHEM, V99, P835, DOI 10.1016/j.foodchem.2005.08.034
NR 44
TC 53
Z9 57
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD APR 15
PY 2013
VL 86
IS 
BP 115
EP 122
DI 10.1016/j.fitote.2013.02.008
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 145PR
UT WOS:000319029800016
PM 23422228
DA 2025-04-28
ER

PT J
AU Baret, P
   Septembre-Malaterre, A
   Rigoulet, M
   d'Hellencourt, CL
   Priault, M
   Gonthier, MP
   Devin, A
AF Baret, Pascal
   Septembre-Malaterre, Axelle
   Rigoulet, Michel
   d'Hellencourt, Christian Lefebvre
   Priault, Muriel
   Gonthier, Marie-Paule
   Devin, Anne
TI Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from mitochondrial alterations induced by oxidative stress
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Mitochondria biogenesis; Polyphenols; Oxidative stress; 3T3-L1 pre-adipocytes
ID induced insulin-resistance; hydrogen-peroxide; adipocyte differentiation; adipose-tissue; obesity; metabolism; adipogenesis; fibroblasts; dysfunction; biogenesis
AB Numerous studies indicate that an increase in reactive oxygen species (ROS) significantly affects white adipose tissue biology and leads to an inflammatory profile and insulin resistance, which could contribute to obesity-associated diabetes and cardiovascular diseases. Mitochondria play a key role in adipose tissue energy metabolism and constitute the main source of cellular ROS such as H2O2. Polyphenols constitute the most abundant antioxidants provided by the human diet. Indeed, they are widely distributed in fruits, vegetables and some plant-derived beverages such as coffee and tea. Thus, the biological effects of dietary polyphenols that may increase the antioxidant capacity of the body against obesity-induced oxidative stress are of high interest. Here, we studied the capacity of polyphenols to modulate the impact of oxidative stress on the mitochondria of preadipocytes, which are important cells governing the adipose tissue development for energy homeostasis. Whereas H2O2 treatment induces a proliferation arrest associated with an increase in mitochondrial content in 3T3-L1 preadipocytes, preconditioning with some major dietary polyphenols totally or partially protects the cells against oxidative stress consequences. This article is part of a Directed Issue entitled: Bioenergetic dysfunction, adaptation and therapy. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Baret, Pascal; Septembre-Malaterre, Axelle; d'Hellencourt, Christian Lefebvre; Gonthier, Marie-Paule] Univ La Reunion, Grp Etud Inflammat Chron & Obesite EA 4516, F-97715 St Denis Messag 9, France.
   [Baret, Pascal; Rigoulet, Michel; Priault, Muriel; Devin, Anne] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
   [Baret, Pascal; Rigoulet, Michel; Priault, Muriel; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
C3 University of La Reunion; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bordeaux
RP Devin, A (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
EM anne.devin@ibgc.u-bordeaux2.fr
FU Agence Nationale de la Recherche ANR; Conseil Regional d'Aquitaine; European Union; French Ministere de la recherche; La Region Reunion
CR Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005
   Ailhaud G, 2006, CR BIOL, V329, P570, DOI 10.1016/j.crvi.2005.12.012
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Barnouin K, 2002, J BIOL CHEM, V277, P13761, DOI 10.1074/jbc.M111123200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936
   Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007
   Carrière A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200
   Carrière A, 2003, FEBS LETT, V550, P163, DOI 10.1016/S0014-5793(03)00862-7
   Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984
   Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708
   Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6
   FALOONA GR, 1969, BIOCHEMISTRY-US, V8, P4497, DOI 10.1021/bi00839a041
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gonthier MP, 2003, FREE RADICAL BIO MED, V35, P837, DOI 10.1016/S0891-5849(03)00394-0
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Guo HH, 2008, BIOCHEM PHARMACOL, V75, P1393, DOI 10.1016/j.bcp.2007.11.016
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P7359, DOI 10.1021/jf071223c
   Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005
   Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   MICHIELS C, 1990, J CELL PHYSIOL, V144, P295, DOI 10.1002/jcp.1041440216
   Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h
   Nishikawa T, 2007, DIABETES RES CLIN PR, V77, PS41, DOI 10.1016/j.diabres.2007.01.031
   Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200
   Panickar KS, 2011, INT J MOL SCI, V12, P8181, DOI 10.3390/ijms12118181
   Park HS, 2009, BIOFACTORS, V35, P373, DOI 10.1002/biof.38
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363
   Roche M, 2009, CELL BIOL TOXICOL, V25, P635, DOI 10.1007/s10565-008-9118-2
   Scalbert A, 2000, J NUTR, V130, P2073S, DOI 10.1093/jn/130.8.2073S
   Schönfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243
   Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992
NR 52
TC 33
Z9 33
U1 0
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JAN 15
PY 2013
VL 45
IS 1
BP 167
EP 174
DI 10.1016/j.biocel.2012.10.007
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 078BP
UT WOS:000314073400024
PM 23103716
DA 2025-04-28
ER

PT J
AU Cardoso, GA
   Salgado, JM
   Cesar, MD
   Donado-Pestana, CM
AF Cardoso, Gabrielle Aparecida
   Salgado, Jocelem Mastrodi
   Cesar, Marcelo de Castro
   Donado-Pestana, Carlos Mario
TI The Effects of Green Tea Consumption and Resistance Training on Body Composition and Resting Metabolic Rate in Overweight or Obese Women
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE green tea; obesity; resistance training; resting metabolic rate; thermogenesis
ID 3t3-l1 preadipocytes depends; energy-expenditure; (-)-epigallocatechin gallate; catechin-polyphenols; fat-metabolism; weight-loss; exercise; thermogenesis; caffeine; lipids
AB Green tea has been shown to have thermogenic and antiobesity properties. Therefore, it is important to investigate its effect on weight loss in humans, especially in women. We investigated the effects of green tea consumption combined with resistance training on the body composition and the resting metabolic rate (RMR) in women who were overweight or obese (grade I). After 4 weeks on an adaptive diet, 36 women were divided into four groups (group 1, green tea; group 2, placebo; group 3, green tea plus resistance training; group 4, placebo plus resistance training). The study was double-blinded and placebo-controlled. The RMR and body composition were ascertained for each volunteer, blood tests were performed, and subjects in groups 3 and 4 were tested for their one repetition maximum. Each subject followed the protocol and continued the diet for eight additional weeks, and periodic evaluations were administered. The mean RMR of group 1 decreased significantly and was accompanied by weight loss, maintenance of lean body mass, and decreases in both waist circumference and body mass index. Group 2 showed no variations in anthropometric or blood variables and significantly decreased their mean RMR. Group 3 showed significant increases in RMR, lean body mass, and muscle strength, and significant decreases in body fat, triglycerides, and waist circumference as compared to group 4. Green tea combined with resistance training its potential is increased with decreasing body fat, waist circumference, and triacylglyceride levels and by increasing lean body mass and muscle strength.
C1 [Cardoso, Gabrielle Aparecida; Salgado, Jocelem Mastrodi] Univ Sao Paulo, Dept Agroind Food & Nutr, Luiz de Queiroz Coll Agr ESALQ, BR-13418900 Sao Paulo, Brazil.
   [Donado-Pestana, Carlos Mario] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Foods & Expt Nutr, BR-13418900 Sao Paulo, Brazil.
   [Cesar, Marcelo de Castro] Univ Metodista Piracicaba, Fac Phys Educ, Labs Anthropometr Assessment & Phys Effort, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Metodista de Piracicaba
RP Salgado, JM (corresponding author), Univ Sao Paulo, Dept Agroind Alimentos & Nutr, Escola Super Agr Luiz de Queiroz, Ave Padua Dias 11,Caixa Postal 9, BR-13418900 Sao Paulo, Brazil.
EM jocelemsalgado@usp.br
FU Coordination of Improvement of Personnel of Superior Level (CAPES); Luiz de Queiroz Foundation of Agrarian Studies (FEALQ)
CR Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Brown LE, 2001, PROFESSIONALIZATION, V4, P0, DOI 10.26603/epj.4.1.1
   Cesar MD, 2008, OBES SURG, V18, P1376, DOI 10.1007/s11695-008-9460-8
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chanadiri T, 2005, GEORGIAN MED NEWS, V0, P61
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Drummond MJ, 2005, J STRENGTH COND RES, V19, P332
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   ELLIOT DL, 1989, AM J CLIN NUTR, V49, P93, DOI 10.1093/ajcn/49.1.93
   Evans W J, 1991, EXERC SPORT SCI REV, V19, P99
   GRAY DS, 1989, AM J CLIN NUTR, V50, P255, DOI 10.1093/ajcn/50.2.255
   Häkkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9
   Harber MP, 2008, INT J SPORTS MED, V29, P719, DOI 10.1055/s-2007-989442
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, PC1094, DOI 10.1152/ajpcell.00569.2004
   Kao CC, 2010, PLANTA MED, V76, P694, DOI 10.1055/s-0029-1240623
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Mahan LK, 2004, FOOD NUTR DIET THERA, V11, P0
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   McArdle WD, 2001, EXERCISE PHYSIOLOGY: ENERGY, V0, P0
   Melanson EL, 2009, EXERC SPORT SCI REV, V37, P93, DOI 10.1097/JES.0b013e31819c2f0b
   Misra A, 2008, DIABETES CARE, V31, P1282, DOI 10.2337/dc07-2316
   Murase T, 2006, AM J PHYSIOL-REG I, V290, PR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2005, AM J PHYSIOL-REG I, V288, PR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Ormsbee MJ, 2007, J APPL PHYSIOL, V102, P1767, DOI 10.1152/japplphysiol.00704.2006
   PLOUTZ LL, 1994, J APPL PHYSIOL, V76, P1675, DOI 10.1152/jappl.1994.76.4.1675
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Rodríguez-Bies E, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013900
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Schwartz A, 2010, OBES REV, V11, P531, DOI 10.1111/j.1467-789X.2009.00654.x
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Strasser B, 2011, J OBES, V2011, P0, DOI 10.1155/2011/482564
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu BT, 2005, J AGR FOOD CHEM, V53, P5695, DOI 10.1021/jf050045p
NR 45
TC 49
Z9 51
U1 1
U2 78
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD FEB 15
PY 2013
VL 16
IS 2
BP 120
EP 127
DI 10.1089/jmf.2012.0062
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics
GA 089AH
UT WOS:000314879500005
PM 23140132
DA 2025-04-28
ER

PT J
AU Fiechtner, L
   Block, J
   Duncan, DT
   Gillman, MW
   Gortmaker, SL
   Melly, SJ
   Rifas-Shiman, SL
   Taveras, EM
AF Fiechtner, Lauren
   Block, Jason
   Duncan, Dustin T.
   Gillman, Matthew W.
   Gortmaker, Steven L.
   Melly, Steven J.
   Rifas-Shiman, Sheryl L.
   Taveras, Elsie M.
TI Proximity to supermarkets associated with higher body mass index among overweight and obese preschool-age children
SO PREVENTIVE MEDICINE
LA English
DT Article
DE Supermarkets; Food establishments; Children; Body mass index; Obesity
ID built environment; childhood obesity; food
AB Objective: The objective of this study is to examine associations of proximity to food establishments with body mass index (BMI) among preschool-age children. Methods: We used baseline data from 438 children ages 2-6.9 years with a BMI >= 85th percentile participating in a RCT in Massachusetts from 2006 to 2009. We used a geographic information system to determine proximity to six types of food establishments: 1) convenience stores, 2) bakeries, coffee shops, candy stores, 3) full service restaurants, 4) large supermarkets, 5) small supermarkets, and 6) fast-food restaurants. The main outcome was child's BMI. Results: Children's mean (SD) BMI was 19.2 (2.4) kg/m(2); 35% lived <= 1 mile from a large supermarket, 42% lived > 1 to 2 miles, and 22% lived > 2 miles. Compared to children living > 2 miles from a large supermarket, those who lived within I mile had a BMI 1.06 kg/m(2) higher. Adjustment for socioeconomic characteristics and distance to fast-food restaurants attenuated this estimate to 0.77 kg/m(2). Living in any other distance category from a large supermarket and proximity to other food establishments were not associated with child BMI. Conclusions: Living closer to a large supermarket was associated with higher BMI among preschool-age children who were overweight or obese. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Fiechtner, Lauren] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA USA.
   [Block, Jason; Gillman, Matthew W.; Rifas-Shiman, Sheryl L.; Taveras, Elsie M.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02215 USA.
   [Block, Jason; Gillman, Matthew W.; Rifas-Shiman, Sheryl L.; Taveras, Elsie M.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.
   [Duncan, Dustin T.; Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02215 USA.
   [Melly, Steven J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.
C3 Harvard University; Harvard University Medical Affiliates; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health
RP Taveras, EM (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.
EM Elsie_Taveras@harvardpilgrim.org
FU Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD 050966]
CR Arnas YA, 2006, PEDIATR INT, V48, P138, DOI 10.1111/j.1442-200X.2006.02180.x
   Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244
   Fraser LK, 2010, HEALTH PLACE, V16, P1124, DOI 10.1016/j.healthplace.2010.07.003
   Galvez MP, 2010, CURR OPIN PEDIATR, V22, P202, DOI 10.1097/MOP.0b013e328336eb6f
   Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018
   Murakami K, 2011, J NUTR SCI VITAMINOL, V57, P87, DOI 10.3177/jnsv.57.87
   Navalpotro L, 2012, PREV MED, V55, P102, DOI 10.1016/j.ypmed.2012.05.012
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009
   Powell LM, 2007, AM J PREV MED, V33, PS301, DOI 10.1016/j.amepre.2007.07.007
   Powell LM, 2010, J NUTR, V140, P1175, DOI 10.3945/jn.109.111526
   Timperio A, 2008, PREV MED, V46, P331, DOI 10.1016/j.ypmed.2007.11.011
   Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67
   White House Task Force on Childhood Obesity, 2010, WHIT HOUS TASK FORC, V0, P0
NR 13
TC 32
Z9 40
U1 0
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
EI 
J9 PREV MED
JI Prev. Med.
PD MAR-APR 15
PY 2013
VL 56
IS 3-4
BP 218
EP 221
DI 10.1016/j.ypmed.2012.11.023
PG 4
WC Public, Environmental & Occupational Health; Medicine, General & Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 101FM
UT WOS:000315760600010
PM 23219681
DA 2025-04-28
ER

PT J
AU Seliske, L
   Pickett, W
   Rosu, A
   Janssen, I
AF Seliske, Laura
   Pickett, William
   Rosu, Andrei
   Janssen, Ian
TI The number and type of food retailers surrounding schools and their association with lunchtime eating behaviours in students
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Eating behaviours; Youth; Food retail environment; Schools
ID dietary behaviors; physical-activity; nutrient intake; us children; adolescents; obesity; environments; consumption; restaurants; overweight
AB Background: The primary study objective was to examine whether the presence of food retailers surrounding schools was associated with students' lunchtime eating behaviours. The secondary objective was to determine whether measures of the food retail environment around schools captured using road network or circular buffers were more strongly related to eating behaviours while at school. Methods: Grade 9 and 10 students (N=6,971) who participated in the 2009/10 Canadian Health Behaviour in School Aged Children Survey were included in this study. The outcome was determined by students' self-reports of where they typically ate their lunch during school days. Circular and road network-based buffers were created for a 1 km distance surrounding 158 schools participating in the HBSC. The addresses of fast food restaurants, convenience stores and coffee/donut shops were mapped within the buffers. Multilevel logistic regression was used to determine whether there was a relationship between the presence of food retailers near schools and students regularly eating their lunch at a fast food restaurant, snack-bar or cafe. The Akaike Information Criteria (AIC) value, a measure of goodness-of-fit, was used to determine the optimal buffer type. Results: For the 1 km circular buffers, students with 1-2 (OR=1.10, 95% CI: 0.57-2.11), 3-4 (OR=1.45, 95% CI: 0.75-2.82) and >= 5 nearby food retailers (OR=2.94, 95% CI: 1.71-5.09) were more likely to eat lunch at a food retailer compared to students with no nearby food retailers. The relationships were slightly stronger when assessed via 1 km road network buffers, with a greater likelihood of eating at a food retailer for 1-2 (OR=1.20, 95% CI: 0.74-1.95), 3-4 (OR=3.19, 95% CI: 1.66-6.13) and >= 5 nearby food retailers (OR=3.54, 95% CI: 2.08-6.02). Road network buffers appeared to provide a better measure of the food retail environment, as indicated by a lower AIC value (3332 vs. 3346). Conclusions: There was a strong relationship between the presence of food retailers near schools and students' lunchtime eating behaviours. Results from the goodness of fit analysis suggests that road network buffers provide a more optimal measure of school neighbourhood food environments relative to circular buffers.
C1 [Seliske, Laura; Pickett, William; Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada.
   [Pickett, William] Kingston Gen Hosp, Dept Emergency Med, Kingston, ON K7L 2V7, Canada.
   [Rosu, Andrei; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada.
C3 Queens University - Canada; Queens University - Canada; Queens University Hospital; Queens University - Canada
RP Janssen, I (corresponding author), Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada.
EM ian.janssen@queensu.ca
FU Public Health Agency of Canada; Canadian Institutes of Health Research [MOP 97962]; Health Canada; Heart and Stroke Foundation of Canada [PCR 101415]; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research; Canada Research Chair; Ontario Ministry of Research and Innovation
CR Alter DA, 2005, CAN J PUBLIC HEALTH, V96, P173, DOI 10.1007/BF03403684
   Anderson DR, 2002, MODEL SELECTION MULT, V0, P0
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Bradlee ML, 2010, PUBLIC HEALTH NUTR, V13, P797, DOI 10.1017/S1368980009991546
   Briefel RR, 2009, J AM DIET ASSOC, V109, PS91, DOI 10.1016/j.jada.2008.10.059
   Campbell K, 2002, ASIA PAC J CLIN NUTR, V11, PS553, DOI 10.1046/j.0964-7058.2002.00346.x
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Crawford DA, 2008, INT J PEDIATR OBES, V3, P249, DOI 10.1080/17477160802113225
   Currie C, 2010, HEALTH BEHAV. SCHOOL-AGED CHILD. (HBSC) STUDY: INTERN. REPORT, V0, P0
   Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024
   Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638
   Day PL, 2011, AM J PREV MED, V40, P113, DOI 10.1016/j.amepre.2010.10.018
   French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820
   Gordis L, 2004, EPIDEMIOLOGY, V3rd, P0
   Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.036
   Kubik MY, 2003, AM J PUBLIC HEALTH, V93, P1168, DOI 10.2105/AJPH.93.7.1168
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564
   Leatherdale ST, 2011, INT J PUBLIC HEALTH, V56, P237, DOI 10.1007/s00038-010-0206-8
   Lindquist CH, 2000, AM J CLIN NUTR, V71, P725, DOI 10.1093/ajcn/71.3.725
   McNaughton SA, 2008, J NUTR, V138, P364, DOI 10.1093/jn/138.2.364
   Motulsky H, 2003, FITTING MODELS TO BIOLOGICAL DATA USING LINEAR AND NON-LINEAR REGRESSION: A PRACTICAL GUIDE TO CURVE FITTING, V0, P0, DOI DOI 10.5206/mase/10847
   Oliver LN, 2007, INT J HEALTH GEOGR, V6, P0, DOI 10.1186/1476-072X-6-41
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Park S, 2010, J AM DIET ASSOC, V110, P1532, DOI 10.1016/j.jada.2010.07.003
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Piernas C, 2010, HEALTH AFFAIR, V29, P398, DOI 10.1377/hlthaff.2009.0666
   Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1
   Seliske L, 2012, INT J ENV RES PUB HE, V9, P2601, DOI 10.3390/ijerph9082601
   Sturm R, 2009, HEALTH AFFAIR, V28, PW1088, DOI 10.1377/hlthaff.28.6.w1088
   Taveras EM, 2005, PEDIATRICS, V116, PE518, DOI 10.1542/peds.2004-2732
   Technomic, 2010, TECHN TOP 200 CAN CH, V0, P0
   van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Wrigley N, 2003, ENVIRON PLANN A, V35, P151, DOI 10.1068/a35150
NR 36
TC 38
Z9 45
U1 0
U2 33
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5868
EI 
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD FEB 7
PY 2013
VL 10
IS 
BP 
EP 
DI 10.1186/1479-5868-10-19
PG 9
WC Nutrition & Dietetics; Physiology
SC Nutrition & Dietetics; Physiology
GA 096EI
UT WOS:000315386600001
PM 23391296
DA 2025-04-28
ER

PT J
AU Han, E
   Kim, TH
   Powell, LM
AF Han, Euna
   Kim, Tae Hyun
   Powell, Lisa M.
TI Beverage consumption and individual-level associations in South Korea
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Beverage consumption; Individual-level associations; Two-part regression model; South Korea
ID sugar-sweetened beverages; soft drink consumption; nutrition transition; dietary patterns; united-states; us children; obesity; adolescents; prevalence; overweight
AB Background: Few previous studies investigated consumption distributions of sugar-sweetened beverages (SSBs) over time and individual-level associations in Asia despite the recent interest in SSBs regarding obesity control. This study aimed to provide recent evidence on beverage consumption trends from 2001 to 2009 for overall and subtypes of SSBs and for milk as a comparable healthy beverage in South Korea, as well as associations with individual-level socioeconomic status (SES). Methods: The Korean National Health and Nutrition Examination Surveys from 2001 to 2009 were used. Consumption prevalence and average caloric intake by SSB type were examined. Associations of SES with consumption were assessed in a multivariate logistic regression model (consumption prevalence) and in a multivariate two-part regression model (overall caloric intake adjusting for consumption probability). Results: SSB consumption prevalence increased to 38%, 69%, 70%, and 50% by 2009 up from 31%, 66%, 63%, and 32% in 2001 among adolescents, young adults, adults, and the elderly, respectively. Miscellaneous SSBs (sports/energy drinks, coffee/tea products, flavored milk, and others) were the most prevalent and their prevalence increased among adults (from 62% to 69%) and the elderly (from 30% to 47%) between 2001 and 2009. Adolescents consumed the most calories from miscellaneous SSBs among all beverage types although its prevalence was lower than regular soda and milk in both 2001 and 2009. Women (top-income group only) and men in higher income groups showed higher odds of consuming total SSBs (OR = 1.18-1.25), soda (OR = 1.18, men only), fruit drinks (OR = 1.18, the top-income only for both genders), and miscellaneous SSBs (OR = 1.1-1.2). Men with higher-education showed higher odds of total SSB consumption (OR = 1.14-1.20), and all subtypes of SSBs (OR = 1.18, 1.29, 1.19 for soda, fruit drinks, and miscellaneous SSBs, respectively for the top-education group only). There were statistically significant but minimal differences in the overall amount of caloric intake from SSBs by individual SES for both genders. Conclusions: South Korea is following the global nutrition transition toward greater consumption of SSBs. However, unlike other developed countries, SSB consumption prevalence was higher among high-SES individuals, particularly for fruit drinks and miscellaneous SSBs. Further research is needed to build the international evidence base.
C1 [Han, Euna] Gachon Univ, Coll Pharm, Dept Pharm, Inchon 406799, South Korea.
   [Han, Euna] Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406799, South Korea.
   [Kim, Tae Hyun] Yonsei Univ, Sch Publ Hlth, Seoul 120749, South Korea.
   [Kim, Tae Hyun] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea.
   [Powell, Lisa M.] Univ Illinois, Sch Publ Hlth, Dept Hlth Policy & Adm, Chicago, IL USA.
   [Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
C3 Gachon University; Gachon University; Yonsei University; Yonsei University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital
RP Kim, TH (corresponding author), Yonsei Univ, Sch Publ Hlth, 50 Yonsei Ro, Seoul 120749, South Korea.
EM thkim@yuhs.ac
FU Korea National Research Foundation [NRF-2012007096]
CR Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618
   Unknown -, 2002, GLOBALIZATION DIETS, V0, P0
   Arcan C, 2009, J AM DIET ASSOC, V109, P823, DOI 10.1016/j.jada.2009.02.001
   Bleich SN, 2011, DIABETES CARE, V34, P551, DOI 10.2337/dc10-1687
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392
   Center for Science in the Public Interest, 2009, LIQ CAND WHY TAX SOF, V0, P0
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001
   Eisenmann JC, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-607
   Evans AE, 2010, J AM COLL NUTR, V29, P387, DOI 10.1080/07315724.2010.10719856
   Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Hafekost K, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-950
   Han E, 2005, J MENT HEALTH POLICY, V8, P131
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   HARRIS SS, 1994, AM J CLIN NUTR, V60, P573, DOI 10.1093/ajcn/60.4.573
   International Monetary Fund, 2010, WORLD EC OUTL DAT, V0, P0
   Kim E, 2005, OBES RES, V13, P1510, DOI 10.1038/oby.2005.183
   Kim S, 2000, AM J CLIN NUTR, V71, P44
   Korean Center of Disease and Control, 2011, US GUID KOR NAT HLTH, V0, P0
   Korean Statistical Information Service, 2009, MIN MAN SURV C2008, V0, P0
   Lee HS, 2012, ASIA PAC J CLIN NUTR, V21, P618
   Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294
   Lee SK, 2003, PUBLIC HEALTH NUTR, V6, P665, DOI 10.1079/PHN2003485
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   MANNING WG, 1987, J ECONOMETRICS, V35, P59, DOI 10.1016/0304-4076(87)90081-9
   McKinley J, 2007, NY TIMES, V0, P0
   Moon HK, 1994, KOREAN J NUTR, V27, P509
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Park MH, 2003, CULTURAL LIFE KOREA, V0, P0
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Patrick DL, 2009, FY2010 HOUSE BUDGET, V0, P0
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2004, INT J OBESITY, V28, PS2, DOI 10.1038/sj.ijo.0802804
   Putnam JudithJ, 1999, FOOD CONSUMPTION PRI, V0, P0
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   Johnson Kay, 2006, MORBIDITY AND MORTALITY WEEKLY REPORT, V55, P1, DOI 10.1542/peds.2018-0939
   Song Y, 2005, BRIT J NUTR, V93, P943, DOI 10.1079/BJN20051435
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   World Health Organization, 2003, INF SHEET OB OV, V0, P0
   Zoellner J, 2011, J AM DIET ASSOC, V111, P1012, DOI 10.1016/j.jada.2011.04.010
NR 49
TC 33
Z9 35
U1 1
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 6
PY 2013
VL 13
IS 
BP 
EP 
DI 10.1186/1471-2458-13-195
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 128JQ
UT WOS:000317765700001
PM 23497024
DA 2025-04-28
ER

PT J
AU Takami, H
   Nakamoto, M
   Uemura, H
   Katsuura, S
   Yamaguchi, M
   Hiyoshi, M
   Sawachika, F
   Juta, T
   Arisawa, K
AF Takami, Hidenobu
   Nakamoto, Mariko
   Uemura, Hirokazu
   Katsuura, Sakurako
   Yamaguchi, Miwa
   Hiyoshi, Mineyoshi
   Sawachika, Fusakazu
   Juta, Tomoya
   Arisawa, Kokichi
TI Inverse Correlation Between Coffee Consumption and Prevalence of Metabolic Syndrome: Baseline Survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan
SO JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE metabolic syndrome; coffee; serum triglycerides; plasma glucose; green tea
ID randomized controlled-trial; coronary-heart-disease; life-style factors; green tea; habitual coffee; caffeine intake; filtered-coffee; blood-pressure; serum-lipids; body-fat
AB Background: It is unclear whether consumption of coffee and green tea is associated with metabolic syndrome. Methods: This cross-sectional study enrolled 554 adults who had participated in the baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima Prefecture, Japan. Consumption of coffee and green tea was assessed using a questionnaire Metabolic syndrome was diagnosed using the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) and the Japan Society for the Study of Obesity (JASSO). Logistic regression analysis was used to examine the association between consumption of coffee and green tea and prevalence of metabolic syndrome and its components. Results: After adjustment for sex, age, and other potential confounders, greater coffee consumption was associated with a significantly lower prevalence of metabolic syndrome, as defined by NCEP ATP III criteria (P for trend = 0.03). Participants who drank more coffee had a lower odds ratio (OR) for high serum triglycerides (P for trend = 0.02), but not for increased waist circumference or high blood pressure. Using JASSO criteria, moderate coffee consumption (1.5 to < 3 cups/day) was associated with a significantly lower OR for high plasma glucose (OR = 0.51, 95% CI 0.28-0.93). Green tea consumption was not associated with the prevalence of metabolic syndrome or any of its components. Conclusions: Coffee consumption was inversely correlated with metabolic syndrome diagnosed using NCEP ATP III criteria, mainly because it was associated with lower serum triglyceride levels. This association highlights the need for further prospective studies of the causality of these relationships.
C1 [Takami, Hidenobu; Nakamoto, Mariko; Uemura, Hirokazu; Katsuura, Sakurako; Yamaguchi, Miwa; Hiyoshi, Mineyoshi; Sawachika, Fusakazu; Juta, Tomoya; Arisawa, Kokichi] Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima, Tokushima 7708503, Japan.
C3 Tokushima University
RP Arisawa, K (corresponding author), Univ Tokushima Grad Sch, Inst Hlth Biosci, Dept Prevent Med, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.
EM karisawa@basic.med.tokushima-u.ac.jp
FU Japanese Ministry of Education, Culture, Sports, Science and Technology [17015018, 221S0001]; Grants-in-Aid for Scientific Research [12J08918] Funding Source: KAKEN
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261
   Doi Y, 2009, STROKE, V40, P1187, DOI 10.1161/STROKEAHA.108.531319
   Du Y, 2005, EUR J EPIDEMIOL, V20, P311, DOI 10.1007/s10654-004-7536-x
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   FRIED RE, 1992, JAMA-J AM MED ASSOC, V267, P811, DOI 10.1001/jama.267.6.811
   Funatsu K, 2005, HYPERTENS RES, V28, P521, DOI 10.1291/hypres.28.521
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ilanne-Parikka P, 2010, DIABETES CARE, V33, P1610, DOI 10.2337/dc09-2155
   IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301
   Millen BE, 2006, AM J CLIN NUTR, V84, P434
   Miyake Y, 1999, ANN EPIDEMIOL, V9, P121, DOI 10.1016/S1047-2797(98)00051-9
   Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakanishi N, 2000, J EPIDEMIOL, V10, P216
   SAS Institute, 2007, SAS STAT SOFTW CHANG, V8, P0
   Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94
   Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135
   Urgert R, 1996, BRIT MED J, V313, P1362, DOI 10.1136/bmj.313.7069.1362
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   VANROOIJ J, 1995, AM J CLIN NUTR, V61, P1277, DOI 10.1093/ajcn/61.6.1277
   Wakabayashi K, 1998, EUR J EPIDEMIOL, V14, P669, DOI 10.1023/A:1007478522638
   Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
NR 44
TC 64
Z9 65
U1 0
U2 22
PU JAPAN EPIDEMIOLOGICAL ASSOC
PI TOCHIGI
PA JICHI MEDICAL SCHOOL, DEPT PUBLIC HEALTH, 3311-1 YAKUSHIJI, MINAMIKAWACH, TOCHIGI, 329-0498, JAPAN
SN 0917-5040
EI 
J9 J EPIDEMIOL
JI J. Epidemiol.
PD JAN 15
PY 2013
VL 23
IS 1
BP 12
EP 20
DI 10.2188/jea.JE20120053
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 075XT
UT WOS:000313921200004
PM 23047663
DA 2025-04-28
ER

PT J
AU Borges, MC
   Vinolo, MAR
   Nakajima, K
   De Castro, IA
   Bastos, DHM
   Borelli, P
   Fock, RA
   Tirapegui, J
   Curi, R
   Rogero, MM
AF Borges, Maria Carolina
   Ramirez Vinolo, Marco Aurelio
   Nakajima, Karina
   De Castro, Inar Alvesde
   Markowicz Bastos, Deborah Helena
   Borelli, Primavera
   Fock, Ricardo Ambrosio
   Tirapegui, Julio
   Curi, Rui
   Rogero, Marcelo Macedo
TI The effect of mate tea (Ilex paraguariensis) on metabolic and inflammatory parameters in high-fat diet-fed Wistar rats
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE high-fat diet; inflammation; macrophages; nuclear factor-kappa B; yerba mate
ID nf-kappa-b; bioactive compounds; chlorogenic acid; induced obesity; macrophages
AB This study investigated the effects of mate tea (Ilex paraguariensis) aqueous extract consumption on metabolic indicators and inflammatory response of peritoneal macrophages in rats fed a high-fat diet (HFD). Male Wistar rats were fed a control diet or a HFD for 12 weeks. At the end of this period, rats received, or not, daily doses of yerba mate for 4 weeks. The consumption of yerba mate promoted weight loss, attenuated the HFD-detrimental effects on adiposity and insulin sensitivity and decreased blood levels of the inflammatory biomarkers (p < 0.05). Concerning peritoneal macrophages, mate tea consumption decreased the production of interleukin (IL)-6, but did not influence the production of IL-1 beta, tumour necrosis factor-a and nitric oxide; cytokine mRNA expression; or the activation of the nuclear factor-kappa B signalling pathway. In summary, the consumption of mate tea had no consistent effect in the inflammatory response of peritoneal macrophages, but reduced cardiometabolic risk markers.
C1 [Borges, Maria Carolina; Markowicz Bastos, Deborah Helena; Rogero, Marcelo Macedo] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.
   [Ramirez Vinolo, Marco Aurelio; Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508000 Sao Paulo, Brazil.
   [Nakajima, Karina; Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
   [De Castro, Inar Alvesde; Tirapegui, Julio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, BR-05508000 Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Institute Biomed Science, University Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo
RP Rogero, MM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, Brazil.
EM mmrogero@usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/50269-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [470418/2009-5]; FAPESP [2009/02371-0]; Swedish Research Council [2009-02371] Funding Source: Swedish Research Council; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/02371-0] Funding Source: FAPESP
CR Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68
   Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Bastos DHM, 2009, ARQ BRAS ENDOCRINOL, V53, P646, DOI 10.1590/S0004-27302009000500017
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Borges MC, 2012, NUTRITION, V0, P0
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210
   Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008
   Fock RA, 2010, INFLAMMATION, V33, P101, DOI 10.1007/s10753-009-9163-x
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Jaiswal R, 2010, J AGR FOOD CHEM, V58, P5471, DOI 10.1021/jf904537z
   Martins F, 2009, BRIT J NUTR, V101, P527, DOI 10.1017/S000711450802504X
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200
   Olmos A, 2008, ARCH BIOCHEM BIOPHYS, V475, P66, DOI 10.1016/j.abb.2008.04.012
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P0, DOI 10.1093/nar/29.9.e45
   Pimentel GD, 2012, J NUTR BIOCH, V0, P0, DOI DOI 10.1016/j.jnutbio.2012.04.016.
   Puangpraphant S, 2011, MOL NUTR FOOD RES, V55, P1509, DOI 10.1002/mnfr.201100128
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rogero MM, 2010, AMINO ACIDS, V39, P435, DOI 10.1007/s00726-009-0459-9
   Rong YQ, 1996, J NEUROCHEM, V67, P662
   Rosa FT, 2012, INT J FOOD SCI NUTR, V63, P749, DOI 10.3109/09637486.2011.649250
   Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009
   Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106
NR 35
TC 18
Z9 23
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD AUG 15
PY 2013
VL 64
IS 5
BP 561
EP 569
DI 10.3109/09637486.2012.759188
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 180IZ
UT WOS:000321588700006
PM 23317109
DA 2025-04-28
ER

PT J
AU Zheng, XX
   Xu, YL
   Li, SH
   Hui, RT
   Wu, YJ
   Huang, XH
AF Zheng, Xin-Xin
   Xu, Yan-Lu
   Li, Shao-Hua
   Hui, Rutai
   Wu, Yong-Jian
   Huang, Xiao-Hong
TI Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID type-2 diabetes-mellitus; insulin-resistance; weight maintenance; fat oxidation; double-blind; body-weight; metabolic syndrome; glucose control; extract; obesity
AB Background: The effect of green tea catechins (GTCs) with or without caffeine on glycemic control is controversial. Objective: We aimed to identify and quantify the effects of GTCs or GTC-caffeine mixtures on glucose metabolism in adults. Design: A comprehensive literature search was conducted to identify relevant trials of GTCs with or without caffeine on markers of glycemic control [fasting blood glucose (FBG), fasting blood insulin (FBI), glycated hemoglobin (Hb A(1c)), and homeostatic model assessment of insulin resistance (HOMA-IR)]. Weighted mean differences were calculated for net changes by using fixed-effects models. Pre-specified subgroup analyses were performed to explore the influence of covariates on net changes in FBG and FBI concentrations. Results: Twenty-two eligible randomized controlled trials with 1584 subjects were identified. Pooled analyses showed that FBG (-1.48 mg/dL; 95% CI: -2.57, -0.40 mg/dL) decreased significantly with GTCs with or without caffeine, whereas FBI (0.04 mu U/mL; 95% CI: -0.36, 0.45 mu U/mL), Hb A(1c) (-0.04%; 95% CI: -0.15, 0.08%), and HOMA-IR (-0.05; 95% CI: -0.37, 0.26) did not. Subgroup analyses indicated that the glucose-lowering effect was apparent when the duration of follow-up was over a median of 12 wk. Overall, no significant heterogeneity was detected for FBG, FBI, Hb A(1c), or HOMA-IR. Conclusions: The meta-analysis showed that the administration of GTCs with or without caffeine resulted in a significant reduction in FBG. The limited data available on GTCs did not support a positive effect on FBI, Hb A(1c), or HOMA-IR. Thus, more large and well-designed trials are needed in the future. This trial was registered at http://www.crd.york.ac.uk/prospero as CRD42012002139. Am J Clin Nutr 2013;97:750-62.
C1 [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Dept Cardiol, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Key Lab Clin Cardiovasc Genet, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Peking Union Med Coll, Beijing 100021, Peoples R China.
   [Li, Shao-Hua] Shandong Univ, Dept Cardiol, Prov Hosp, Jinan 250100, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong University
RP Huang, XH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, 167 Beilishi Rd, Beijing 100037, Peoples R China.
EM fuwaihospital@gmail.com; huangxhong12@gmail.com
FU Ministry of Science and Technology of China; National High-Rech Research and Development Program of China
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bonora E, 2002, DIABETES CARE, V25, P1135, DOI 10.2337/diacare.25.7.1135
   Broadhurst CL, 2000, J AGR FOOD CHEM, V48, P849, DOI 10.1021/jf9904517
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Di Pierro F, 2009, ALTERN MED REV, V14, P154
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014
   Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761
   Hase T, 2001, JOURNAL OF OLEO SCIENCE, V50, P599, DOI 10.5650/jos.50.599
   Higgins J, 2009, COCHRANE HANDBOOK FOR SYSTEMATIC REVIEWS OF INTERVENTIONS, V0, P0
   Higgins JP, 2003, BMJ, V327, P557
   Hill AM, 2007, J AM COLL NUTR, V26, P396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu Chung-Hua, 2011, ALTERN MED REV, V16, P157
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Josic J, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-63
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kozuma K, 2005, PROG MED, V25, P1945
   LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, PS4, DOI 10.1055/s-2008-1081488
   MacKenzie T, 2007, METABOLISM, V56, P1340, DOI 10.1016/j.metabol.2007.05.018
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mann JI, 2006, NUTR REV, V64, P422, DOI 10.1111/j.1753-4887.2006.tb00227.x
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   Mirzaei K, 2009, DARU, V17, P38
   Mohammadi S, 2010, J ZANJAN UNIV MED SCI HEALTH SERVICES, V18, P44
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Naqshbandi M, 2008, DIABETES RES CLIN PR, V82, P1, DOI 10.1016/j.diabres.2008.07.017
   Panagiotakos DB, 2009, YONSEI MED J, V50, P31, DOI 10.3349/ymj.2009.50.1.31
   Penugonda K, 2009, THE FASEB JOURNAL, V23, P0
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Roghani Mehrdad, 2010, PATHOPHYSIOLOGY, V17, P55, DOI 10.1016/j.pathophys.2009.07.004
   Rondanelli M, 2009, BRIT J NUTR, V101, P457, DOI 10.1017/S0007114508024008
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   Sakurai N, 2009, NUTRITION, V25, P1047, DOI 10.1016/j.nut.2009.02.012
   Sano M, 2001, ANALYST, V126, P816, DOI 10.1039/b102541b
   Sone T, 2011, FOOD NUTR RES, V55, P0, DOI 10.3402/fnr.v55i0.8326
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Takabayashi F, 2004, BIOFACTORS, V21, P335, DOI 10.1002/biof.552210165
   tsuchida t, 2002, PROG MED, V9, P2189
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
NR 64
TC 111
Z9 117
U1 0
U2 61
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD APR 15
PY 2013
VL 97
IS 4
BP 750
EP 762
DI 10.3945/ajcn.111.032573
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 113CQ
UT WOS:000316644200011
PM 23426037
DA 2025-04-28
ER

PT J
AU Zhang, Q
   Jones, S
   Ruhm, CJ
   Andrews, M
AF Zhang, Qi
   Jones, Sonya
   Ruhm, Christopher J.
   Andrews, Margaret
TI Higher Food Prices May Threaten Food Security Status among American Low-Income Households with Children
SO JOURNAL OF NUTRITION
LA English
DT Article
ID physical-activity; health outcm; us adults; insecurity; consumption; obesity; economics; dietary; tax
AB Children in food-insecure households are more likely to experience poorer health function and worse academic achievement. To investigate the relation between economic environmental factors and food insecurity among children, we examined the relation between general and specific food prices (fast food, fruits and vegetables, beverages) and risk of low (LFS) and very low food security (VLFS) status among low-income American households with children. Using information for 27,900 child-year observations from the Early Childhood Longitudinal Study-Kindergarten Class of 1998 1999 linked with food prices obtained from the Cost of Living Data of the Council for Community and Economic Research, formerly known as the American Chamber of Commerce Researchers' Association, fixed effects models were estimated within stratified income groups. Higher overall food prices were associated with increased risk of LFS and VLFS (coefficient = 0.617; P < 0.05). Higher fast food and fruit and vegetable prices also contributed to higher risk of food insecurity (coefficient = 0.632, P < 0.01 for fast food; coefficient = 0.879, P < 0.01 for fruits and vegetables). However, increasing beverage prices, including the prices of soft drinks, orange juice, and coffee, had a protective effect on food security status, even when controlling for general food prices. Thus, although food price changes were strongly related to food security status among low-income American households with children, the effects were not uniform across types of food. These relations should be accounted for when implementing policies that change specific food prices.
C1 [Zhang, Qi] Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA 23529 USA.
   [Jones, Sonya] Univ S Carolina, Ctr Res Nutr & Hlth Dispar, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.
   [Ruhm, Christopher J.] Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA USA.
   [Andrews, Margaret] USDA, Econ Res Serv, Washington, DC USA.
C3 Old Dominion University; University of South Carolina System; University of South Carolina Columbia; University of Virginia; United States Department of Agriculture (USDA)
RP Zhang, Q (corresponding author), Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA 23529 USA.
EM qzhang@odu.edu
FU USDA/Economic Research Service, Food Assistance and Nutrition Research Program [58-5000-0-0089]
CR Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   Unknown -, 2000, GUIDE TO MEASURING HOUSEHOLD FOOD INSECURITY, V0, P0
   Unknown -, 2007, HLTH SUST FOOD SYST, V0, P0
   Unknown -, 2002, THE STATE OF FOOD INSECURITY IN THE WORLD 2001, V0, P0
   Bartfield J, 2006, J POLICY ANAL MANAG, V25, P921, DOI 10.1002/pam.20214
   Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687
   Bureau of Labor and Statistics, 2013, CONS EXP SURV, V0, P0
   Cawley J, 2010, HEALTH AFFAIR, V29, P364, DOI 10.1377/hlthaff.2009.0721
   Census Bureau, 2013, HIST POV TABL, V0, P0
   Cook JT, 2004, J NUTR, V134, P1432
   Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738
   Drewnowski A, 2005, AM J CLIN NUTR, V82, P265S, DOI 10.1093/ajcn/82.1.265S
   Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545
   Fram MS, 2011, J NUTR, V141, P1114, DOI 10.3945/jn.110.135988
   Gundersen C, 2011, APPL ECON PERSPECT P, V33, P281, DOI 10.1093/aepp/ppr022
   Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831
   Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826
   Kuchler F, 2008, PRICE TRENDS ARE SIMILAR FOR FRUITS, Vegetables, P0
   Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001
   Lin BH, 2007, EC INFORM B, V0, P0
   Lipsky LM, 2009, AM J CLIN NUTR, V90, P1397, DOI 10.3945/ajcn.2008.27384
   Liu JH, 2012, CHILD OBES, V8, P440, DOI 10.1089/chi.2011.0090
   Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009
   Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002
   National Center for Education Statistics, 2013, EARL CHILDH LONG STU, V0, P0
   NORD M, 2004, 42 USDA EC RES SERV, V0, P0
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Powell LM, 2009, J HEALTH ECON, V28, P963, DOI 10.1016/j.jhealeco.2009.06.009
   Powell LM, 2009, HEALTH PLACE, V15, P1064, DOI 10.1016/j.healthplace.2009.05.002
   Rickard BJ, 2013, HEALTH ECON, V22, P316, DOI 10.1002/hec.2799
   StataCorp, 2012, STAT SOFTW REL 12 0, V0, P0
   Todd JE, 2010, USDA EC RES SERVICE, V1926, P0
   Yaniv G, 2009, J PUBLIC ECON, V93, P823, DOI 10.1016/j.jpubeco.2009.02.004
   Yen ST, 2004, AGRIBUSINESS (NEW YORK), V20, P309, DOI 10.1002/agr.20015
   Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202
   Zhang Q, 2007, INT J EPIDEMIOL, V36, P916, DOI 10.1093/ije/dym064
NR 42
TC 16
Z9 25
U1 0
U2 23
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD OCT 15
PY 2013
VL 143
IS 10
BP 1659
EP 1665
DI 10.3945/jn.112.170506
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 298NW
UT WOS:000330331700018
PM 23946342
DA 2025-04-28
ER

PT J
AU Lanfer, A
   Bammann, K
   Knof, K
   Buchecker, K
   Russo, P
   Veidebaum, T
   Kourides, Y
   de Henauw, S
   Molnar, D
   Bel-Serrat, S
   Lissner, L
   Ahrens, W
AF Lanfer, Anne
   Bammann, Karin
   Knof, Kolja
   Buchecker, Kirsten
   Russo, Paola
   Veidebaum, Toomas
   Kourides, Yiannis
   de Henauw, Stefaan
   Molnar, Denes
   Bel-Serrat, Silvia
   Lissner, Lauren
   Ahrens, Wolfgang
TI Predictors and correlates of taste preferences in European children: The IDEFICS study
SO FOOD QUALITY AND PREFERENCE
LA English
DT Article
DE Taste preference; Cross-cultural comparison; Age; Children; Europe
ID consumption frequency; food-consumption; body-composition; sweet; age; perception; obesity; habits; humans; fat
AB The present study investigated taste preferences in a sample of 1705 children aged 6 to 9 years from survey centres in Italy, Estonia, Cyprus, Belgium, Sweden, Germany, Hungary, and Spain and aimed to identify factors correlated with taste preference. Children's preferences for varying levels of sucrose (sweet) in apple juice and fat, sodium chloride (salt) and monosodium glutamate (umami) in crackers were assessed using paired-comparison tests. Socio-demographics (age, sex, parental education), early feeding practises (breastfeeding, introduction of fruits), parenting behaviour (TV viewing, using food as a reward) and taste threshold sensitivity for sucrose (sweet), sodium chloride (salt), caffeine (bitter) and monosodium glutamate (umami) were investigated as possible correlates of taste preferences. Parents reported on socio-demographics, early feeding and parenting behaviour. Taste thresholds were determined via a paired-comparison staircase method. Country of residence was the strongest factor related to preferences for all four tastes. Taste preferences also differed by age. Preference for sugar and salt increased between 6 and 9 years of age while preference for monosodium glutamate decreased. The age differences remained significant even after adjustment for sex, country of residence, parental education and early feeding habits. Sex, parental education, early feeding habits, TV viewing, using food as a reward and taste thresholds were not consistently related to taste preferences among the survey centres. In summary, the results highlight the importance of culture and age in taste preferences in children younger than 10 years of age. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Lanfer, Anne; Bammann, Karin; Ahrens, Wolfgang] BIPS Inst Epidemiol & Prevent Res, D-28359 Bremen, Germany.
   [Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Sci IPP, D-28359 Bremen, Germany.
   [Knof, Kolja; Buchecker, Kirsten] Ttz Bremerhaven, Dept Food Sci, D-27572 Bremerhaven, Germany.
   [Russo, Paola] CNR, Inst Food Sci, I-83100 Avellino, Italy.
   [Veidebaum, Toomas] Natl Inst Hlth Dev, EE-11619 Tallinn, Estonia.
   [Kourides, Yiannis] Child Hlth Res & Educ Inst, CY-2035 Strovolos, Cyprus.
   [de Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.
   [de Henauw, Stefaan] Univ Coll Ghent, Fac Hlth Care Vesalius, Dept Nutr & Dietet, B-9000 Ghent, Belgium.
   [Molnar, Denes] Univ Pecs, Dept Pediat, H-7623 Pecs, Hungary.
   [Bel-Serrat, Silvia] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, E-50009 Zaragoza, Spain.
   [Lissner, Lauren] Univ Gothenburg, Dept Publ Hlth & Community Med, S-40530 Gothenburg, Sweden.
C3 Leibniz Association; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); National Institute for Health Development - Estonia; Ghent University; HOGENT University College of Applied Sciences & Arts; University of Pecs; University of Zaragoza; University of Gothenburg
RP Ahrens, W (corresponding author), BIPS Inst Epidemiol & Prevent Res, Achterstr 30, D-28359 Bremen, Germany.
EM ahrens@bips.uni-bremen.de
FU European Community [016181 (FOOD)]; Hans-Bockler-Stiftung
CR Ahrens W, 2011, INT J OBESITY, V35, PS3, DOI 10.1038/ijo.2011.30
   Unknown -, 1998, J AM DIET ASSOC, V0, P0
   Unknown -, 2006, INT STAND CLASS ED I, V0, P0
   Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853
   Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41
   Brug J, 2008, BRIT J NUTR, V99, PS7, DOI 10.1017/S0007114508892458
   Cervellon MC, 2005, FOOD QUAL PREFER, V16, P455, DOI 10.1016/j.foodqual.2004.09.002
   Coldwell SE, 2009, PHYSIOL BEHAV, V96, P574
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527
   Cornwell TB, 2011, APPETITE, V56, P428, DOI 10.1016/j.appet.2011.01.010
   De Graaf C, 1999, PHYSIOL BEHAV, V67, P513, DOI 10.1016/S0031-9384(99)00090-6
   DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365
   DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1
   DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7
   ENNS MP, 1979, PHYSIOL BEHAV, V22, P999, DOI 10.1016/0031-9384(79)90346-9
   Harris J, 2009, DANCING TIMES, V99, P11
   Huybrechts I, 2011, INT J OBESITY, V35, PS69, DOI 10.1038/ijo.2011.37
   KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121
   KLOEHN NW, 1948, AM J PSYCHOL, V61, P90, DOI 10.2307/1417296
   Knof K, 2011, INT J OBESITY, V35, PS131, DOI 10.1038/ijo.2011.45
   Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164
   Lanfer A, 2011, INT J OBESITY, V35, PS61, DOI 10.1038/ijo.2011.36
   Lawless HT, 2004, CHEM SENSES, V29, P25, DOI 10.1093/chemse/bjh003
   MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908
   Mojet J, 2005, FOOD QUAL PREFER, V16, P413, DOI 10.1016/j.foodqual.2004.08.001
   MONNEUSE MO, 1991, PHYSIOL BEHAV, V50, P1111, DOI 10.1016/0031-9384(91)90569-A
   Prescott J, 2002, FOOD QUAL PREFER, V13, P489, DOI 10.1016/S0950-3293(02)00010-1
   PRESCOTT J, 1995, TRENDS FOOD SCI TECH, V6, P201, DOI 10.1016/S0924-2244(00)89055-X
   Ricketts CD, 1997, EUR J CLIN NUTR, V51, P778, DOI 10.1038/sj.ejcn.1600487
   ROZIN P, 1986, ANNU REV NUTR, V6, P433, DOI 10.1146/annurev.nu.06.070186.002245
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Suling M, 2011, INT J OBESITY, V35, PS30, DOI 10.1038/ijo.2011.33
   SULLIVAN SA, 1994, PEDIATRICS, V93, P271
   Tabacchi G, 2007, NUTR RES, V27, P587, DOI 10.1016/j.nutres.2007.06.001
   Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458
   Wright LT, 2001, BRIT FOOD J, V103, P348, DOI 10.1108/00070700110396321
NR 37
TC 20
Z9 23
U1 2
U2 117
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0950-3293
EI 
J9 FOOD QUAL PREFER
JI Food. Qual. Prefer.
PD MAR 15
PY 2013
VL 27
IS 2
BP 128
EP 136
DI 10.1016/j.foodqual.2012.09.006
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 054OL
UT WOS:000312353000004
DA 2025-04-28
ER

PT J
AU Stacewicz-Sapuntzakis, M
AF Stacewicz-Sapuntzakis, M.
TI Dried Plums and Their Products: Composition and Health Effects-An Updated Review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Prunes; prune juice; sorbitol; chlorogenic acids; quinic acid; laxation
ID prunus-domestica l.; colon-cancer risk; chlorogenic acid; in-vitro; phenolic-acids; antioxidant capacity; common foods; urinary-excretion; bone-resorption; cranberry juice
AB This paper describes composition of dried plums and their products (prune juice and dried plum powder) with special attention to possibly bioactive compounds. Dried plums contain significant amounts of sorbitol, quinic acid, chlorogenic acids, vitamin K1, boron, copper, and potassium. Synergistic action of these and other compounds, which are also present in dried plums in less conspicuous amounts, may have beneficial health effects when dried plums are regularly consumed. Snacking on dried plums may increase satiety and reduce the subsequent intake of food, helping to control obesity, diabetes, and related cardiovascular diseases. Despite their sweet taste, dried plums do not cause large postprandial rise in blood glucose and insulin. Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer. The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts. The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures. Further investigation of phenolic compounds in dried plums, particularly of high molecular weight polymers, their metabolism and biological actions, alone and in synergy with other dried plum constituents, is necessary to elucidate the observed health effects and to indicate other benefits.
C1 Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60612 USA.
C3 University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital
RP Stacewicz-Sapuntzakis, M (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, 1919 West Taylor St, Chicago, IL 60612 USA.
EM msapuntz@uic.edu
FU California Dried Plum Board, Sacramento, CA
CR Amakura Y, 2000, J CHROMATOGR A, V891, P183, DOI 10.1016/S0021-9673(00)00625-7
   Anderson David L, 1994, JOURNAL OF FOOD COMPOSITION AND ANALYSIS, V7, P59, DOI 10.1006/jfca.1994.1006
   Unknown -, 2007, DATABASE FOR THE FLAVONOID CONTENT OF SELECTED FOODS, V0, P0
   Unknown -, 2000, DIETARY REFERENCE INTAKES FOR VITAMIN C, Vitamin E, P0
   Arjmandi BH, 2007, J BONE MINER RES, V22, P0
   Arjmandi BH, 2001, JANA, V4, P50
   Arjmandi BH, 2002, J WOMEN HEALTH GEN-B, V11, P61, DOI 10.1089/152460902753473471
   Attaluri A, 2011, ALIMENT PHARM THER, V33, P822, DOI 10.1111/j.1365-2036.2011.04594.x
   Badary OA, 2006, WORLD J GASTROENTERO, V12, P5363, DOI 10.3748/wjg.v12.i33.5363
   BAUER LL, 2004, CHEM COMPOSITION SEL, V0, P0
   Bennett LE, 2011, CRIT REV FOOD SCI, V51, P38, DOI 10.1080/10408390903044552
   Blatherwick NR, 1914, ARCH INTERN MED, V14, P409
   Blatherwick NR, 1923, J BIOL CHEM, V57, P815
   Boateng J, 2007, FOOD CHEM TOXICOL, V45, P725, DOI 10.1016/j.fct.2006.10.019
   Boato F, 2002, J AGR FOOD CHEM, V50, P6935, DOI 10.1021/jf025832q
   BODEL PT, 1959, J LAB CLIN MED, V54, P881
   Bodet C, 2006, J ANTIMICROB CHEMOTH, V57, P685, DOI 10.1093/jac/dkl031
   Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028
   Bu SY, 2007, OSTEOPOROSIS INT, V18, P931, DOI 10.1007/s00198-007-0335-y
   Bu SY, 2008, CALCIFIED TISSUE INT, V82, P475, DOI 10.1007/s00223-008-9139-0
   Bu SY, 2009, J NUTR BIOCHEM, V20, P35, DOI 10.1016/j.jnutbio.2007.11.012
   Burger O, 2002, CRIT REV FOOD SCI, V42, P279, DOI 10.1080/10408390209351916
   Burt BA, 2006, J AM DENT ASSOC, V137, P190, DOI 10.14219/jada.archive.2006.0144
   CATHCARTRAKE W, 1975, AM J CLIN NUTR, V28, P1110, DOI 10.1093/ajcn/28.10.1110
   Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137
   *CHIN I NUTR FOOD, 2005, 200503024 CHIN I NUT, V0, P0
   *CHIN I NUTR FOOD, 2006, 200503024 CHIN I NUT, V0, P0
   Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001
   CLEMENTS RS, 1980, AM J CLIN NUTR, V33, P1954, DOI 10.1093/ajcn/33.9.1954
   COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803
   Cremin P, 2001, J AGR FOOD CHEM, V49, P1747, DOI 10.1021/jf000764y
   CUMMINGS JH, 1992, GASTROENTEROLOGY, V103, P1783, DOI 10.1016/0016-5085(92)91435-7
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P545
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Del Caro A, 2004, J AGR FOOD CHEM, V52, P4780, DOI 10.1021/jf049889j
   Devirian TA, 2003, CRIT REV FOOD SCI, V43, P219, DOI 10.1080/10408690390826491
   Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b
   Dikeman CL, 2004, J AGR FOOD CHEM, V52, P853, DOI 10.1021/jf034858u
   Dismore ML, 2003, J AM DIET ASSOC, V103, P1650, DOI 10.1016/j.jada.2003.09.028
   Druzic Jasmina, 2007, AGRICULTURAE CONSPECTUS SCIENTIFICUS, V72, P307
   Durand P J, 1991, CAN NURSE, V87, P35
   Edenharder R, 2002, MUTAT RES-GEN TOX EN, V521, P57, DOI 10.1016/S1383-5718(02)00212-7
   Ertekin C, 2006, J FOOD ENG, V75, P508, DOI 10.1016/j.jfoodeng.2005.04.034
   Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farajian P, 2010, EAT BEHAV, V11, P201, DOI 10.1016/j.eatbeh.2010.02.004
   Fatimi A, 2007, SCI ALIMENT, V27, P423, DOI 10.3166/sda.27.423-430
   FDA, 2001, DIETARY REFERENCE INTAKES FOR VITAMIN A, Vitamin K, P0
   FELDMAN JM, 1985, AM J CLIN NUTR, V42, P639, DOI 10.1093/ajcn/42.4.639
   FERRER FP, 1955, AM J DIG DIS, V22, P272
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Franklin M, 2006, BONE, V39, P1331, DOI 10.1016/j.bone.2006.05.024
   Fujii T, 2006, J NUTR SCI VITAMINOL, V52, P389, DOI 10.3177/jnsv.52.389
   Fung DYC, 2009, INT. REV. FOOD SCI. TECHNOL, V1, P80
   FUNG DYC, 2001, EFFECTS DRIED PLUMS, V0, P0
   Furchner-Evanson A, 2010, APPETITE, V54, P564, DOI 10.1016/j.appet.2010.02.015
   Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684
   *GLYC IND TEST INC, 2004, DET GI PRUN PRUN JUI, V0, P0
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Grabitske H, 2009, CRIT REV FOOD SCI, V49, P327, DOI 10.1080/10408390802067126
   Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613
   HAGL S, 2011, MOL NUTR FOOD RES, V54, P1781
   Halloran BP, 2010, J NUTR, V140, P1781, DOI 10.3945/jn.110.124198
   Hönow R, 2002, FOOD CHEM, V78, P511, DOI 10.1016/S0308-8146(02)00212-1
   Hooshmand S, 2014, BR J NUTR, V0, P0
   HOOSHMAND S, 2008, J BONE MINER RES, V23, P0
   Hooshmand S, 2009, AGEING RES REV, V8, P122, DOI 10.1016/j.arr.2009.01.002
   Howarth L, 2010, J AM DIET ASSOC, V110, P1322, DOI 10.1016/j.jada.2010.06.002
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   HUGHES DA, 2004, DIET HUMAN IMMUNE FU, V0, P0
   Hushmendy S, 2009, NUTR RES, V29, P568, DOI 10.1016/j.nutres.2009.08.003
   Institute of Medicine, 1997, PHOSPHORUS, V0, P0
   Institute of Medicine Food and Nutrition Board, 2005, DIET REF INT EN CARB, V0, P0, DOI DOI 10.17226/10490
   Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate Other B Vitamins and Choline, 1998, DIET REF INT THAIM R, V0, P0
   Jiang Y, 2000, PHYTOMEDICINE, V7, P483, DOI 10.1016/S0944-7113(00)80034-3
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Joseph JA, 2004, J ALZHEIMERS DIS, V6, P403
   Kahlon TS, 2007, FOOD CHEM, V100, P1182, DOI 10.1016/j.foodchem.2005.10.066
   KAMKAR L, 2006, J BONE MINER RES, V21, P0
   Kamkar LL, 2005, J BONE MINER RES, V20, P0
   Kaper S, 2010, FASEB J, V24, P0
   Karakaya S, 2001, INT J FOOD SCI NUTR, V52, P501, DOI 10.1080/713671810
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kasim-Karakas SE, 2002, AM J CLIN NUTR, V76, P1422, DOI 10.1093/ajcn/76.6.1422
   Kayano S, 2004, BIOSCI BIOTECH BIOCH, V68, P942, DOI 10.1271/bbb.68.942
   Kayano S, 2003, J AGR FOOD CHEM, V51, P1480, DOI 10.1021/jf025929c
   Kayano S, 2002, J AGR FOOD CHEM, V50, P3708, DOI 10.1021/jf0200164
   KAYANO S, 2003, ITE LETT, V4, P639
   Kayano SI, 2004, BIOFACTORS, V21, P309, DOI 10.1002/biof.552210160
   KEAST DR, 2009, FASEB J, V23, P0
   Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x
   Kikuzaki H, 2004, J AGR FOOD CHEM, V52, P344, DOI 10.1021/jf034954v
   Kimura Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1615, DOI 10.1271/bbb.70823
   KINNEY AB, 1979, NURS RES, V28, P287
   KNUUTTILA M, 1989, BONE MINER, V6, P25, DOI 10.1016/0169-6009(89)90020-2
   Koontz JL, 2005, J AOAC INT, V88, P805
   Kravetz RE, 2002, AM J GASTROENTEROL, V97, P2914
   Kumar Ajay, 2009, FASEB JOURNAL, V23, P0
   Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128
   Lee SH, 2008, COMP IMMUNOL MICROB, V31, P389, DOI 10.1016/j.cimid.2007.06.005
   Levine J, 1997, EUR NEUROPSYCHOPHARM, V7, P147, DOI 10.1016/S0924-977X(97)00409-4
   LIM YF, 2009, FASEB J, V23, P0
   Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014
   Livesey G, 2003, NUTR RES REV, V16, P163, DOI 10.1079/NRR200371
   Livesey G, 2001, BRIT J NUTR, V85, PS7, DOI 10.1079/BJN2000253
   Los Jadwiga, 2000, POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES, V9, P35
   Lucas EA, 2004, JOURNAL OF APPLIED RESEARCH, V4, P37
   Lugasi A, 2003, NAHRUNG, V47, P79, DOI 10.1002/food.200390031
   Lundberg A, 1984, VARDFACKET, V8, P46
   Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019
   Mattila PT, 1996, J NUTR, V126, P1865
   McRorie J, 2000, REGUL TOXICOL PHARM, V31, P59, DOI 10.1006/rtph.1999.1368
   MORGAN TB, 1957, NATURE, V180, P543, DOI 10.1038/180543a0
   Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116
   Mühlbauer RC, 2003, J NUTR, V133, P3592, DOI 10.1093/jn/133.11.3592
   Müller-Lissner SA, 2005, EUR J GASTROEN HEPAT, V17, P109
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   *NDS R, 2008, NUTR TOT REP, V0, P0
   Negishi H, 2007, CLIN EXP PHARMACOL P, V34, PS47, DOI 10.1111/j.1440-1681.2007.04775.x
   Nicklas TA, 2009, J AM COLL NUTR, V28, P73S, DOI 10.1080/07315724.2009.10719807
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Nunes C, 2008, J AGR FOOD CHEM, V56, P5188, DOI 10.1021/jf8006135
   Olsson ME, 2004, J AGR FOOD CHEM, V52, P7264, DOI 10.1021/jf030479p
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067
   PEPPLER E, 1960, J NUTR, V71, P91, DOI 10.1093/jn/71.1.91
   Piga A, 2003, J AGR FOOD CHEM, V51, P3675, DOI 10.1021/jf021207+
   Piirainen L, 2007, NUTR RES, V27, P511, DOI 10.1016/j.nutres.2007.06.008
   Prior RL, 2002, FASEB J, V16, P0
   Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025
   Prior RL, 2007, J AM COLL NUTR, V26, P170, DOI 10.1080/07315724.2007.10719599
   RAYNAL J, 1989, J AGR FOOD CHEM, V37, P1046, DOI 10.1021/jf00088a050
   REELE SB, 1985, INT J CLIN PHARM TH, V23, P403
   RENDINA E, 2009, FASEB J, V23, P563
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Rocha BS, 2009, TOXICOLOGY, V265, P41, DOI 10.1016/j.tox.2009.09.008
   Rop O, 2009, SCI HORTIC-AMSTERDAM, V122, P545, DOI 10.1016/j.scienta.2009.06.036
   Sabarez HT, 2000, J AGR FOOD CHEM, V48, P1838, DOI 10.1021/jf990553x
   Sairanen U, 2007, EUR J CLIN NUTR, V61, P1423, DOI 10.1038/sj.ejcn.1602670
   Salvador MT, 2000, CAN J PHYSIOL PHARM, V78, P359, DOI 10.1139/cjpp-78-5-359
   Sanz ML, 2001, J AGR FOOD CHEM, V49, P5228, DOI 10.1021/jf010580z
   Shahidi F, 2010, PHYTOCHEM REV, V9, P147, DOI 10.1007/s11101-009-9142-8
   Sherry CL, 2010, BRAIN BEHAV IMMUN, V24, P631, DOI 10.1016/j.bbi.2010.01.015
   Shukitt-Hale B, 2009, NUTRITION, V25, P567, DOI 10.1016/j.nut.2008.10.018
   Smith BJ, 2003, J BONE MINER RES, V18, P0
   SOBOTA AE, 1984, J UROLOGY, V131, P1013, DOI 10.1016/S0022-5347(17)50751-X
   Somogyi LP, 2005, PROCESSING FRUITS: SCIENCE AND TECHNOLOGY, V2nd, P513
   Stacewicz-Sapuntzakis M, 2001, CRIT REV FOOD SCI, V41, P251, DOI 10.1080/20014091091814
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   STERN FH, 1966, J AM GERIATR SOC, V14, P1153, DOI 10.1111/j.1532-5415.1966.tb02869.x
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Townsley ED, 2009, FASEB J, V23, P0
   *USDA, 2007, OXYG RAD ABS CAP ORA, V0, P0
   *USDA, 1987, SUG CONT SEL FOODS I, V0, P0
   USDA, 2008, DATABASE FOR THE CHOLINE CONTENT OF COMMON FOODS, V0, P0
   *USDA, 2010, SR 25 PAG REP, V0, P0
   Utsunomiya H, 2002, LIFE SCI, V72, P659, DOI 10.1016/S0024-3205(02)02300-7
   Utsunomiya H, 2005, BIOMED RES-TOKYO, V26, P193, DOI 10.2220/biomedres.26.193
   VANGORSEL H, 1992, J AGR FOOD CHEM, V40, P784, DOI 10.1021/jf00017a016
   VAUGHAN OW, 1960, J NUTR, V71, P10, DOI 10.1093/jn/71.1.10
   Viani R, 1988, COFFEE, V3, P1
   Vinson JA, 2005, J AM COLL NUTR, V24, P44, DOI 10.1080/07315724.2005.10719442
   Vinson JA, 1999, J AGR FOOD CHEM, V47, P2502, DOI 10.1021/jf9902393
   Walkowiak-Tomczak Dorota, 2008, POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES, V58, P401
   Walkowiak-Tomczak Dorota, 2008, BROMATOLOGIA I CHEMIA TOKSYKOLOGICZNA, V41, P562
   Wu HY, 2003, AM J CLIN NUTR, V78, P1085, DOI 10.1093/ajcn/78.6.1085
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Yang YQ, 2005, NUTR CANCER, V53, P117, DOI 10.1207/s15327914nc5301_14
   Yu MH, 2007, INT J FOOD SCI NUTR, V58, P42, DOI 10.1080/09637480601121938
   ZAREMBSKI PM, 1962, BRIT J NUTR, V16, P627, DOI 10.1079/BJN19620061
   Zittermann A, 2001, CURR OPIN CLIN NUTR, V4, P483, DOI 10.1097/00075197-200111000-00003
NR 174
TC 75
Z9 88
U1 0
U2 98
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JAN 1
PY 2013
VL 53
IS 12
BP 1277
EP 1302
DI 10.1080/10408398.2011.563880
PG 26
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 227OW
UT WOS:000325124200003
PM 24090144
DA 2025-04-28
ER

PT J
AU Drewnowski, A
   Rehm, CD
   Constant, F
AF Drewnowski, Adam
   Rehm, Colin D.
   Constant, Florence
TI Water and beverage consumption among children age 4-13y in the United States: analyses of 2005-2010 NHANES data
SO NUTRITION JOURNAL
LA English
DT Article
DE Drinking water; Water consumption; Children; Adequate hydration; Beverages; Dietary surveillance
ID youth physical-activity; dietary energy density; drinking-water; essential nutrient; national-health; body-weight; hydration; nutrition; adolescents; obesity
AB Background: Few studies have examined water consumption patterns among US children. Additionally, recent data on total water consumption as it relates to the Dietary Reference Intakes (DRI) are lacking. This study evaluated the consumption of plain water (tap and bottled) and other beverages among US children by age group, gender, income-to -poverty ratio, and race/ethnicity. Comparisons were made to DRI values for water consumption from all sources. Methods: Data from two non-consecutive 24-hour recalls from 3 cycles of NHANES (2005-2006, 2007-2008 and 2009-2010) were used to assess water and beverage consumption among 4,766 children age 4-13y. Beverages were classified into 9 groups: water (tap and bottled), plain and flavored milk, 100% fruit juice, soda/soft drinks (regular and diet), fruit drinks, sports drinks, coffee, tea, and energy drinks. Total water intakes from plain water, beverages, and food were compared to DRIs for the US. Total water volume per 1,000 kcal was also examined. Results: Water and other beverages contributed 70-75% of dietary water, with 25-30% provided by moisture in foods, depending on age. Plain water, tap and bottled, contributed 25-30% of total dietary water. In general, tap water represented 60% of drinking water volume whereas bottled water represented 40%. Non-Hispanic white children consumed the most tap water, whereas Mexican-American children consumed the most bottled water. Plain water consumption (bottled and tap) tended to be associated with higher incomes. No group of US children came close to satisfying the DRIs for water. At least 75% of children 4-8y, 87% of girls 9-13y, and 85% of boys 9-13y did not meet DRIs for total water intake. Water volume per 1,000 kcal, another criterion of adequate hydration, was 0.85-0.95 L/1,000 kcal, short of the desirable levels of 1.0-1.5 L/1,000 kcal. Conclusions: Water intakes at below-recommended levels may be a cause for concern. Data on water and beverage intake for the population and by socio-demographic group provides useful information to target interventions for increasing water intake among children.
C1 [Drewnowski, Adam] Univ Paris 06, Grp Hosp Pitie Salpetriere, F-75013 Paris, France.
   [Drewnowski, Adam; Rehm, Colin D.] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA.
   [Constant, Florence] Nestle Waters France, F-92130 Issy Les Moulineaux, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; University of Washington; University of Washington Seattle
RP Drewnowski, A (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, 47 Blvd Hop, F-75013 Paris, France.
EM adamdrew@uw.edu
FU Nestle Waters MT
CR Unknown -, 2010, DIETARY GUIDELINES FOR AMERICANS, V0, P0
   Unknown -, 2010, REPORT OF THE DIETARY GUIDELINES ADVISORY COMMITTEE ON THE DIETARY GUIDELINES FOR AMERICANS, V0, P0
   ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265
   Armstrong LE, 2010, P 1 HYDR HLTH SCI M, V45, P45
   Campbell SM, 2007, J AM COLL NUTR, V26, P585S, DOI 10.1080/07315724.2007.10719662
   DAnci KE, 2006, NUTR REV, V64, P457, DOI 10.1301/nr.2006.oct.457-464
   Drewnowski A, 1998, NUTR REV, V56, P347, DOI 10.1111/j.1753-4887.1998.tb01677.x
   EFSA, 2016, EFSA J, V8, P0, DOI 10.2903/j.efsa.2010.1459
   Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465
   [Food and Nutrition Board Institute of Medicine], 2004, DIET REF INT WAT POT, V0, P0
   Fulgoni VL III, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-92
   Grandjean AC, 2003, NUTR REV, V61, P261, DOI 10.1301/nr.2003.aug.261-271
   Jéquier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111
   Kant AK, 2010, AM J CLIN NUTR, V92, P887, DOI 10.3945/ajcn.2010.29708
   Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749
   Kenefick RW, 2012, NUTR REV, V70, PS137, DOI 10.1111/j.1753-4887.2012.00523.x
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Manz F, 2002, J PEDIATR-US, V141, P587, DOI 10.1067/mpd.2002.128031
   Manz F, 2007, J AM COLL NUTR, V26, P562S, DOI 10.1080/07315724.2007.10719659
   Muckelbauer R, 2009, PEDIATRICS, V123, PE661, DOI 10.1542/peds.2008-2186
   OConnor TM, 2006, PEDIATRICS, V118, PE1010, DOI 10.1542/peds.2005-2348
   Oza-Frank R, 2012, J ACAD NUTR DIET, V112, P1390, DOI 10.1016/j.jand.2012.05.011
   Park S, 2012, J ACAD NUTR DIET, V112, P1421, DOI 10.1016/j.jand.2012.04.014
   Park S, 2011, J AM DIET ASSOC, V111, P1211, DOI 10.1016/j.jada.2011.05.006
   Patel AI, 2011, PREV CHRONIC DIS, V8, P0
   Pérez-Escamilla R, 2012, J ACAD NUTR DIET, V112, P671, DOI 10.1016/j.jand.2012.01.020
   Sawka MN, 2005, NUTR REV, V63, PS30, DOI 10.1301/nr.2005.jun.S30-S39
   Stookey JD, 2010, NUTRITION TODAY, V45, PS7, DOI 10.1097/NT.0b013e3181fe15a8
   Stookey JD, 2012, PUBLIC HEALTH NUTR, V15, P2148, DOI 10.1017/S1368980011003648
   Taras HL, 2004, PEDIATRICS, V113, P152
NR 32
TC 93
Z9 108
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD JUN 19
PY 2013
VL 12
IS 
BP 
EP 
DI 10.1186/1475-2891-12-85
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 174JO
UT WOS:000321151700001
PM 23782914
DA 2025-04-28
ER

